[{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"222322612158734337","referenced_tweets":[{"type":"retweeted","id":"222322141503299584"}],"text":"RT @WHO_Europe_VPI: Students &amp; recent grads...have a brilliant idea for vaccine communications? Then this challenge is for you http: ...","id":"222322612158734337","lang":"en","created_at":"2012-07-09T13:33:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":79,"end":90,"tag":"Innovation"},{"start":95,"end":103,"tag":"Science"},{"start":104,"end":108,"tag":"FP7"}],"annotations":[{"start":21,"end":35,"probability":0.6896,"type":"Person","normalized_text":"Máire GEOGHEGAN"},{"start":37,"end":76,"probability":0.3941,"type":"Other","normalized_text":"QUINN European Commissioner for Research"}],"urls":{}},"source":"TweetDeck","conversation_id":"222320769793921025","referenced_tweets":[{"type":"retweeted","id":"222314983940300800"}],"text":"RT @innovationunion: Máire GEOGHEGAN-QUINN European Commissioner for Research, #Innovation and #Science #FP7 Final calls Press... http:/ ...","id":"222320769793921025","lang":"en","created_at":"2012-07-09T13:26:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"annotations":{},"urls":[{"start":107,"end":127,"url":"http://t.co/u60qXXrN","expanded_url":"http://1.usa.gov/MdgL1B","display_url":"1.usa.gov/MdgL1B"}]},"source":"TweetDeck","conversation_id":"222320656447053824","referenced_tweets":[{"type":"retweeted","id":"222310838759985152"}],"text":"RT @FDADeviceInfo: #FDA approves genetic test 2 help colon cancer patients, physicians considering Erbitux http://t.co/u60qXXrN #medical ...","id":"222320656447053824","lang":"en","created_at":"2012-07-09T13:25:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"222320613904228353","referenced_tweets":[{"type":"retweeted","id":"222310624808550400"}],"text":"RT @ECDC_EU: #ESCAIDE 2012: Check all information about the EAN travel grants, supporting transport and accommodation costs http://t.co/ ...","id":"222320613904228353","lang":"en","created_at":"2012-07-09T13:25:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":7,"tag":"Sanofi"},{"start":70,"end":78,"tag":"Mulsevo"},{"start":80,"end":92,"tag":"semuloparin"}],"annotations":{},"urls":[{"start":101,"end":121,"url":"http://t.co/SriIRIaS","expanded_url":"http://bit.ly/NjFCUi","display_url":"bit.ly/NjFCUi"}]},"source":"bitly bitlink","conversation_id":"222320180074790914","referenced_tweets":{},"text":"#Sanofi-aventis withdraws its marketing authorisation application for #Mulsevo (#semuloparin sodium) http://t.co/SriIRIaS","id":"222320180074790914","lang":"en","created_at":"2012-07-09T13:23:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":13,"end":22,"tag":"patients"},{"start":27,"end":38,"tag":"healthcare"}],"annotations":{},"urls":[{"start":102,"end":122,"url":"http://t.co/nVRxKm4v","expanded_url":"http://bit.ly/PzMEqH","display_url":"bit.ly/PzMEqH"}]},"source":"bitly bitlink","conversation_id":"222301601019346946","referenced_tweets":{},"text":"New call for #patients and #healthcare professionals to join our committees. Deadline 1 October 2012: http://t.co/nVRxKm4v","id":"222301601019346946","lang":"en","created_at":"2012-07-09T12:10:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":50,"end":57,"tag":"Cancer"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/SWeCa4cG","expanded_url":"http://dlvr.it/1qZzlQ","display_url":"dlvr.it/1qZzlQ"}]},"source":"TweetDeck","conversation_id":"222284585105489920","referenced_tweets":[{"type":"retweeted","id":"222284469606948864"}],"text":"RT @innovationunion: Developing new therapies for #Cancer, infectious and virus-related diseases http://t.co/SWeCa4cG","id":"222284585105489920","lang":"en","created_at":"2012-07-09T11:02:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":66,"end":79,"tag":"interactions"}],"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/vsCCTqKs","expanded_url":"http://bit.ly/LCw3O0","display_url":"bit.ly/LCw3O0"}]},"source":"Twitter Web Client","conversation_id":"222269434490920960","referenced_tweets":{},"text":"On Friday we published our updated guideline on how to study drug #interactions. Effective from 1 January 2013: http://t.co/vsCCTqKs","id":"222269434490920960","lang":"en","created_at":"2012-07-09T10:02:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":50,"end":60,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":89,"end":109,"url":"http://t.co/mkGUM2ec","expanded_url":"http://bit.ly/NbQ2Wj","display_url":"bit.ly/NbQ2Wj"}]},"source":"Twitter Web Client","conversation_id":"222269146459668483","referenced_tweets":{},"text":"Our updated guideline on developing medicines for #Parkinson's disease is now available: http://t.co/mkGUM2ec","id":"222269146459668483","lang":"en","created_at":"2012-07-09T10:01:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/AmRuPumg","expanded_url":"http://bit.ly/OouD9O","display_url":"bit.ly/OouD9O"}]},"source":"TweetDeck","conversation_id":"222267809273618432","referenced_tweets":[{"type":"retweeted","id":"222267773915631617"}],"text":"RT @IMI_JU: Sign up for IMI’s webinars on the 7th Call clinical effectiveness topic on 20 July and 2 August http://t.co/AmRuPumg","id":"222267809273618432","lang":"en","created_at":"2012-07-09T09:55:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":66,"end":75,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":45,"end":65,"url":"http://t.co/oAL5cUAZ","expanded_url":"http://bit.ly/MFPERz","display_url":"bit.ly/MFPERz"}]},"source":"Twitter for iPhone","conversation_id":"221271849756131330","referenced_tweets":[{"type":"retweeted","id":"221271641047576577"}],"text":"RT @LV_MPA: Upphandlare - vikariat 6 månader http://t.co/oAL5cUAZ #nyttjobb","id":"221271849756131330","lang":"sv","created_at":"2012-07-06T15:58:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":70,"end":79,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":49,"end":69,"url":"http://t.co/YPVR9fGu","expanded_url":"http://bit.ly/RsPcVR","display_url":"bit.ly/RsPcVR"}]},"source":"Twitter for iPhone","conversation_id":"221271830659473409","referenced_tweets":[{"type":"retweeted","id":"221271640212897792"}],"text":"RT @LV_MPA: Ämnesområdesutvecklare farmakoterapi http://t.co/YPVR9fGu #nyttjobb","id":"221271830659473409","lang":"sv","created_at":"2012-07-06T15:58:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":78,"end":91,"tag":"interactions"}],"annotations":{},"urls":[{"start":93,"end":113,"url":"http://t.co/vsCCTqKs","expanded_url":"http://bit.ly/LCw3O0","display_url":"bit.ly/LCw3O0"}]},"source":"bitly bitlink","conversation_id":"221264048271015940","referenced_tweets":{},"text":"We've updated our guideline for pharmaceutical companies on how to study drug #interactions: http://t.co/vsCCTqKs","id":"221264048271015940","lang":"en","created_at":"2012-07-06T15:27:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":58,"end":69,"tag":"Innovation"}],"annotations":{},"urls":[{"start":79,"end":99,"url":"http://t.co/SfnLbiQ2","expanded_url":"http://dlvr.it/1pzDF7","display_url":"dlvr.it/1pzDF7"}]},"source":"TweetDeck","conversation_id":"221259215291949056","referenced_tweets":[{"type":"retweeted","id":"221259095594905600"}],"text":"RT @innovationunion: 8 billion euro call for research and #Innovation projects http://t.co/SfnLbiQ2","id":"221259215291949056","lang":"en","created_at":"2012-07-06T15:08:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":115,"end":135,"url":"http://t.co/9l4cCZ5H","expanded_url":"http://bit.ly/KVC2fb","display_url":"bit.ly/KVC2fb"}]},"source":"Twitter Web Client","conversation_id":"221258192242479104","referenced_tweets":{},"text":"Companies: please use our electronic application forms and submission gateway, especially over the Olympic period: http://t.co/9l4cCZ5H","id":"221258192242479104","lang":"en","created_at":"2012-07-06T15:03:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":48,"end":59,"tag":"Dyskinesia"},{"start":63,"end":73,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":85,"end":105,"url":"http://t.co/39AoWUXH","expanded_url":"http://bit.ly/N7Azmg","display_url":"bit.ly/N7Azmg"}]},"source":"TweetDeck","conversation_id":"221257456620277760","referenced_tweets":[{"type":"retweeted","id":"221257212377563137"}],"text":"RT @euparkinsons: A2A Receptor Antagonism &amp; #Dyskinesia in #Parkinson’s Disease: http://t.co/39AoWUXH","id":"221257456620277760","lang":"ro","created_at":"2012-07-06T15:01:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"221251084381995009","referenced_tweets":[{"type":"retweeted","id":"221250904949669889"}],"text":"RT @euparkinsons: Medications, including over-the-counter, can react with each other. Tell ur doctor about ALL medications u take: http: ...","id":"221251084381995009","lang":"en","created_at":"2012-07-06T14:35:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":51,"end":61,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":107,"end":127,"url":"http://t.co/gFPHHSPg","expanded_url":"http://bit.ly/N7zOcK","display_url":"bit.ly/N7zOcK"}]},"source":"TweetDeck","conversation_id":"221242341468549122","referenced_tweets":[{"type":"retweeted","id":"221242119556308995"}],"text":"RT @euparkinsons: Early diagnosis &amp; therapy of #Parkinson’s disease: can disease progression b curbed? http://t.co/gFPHHSPg","id":"221242341468549122","lang":"en","created_at":"2012-07-06T14:00:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":56,"end":66,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":78,"end":98,"url":"http://t.co/mkGUM2ec","expanded_url":"http://bit.ly/NbQ2Wj","display_url":"bit.ly/NbQ2Wj"}]},"source":"bitly bitlink","conversation_id":"221240126368526336","referenced_tweets":{},"text":"We've updated our guideline on developing medicines for #Parkinson's disease: http://t.co/mkGUM2ec","id":"221240126368526336","lang":"en","created_at":"2012-07-06T13:52:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"hashtags":[{"start":12,"end":24,"tag":"Agriculture"},{"start":82,"end":91,"tag":"honeybee"}],"annotations":{},"urls":[{"start":107,"end":127,"url":"http://t.co/w3gBipUU","expanded_url":"http://owl.li/c3Bwl","display_url":"owl.li/c3Bwl"}]},"source":"TweetDeck","conversation_id":"221236532902768641","referenced_tweets":[{"type":"retweeted","id":"221235916327497729"}],"text":"RT @EURLex: #Agriculture: financial support for voluntary surveillance studies on #honeybee colony losses: http://t.co/w3gBipUU","id":"221236532902768641","lang":"en","created_at":"2012-07-06T13:37:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/rVcN4iGG","expanded_url":"http://bit.ly/L8Cp8f","display_url":"bit.ly/L8Cp8f"}]},"source":"TweetDeck","conversation_id":"221234290283909121","referenced_tweets":[{"type":"retweeted","id":"221223713226489856"}],"text":"RT @ECDC_EU: #ESCAIDE call for abstracts closes on 13  July - remember to submit your abstract!  http://t.co/rVcN4iGG","id":"221234290283909121","lang":"en","created_at":"2012-07-06T13:28:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":40,"end":49,"tag":"Croatian"},{"start":57,"end":65,"tag":"Croatia"}],"annotations":[{"start":76,"end":77,"probability":0.4757,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":120,"end":140,"url":"http://t.co/EsPFGMsc","expanded_url":"http://bit.ly/LzoAPF","display_url":"bit.ly/LzoAPF"}]},"source":"Twitter Web Client","conversation_id":"221185352491208704","referenced_tweets":{},"text":"We need to check product information in #Croatian before #Croatia joins the EU. Companies: send translations to us now: http://t.co/EsPFGMsc","id":"221185352491208704","lang":"en","created_at":"2012-07-06T10:14:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/9l4cCZ5H","expanded_url":"http://bit.ly/KVC2fb","display_url":"bit.ly/KVC2fb"}]},"source":"Twitter Web Client","conversation_id":"221184969538670592","referenced_tweets":{},"text":"We have electronic application forms and a submission gateway for companies to use - useful over the Olympic period : http://t.co/9l4cCZ5H","id":"221184969538670592","lang":"en","created_at":"2012-07-06T10:13:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":80,"end":85,"tag":"ECDC"},{"start":120,"end":129,"tag":"westnile"}],"annotations":{},"urls":[{"start":99,"end":119,"url":"http://t.co/VhqLw20S","expanded_url":"http://bit.ly/LIn3v2","display_url":"bit.ly/LIn3v2"}]},"source":"TweetDeck","conversation_id":"221163159682162689","referenced_tweets":[{"type":"retweeted","id":"221163120708698112"}],"text":"RT @ECDC_EU: West Nile fever: no reported human cases so far in 2012. Check out #ECDC weekly maps: http://t.co/VhqLw20S #westnile","id":"221163159682162689","lang":"en","created_at":"2012-07-06T08:46:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":23,"end":31,"tag":"Croatia"},{"start":72,"end":81,"tag":"Croatian"}],"annotations":[{"start":42,"end":43,"probability":0.6607,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":120,"end":140,"url":"http://t.co/EsPFGMsc","expanded_url":"http://bit.ly/LzoAPF","display_url":"bit.ly/LzoAPF"}]},"source":"Twitter Web Client","conversation_id":"220897084889501696","referenced_tweets":{},"text":"Less than a year until #Croatia joins the EU. Companies need to send us #Croatian product information now for checking: http://t.co/EsPFGMsc","id":"220897084889501696","lang":"en","created_at":"2012-07-05T15:09:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":115,"end":135,"url":"http://t.co/fYOLdJo0","expanded_url":"http://bit.ly/Pdprvm","display_url":"bit.ly/Pdprvm"}]},"source":"Twitter Web Client","conversation_id":"220896712649220097","referenced_tweets":{},"text":"Companies need to let us know about new marketing authorisations since 2 July for human medicines (Article 57(2)): http://t.co/fYOLdJo0","id":"220896712649220097","lang":"en","created_at":"2012-07-05T15:07:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":52,"end":67,"tag":"antibacterials"}],"annotations":{},"urls":[{"start":110,"end":130,"url":"http://t.co/v53NGdp0","expanded_url":"http://bit.ly/Ln6UeG","display_url":"bit.ly/Ln6UeG"}]},"source":"Twitter Web Client","conversation_id":"220896052226686976","referenced_tweets":{},"text":"Send us your comments on our guidance on developing #antibacterials. Consultation open until 31 January 2013: http://t.co/v53NGdp0","id":"220896052226686976","lang":"en","created_at":"2012-07-05T15:04:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/9l4cCZ5H","expanded_url":"http://bit.ly/KVC2fb","display_url":"bit.ly/KVC2fb"}]},"source":"bitly bitlink","conversation_id":"220875872276725760","referenced_tweets":{},"text":"Pharmaceutical companies: don't forget that we have electronic application tools for you to use: http://t.co/9l4cCZ5H","id":"220875872276725760","lang":"en","created_at":"2012-07-05T13:44:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":78,"end":87,"tag":"Croatian"}],"annotations":{},"urls":[{"start":102,"end":122,"url":"http://t.co/EsPFGMsc","expanded_url":"http://bit.ly/LzoAPF","display_url":"bit.ly/LzoAPF"}]},"source":"bitly bitlink","conversation_id":"220833409306603520","referenced_tweets":{},"text":"Pharmaceutical companies: don't forget to send us your product information in #Croatian for checking: http://t.co/EsPFGMsc","id":"220833409306603520","lang":"en","created_at":"2012-07-05T10:56:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/fYOLdJo0","expanded_url":"http://bit.ly/Pdprvm","display_url":"bit.ly/Pdprvm"}]},"source":"Twitter Web Client","conversation_id":"220820798368268288","referenced_tweets":{},"text":"Next steps for Article 57(2) implementation: info for companies on new or varied marketing authorisations since 2 July: http://t.co/fYOLdJo0","id":"220820798368268288","lang":"en","created_at":"2012-07-05T10:05:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":34,"end":49,"tag":"antibacterials"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/v53NGdp0","expanded_url":"http://bit.ly/Ln6UeG","display_url":"bit.ly/Ln6UeG"}]},"source":"Twitter Web Client","conversation_id":"220820235140341760","referenced_tweets":{},"text":"Additional guidance on developing #antibacterials open for comments. It includes information on specific indications: http://t.co/v53NGdp0","id":"220820235140341760","lang":"en","created_at":"2012-07-05T10:03:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":48,"end":57,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":27,"end":47,"url":"http://t.co/PhAVJvi7","expanded_url":"http://bit.ly/O8mhmn","display_url":"bit.ly/O8mhmn"}]},"source":"TweetDeck","conversation_id":"220815321970388992","referenced_tweets":[{"type":"retweeted","id":"220815298524233728"}],"text":"RT @LV_MPA: Biostatistiker http://t.co/PhAVJvi7 #nyttjobb","id":"220815321970388992","lang":"de","created_at":"2012-07-05T09:44:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/fYOLdJo0","expanded_url":"http://bit.ly/Pdprvm","display_url":"bit.ly/Pdprvm"}]},"source":"bitly bitlink","conversation_id":"220544657539604481","referenced_tweets":{},"text":"Pharmaceutical companies: information now available on maintenance of electronic info on medicines (Article 57(2)): http://t.co/fYOLdJo0","id":"220544657539604481","lang":"en","created_at":"2012-07-04T15:48:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":48,"end":56,"tag":"Velcade"}],"annotations":{},"urls":[{"start":76,"end":96,"url":"http://t.co/d88aSboU","expanded_url":"http://bit.ly/P2JMlU","display_url":"bit.ly/P2JMlU"}]},"source":"Twitter Web Client","conversation_id":"220541562231328769","referenced_tweets":{},"text":"The application for extension of indication for #Velcade has been withdrawn http://t.co/d88aSboU","id":"220541562231328769","lang":"en","created_at":"2012-07-04T15:36:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":54,"end":69,"tag":"antibacterials"}],"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/v53NGdp0","expanded_url":"http://bit.ly/Ln6UeG","display_url":"bit.ly/Ln6UeG"}]},"source":"bitly bitlink","conversation_id":"220527773847007232","referenced_tweets":{},"text":"We've just released additional guidance on developing #antibacterials. Open for comments until 31 January 2013: http://t.co/v53NGdp0","id":"220527773847007232","lang":"en","created_at":"2012-07-04T14:41:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":58,"end":67,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":37,"end":57,"url":"http://t.co/4REGqGor","expanded_url":"http://bit.ly/RbPoZt","display_url":"bit.ly/RbPoZt"}]},"source":"TweetDeck","conversation_id":"220525753081659393","referenced_tweets":[{"type":"retweeted","id":"220524297616236544"}],"text":"RT @LV_MPA: Regulatorisk handläggare http://t.co/4REGqGor #nyttjobb","id":"220525753081659393","lang":"sv","created_at":"2012-07-04T14:33:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":16,"end":22,"probability":0.5926,"type":"Organization","normalized_text":"Velcade"}],"urls":[{"start":44,"end":64,"url":"http://t.co/d88aSboU","expanded_url":"http://bit.ly/P2JMlU","display_url":"bit.ly/P2JMlU"}]},"source":"Twitter Web Client","conversation_id":"220471923711279105","referenced_tweets":{},"text":"Application for Velcade extension withdrawn http://t.co/d88aSboU","id":"220471923711279105","lang":"en","created_at":"2012-07-04T10:59:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":23,"end":35,"tag":"legislation"}],"annotations":{},"urls":[{"start":85,"end":105,"url":"http://t.co/2kJaMuqI","expanded_url":"http://bit.ly/LKJQod","display_url":"bit.ly/LKJQod"}]},"source":"Twitter Web Client","conversation_id":"220180656355934209","referenced_tweets":{},"text":"New #pharmacovigilance #legislation increases the efficiency of medicines regulation http://t.co/2kJaMuqI","id":"220180656355934209","lang":"en","created_at":"2012-07-03T15:42:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":0,"end":12,"probability":0.6465,"type":"Person","normalized_text":"Janssen-Cilag"},{"start":44,"end":50,"probability":0.6225,"type":"Organization","normalized_text":"Velcade"}],"urls":[{"start":62,"end":82,"url":"http://t.co/d88aSboU","expanded_url":"http://bit.ly/P2JMlU","display_url":"bit.ly/P2JMlU"}]},"source":"bitly bitlink","conversation_id":"220180233041616898","referenced_tweets":{},"text":"Janssen-Cilag withdraws its application for Velcade extention http://t.co/d88aSboU","id":"220180233041616898","lang":"en","created_at":"2012-07-03T15:40:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":18,"end":27,"tag":"renewals"}],"annotations":{},"urls":[{"start":63,"end":83,"url":"http://t.co/SreuvNPe","expanded_url":"http://bit.ly/OcXeCc","display_url":"bit.ly/OcXeCc"}]},"source":"Twitter Web Client","conversation_id":"220155496219414528","referenced_tweets":{},"text":"We've updated our #renewals guideline. Effective as of 2 July: http://t.co/SreuvNPe","id":"220155496219414528","lang":"en","created_at":"2012-07-03T14:02:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":50,"end":59,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":29,"end":49,"url":"http://t.co/PbuWc7PH","expanded_url":"http://bit.ly/Ohr0G3","display_url":"bit.ly/Ohr0G3"}]},"source":"TweetDeck","conversation_id":"220104913491992576","referenced_tweets":[{"type":"retweeted","id":"220104863164538880"}],"text":"RT @LV_MPA: Klinisk utredare http://t.co/PbuWc7PH #nyttjobb","id":"220104913491992576","lang":"no","created_at":"2012-07-03T10:41:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":30,"end":39,"tag":"renewals"},{"start":88,"end":106,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/SreuvNPe","expanded_url":"http://bit.ly/OcXeCc","display_url":"bit.ly/OcXeCc"}]},"source":"Twitter Web Client","conversation_id":"220103459024801792","referenced_tweets":{},"text":"We've updated our guidance on #renewals of marketing authorisation in line with the new #pharmacovigilance legislation: http://t.co/SreuvNPe","id":"220103459024801792","lang":"en","created_at":"2012-07-03T10:35:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":75,"end":91,"tag":"PilloledalMondo"}],"annotations":{},"urls":[{"start":95,"end":115,"url":"http://t.co/WHyZhG6a","expanded_url":"http://fb.me/2pEtrjZ0P","display_url":"fb.me/2pEtrjZ0P"}]},"source":"TweetDeck","conversation_id":"220103254321803264","referenced_tweets":[{"type":"retweeted","id":"220103215574818817"}],"text":"RT @Aifa_ufficiale: La nuova legislazione di farmacovigilanza: cosa cambia #PilloledalMondo... http://t.co/WHyZhG6a","id":"220103254321803264","lang":"it","created_at":"2012-07-03T10:34:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":56,"end":68,"probability":0.6747,"type":"Person","normalized_text":"Enrica Alteri"}],"urls":[{"start":94,"end":114,"url":"http://t.co/2p2pbf6W","expanded_url":"http://bit.ly/LRpZFN","display_url":"bit.ly/LRpZFN"}]},"source":"Twitter Web Client","conversation_id":"220103162281988096","referenced_tweets":{},"text":"We have a new Head of Safety and Efficacy of Medicines, Enrica Alteri. She started yesterday: http://t.co/2p2pbf6W","id":"220103162281988096","lang":"en","created_at":"2012-07-03T10:34:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"}],"annotations":{},"urls":[{"start":110,"end":130,"url":"http://t.co/rVcN4iGG","expanded_url":"http://bit.ly/L8Cp8f","display_url":"bit.ly/L8Cp8f"}]},"source":"TweetDeck","conversation_id":"220102671611346944","referenced_tweets":[{"type":"retweeted","id":"220094231606345729"}],"text":"RT @ECDC_EU: #ESCAIDE 2012: don't forget to submit your abstract for the conference. Deadline: Friday 13 July http://t.co/rVcN4iGG","id":"220102671611346944","lang":"en","created_at":"2012-07-03T10:32:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"},{"start":57,"end":69,"tag":"legislation"}],"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/2kJaMuqI","expanded_url":"http://bit.ly/LKJQod","display_url":"bit.ly/LKJQod"}]},"source":"Twitter Web Client","conversation_id":"220099851432624128","referenced_tweets":{},"text":"New tools for regulators with the new #pharmacovigilance #legislation http://t.co/2kJaMuqI","id":"220099851432624128","lang":"en","created_at":"2012-07-03T10:21:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"hashtags":[{"start":29,"end":33,"tag":"WDD"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"220076085885403136","referenced_tweets":[{"type":"retweeted","id":"220076042289807361"}],"text":"RT @WDD: Did u know that the #WDD Newsletter is translated in Deutsch,Español,Français,Português? Subscribe now 2 stay informed! http:// ...","id":"220076085885403136","lang":"da","created_at":"2012-07-03T08:46:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":{},"annotations":[{"start":16,"end":31,"probability":0.9064,"type":"Person","normalized_text":"Dr Margaret Chan"}],"urls":[{"start":93,"end":113,"url":"http://t.co/Fogn64dl","expanded_url":"http://bit.ly/NgRIvM","display_url":"bit.ly/NgRIvM"}]},"source":"TweetDeck","conversation_id":"220071729349935104","referenced_tweets":[{"type":"retweeted","id":"220071667009986561"}],"text":"RT @WHO_Europe: Dr Margaret Chan, WHO Director-General, began her second term on 1 July 2012 http://t.co/Fogn64dl","id":"220071729349935104","lang":"en","created_at":"2012-07-03T08:29:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":19,"tag":"EFSA"},{"start":104,"end":109,"tag":"risk"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"220071373467418624","referenced_tweets":[{"type":"retweeted","id":"220071328173146112"}],"text":"RT @agesnews: #EFSA holds Scientific conference on November 7th and 8th 2012 \"Challenging boundaries in #risk assessment\" http://t.co/55 ...","id":"220071373467418624","lang":"en","created_at":"2012-07-03T08:27:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":19,"tag":"EFSA"},{"start":86,"end":102,"tag":"Risikobewertung"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"220069851136405504","referenced_tweets":[{"type":"retweeted","id":"220069665806884864"}],"text":"RT @agesnews: #EFSA -Konferenz am 7.11. und 8.11.2012 mit dem Ziel, wissenschaftliche #Risikobewertung weiterzuentwickeln http://t.co/rS ...","id":"220069851136405504","lang":"de","created_at":"2012-07-03T08:21:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":88,"end":108,"url":"http://t.co/qbx890ii","expanded_url":"http://fb.me/1SjA15RsX","display_url":"fb.me/1SjA15RsX"}]},"source":"TweetDeck","conversation_id":"219827628457205761","referenced_tweets":[{"type":"retweeted","id":"219827593023733761"}],"text":"RT @cancereu: Registration for ECPC's Annual General Meeting is now open. Register now! http://t.co/qbx890ii","id":"219827628457205761","lang":"en","created_at":"2012-07-02T16:19:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":16,"end":25,"tag":"renewals"}],"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/SreuvNPe","expanded_url":"http://bit.ly/OcXeCc","display_url":"bit.ly/OcXeCc"}]},"source":"bitly bitlink","conversation_id":"219817029849460736","referenced_tweets":{},"text":"New guidance on #renewals of marketing authorisation comes into force today: http://t.co/SreuvNPe","id":"219817029849460736","lang":"en","created_at":"2012-07-02T15:37:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":94,"end":101,"tag":"Cancer"}],"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/zy0AmDSj","expanded_url":"http://dlvr.it/1nyz6P","display_url":"dlvr.it/1nyz6P"}]},"source":"TweetDeck","conversation_id":"219811145618427905","referenced_tweets":[{"type":"retweeted","id":"219810799596740608"}],"text":"RT @innovationunion: Researchers make progress on early detection of resistance to colorectal #Cancer drugs http://t.co/zy0AmDSj","id":"219811145618427905","lang":"en","created_at":"2012-07-02T15:13:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":101,"end":118,"tag":"farmacovigilanza"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"219777112968663040","referenced_tweets":[{"type":"retweeted","id":"219776536746799106"}],"text":"RT @Aifa_ufficiale: Focus AIFA sulla nuova legislazione di farmacovigilanza che entra in vigore oggi #farmacovigilanza... http://t.co/Fc ...","id":"219777112968663040","lang":"it","created_at":"2012-07-02T12:58:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":23,"end":35,"tag":"legislation"}],"annotations":{},"urls":[{"start":63,"end":83,"url":"http://t.co/2kJaMuqI","expanded_url":"http://bit.ly/LKJQod","display_url":"bit.ly/LKJQod"}]},"source":"bitly bitlink","conversation_id":"219767014300975104","referenced_tweets":{},"text":"New #pharmacovigilance #legislation comes into operation today http://t.co/2kJaMuqI","id":"219767014300975104","lang":"en","created_at":"2012-07-02T12:18:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":50,"end":62,"probability":0.5809,"type":"Person","normalized_text":"Enrica Alteri"}],"urls":[{"start":80,"end":100,"url":"http://t.co/2p2pbf6W","expanded_url":"http://bit.ly/LRpZFN","display_url":"bit.ly/LRpZFN"}]},"source":"Twitter Web Client","conversation_id":"219762624458530816","referenced_tweets":{},"text":"Our new Head of Safety and Efficacy of Medicines, Enrica Alteri, started today: http://t.co/2p2pbf6W","id":"219762624458530816","lang":"en","created_at":"2012-07-02T12:01:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":22,"end":30,"username":"EIP_AHA","id":"416925949"},{"start":35,"end":47,"username":"agescotland","id":"94297570"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"219758897307725824","referenced_tweets":[{"type":"retweeted","id":"219758821013327872"}],"text":"RT @EU_Commission: RT @EIP_AHA: RT @agescotland: The World Congress on Active Ageing fast approaches! Read on for an overview: http://t. ...","id":"219758897307725824","lang":"en","created_at":"2012-07-02T11:46:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":25,"end":38,"tag":"tuberculosis"},{"start":137,"end":140,"tag":"TB"}],"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/lc1FyHhT","expanded_url":"http://bit.ly/N6dhky","display_url":"bit.ly/N6dhky"}]},"source":"TweetDeck","conversation_id":"219750925378666496","referenced_tweets":[{"type":"retweeted","id":"219741037772550144"}],"text":"RT @WHO_Europe: Tackling #tuberculosis means looking beyond the disease: experts meet to address its broader causes http://t.co/lc1FyHhT #TB","id":"219750925378666496","lang":"en","created_at":"2012-07-02T11:14:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":11,"end":23,"probability":0.6824,"type":"Person","normalized_text":"Enrica Alteri"}],"urls":[{"start":82,"end":102,"url":"http://t.co/2p2pbf6W","expanded_url":"http://bit.ly/LRpZFN","display_url":"bit.ly/LRpZFN"}]},"source":"bitly bitlink","conversation_id":"219738406027137024","referenced_tweets":{},"text":"We welcome Enrica Alteri, our new Head of Safety and Efficacy of Medicines today: http://t.co/2p2pbf6W","id":"219738406027137024","lang":"en","created_at":"2012-07-02T10:24:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"Olympic"}],"annotations":[{"start":84,"end":89,"probability":0.996,"type":"Place","normalized_text":"London"}],"urls":[{"start":92,"end":112,"url":"http://t.co/ShgPrcZn","expanded_url":"http://bit.ly/MuWsAO","display_url":"bit.ly/MuWsAO"}]},"source":"Twitter Web Client","conversation_id":"219732683494932480","referenced_tweets":{},"text":"Companies: we recommend you use electronic submission during the #Olympic period in London: http://t.co/ShgPrcZn","id":"219732683494932480","lang":"en","created_at":"2012-07-02T10:02:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":25,"end":34,"tag":"diabetes"},{"start":82,"end":97,"tag":"cardiovascular"}],"annotations":{},"urls":[{"start":106,"end":126,"url":"http://t.co/AjIPQ1uN","expanded_url":"http://bit.ly/KQBE6l","display_url":"bit.ly/KQBE6l"}]},"source":"Twitter Web Client","conversation_id":"219732470420082688","referenced_tweets":{},"text":"Our updated guideline on #diabetes medicines is out. It includes a new section on #cardiovascular safety: http://t.co/AjIPQ1uN","id":"219732470420082688","lang":"en","created_at":"2012-07-02T10:01:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":{},"annotations":[{"start":31,"end":37,"probability":0.5128,"type":"Product","normalized_text":"YouTube"}],"urls":[{"start":79,"end":99,"url":"http://t.co/t7ambav2","expanded_url":"http://www.youtube.com/IAPOPatientVoice","display_url":"youtube.com/IAPOPatientVoi…"}]},"source":"TweetDeck","conversation_id":"219728480202522624","referenced_tweets":[{"type":"retweeted","id":"219699139871641600"}],"text":"RT @IAPOtweets: IAPO is now on YouTube. Find videos of IAPO and its members at http://t.co/t7ambav2","id":"219728480202522624","lang":"en","created_at":"2012-07-02T09:45:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":94,"end":102,"tag":"Olympic"}],"annotations":[{"start":112,"end":117,"probability":0.9954,"type":"Place","normalized_text":"London"}],"urls":[{"start":120,"end":140,"url":"http://t.co/ShgPrcZn","expanded_url":"http://bit.ly/MuWsAO","display_url":"bit.ly/MuWsAO"}]},"source":"Twitter for iPhone","conversation_id":"218737802014228481","referenced_tweets":{},"text":"Reminder to pharmaceutical companies: some of our meetings are off-site before and during the #Olympic Games in London: http://t.co/ShgPrcZn","id":"218737802014228481","lang":"en","created_at":"2012-06-29T16:08:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":40,"end":49,"tag":"diabetes"},{"start":88,"end":103,"tag":"cardiovascular"}],"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/AjIPQ1uN","expanded_url":"http://bit.ly/KQBE6l","display_url":"bit.ly/KQBE6l"}]},"source":"Twitter for iPhone","conversation_id":"218737494567563264","referenced_tweets":{},"text":"We've published an updated guideline on #diabetes medicines, including a new section on #cardiovascular safety: http://t.co/AjIPQ1uN","id":"218737494567563264","lang":"en","created_at":"2012-06-29T16:07:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":72,"end":84,"username":"ICT4Society","id":"965219726334021632"},{"start":85,"end":93,"username":"EIP_AHA","id":"416925949"},{"start":115,"end":131,"username":"DigitalAgendaEU","id":"2894539229"}],"hashtags":{},"annotations":{},"urls":[{"start":94,"end":114,"url":"http://t.co/4gA7ZEvv","expanded_url":"http://dlvr.it/1nK9pZ","display_url":"dlvr.it/1nK9pZ"}]},"source":"TweetDeck","conversation_id":"218730045609488384","referenced_tweets":[{"type":"retweeted","id":"218721560469581825"}],"text":"RT @EU_eHealth: ICT is new weapon in the war on drug-resistant diseases @ICT4Society @EIP_AHA http://t.co/4gA7ZEvv @DigitalAgendaEU","id":"218730045609488384","lang":"en","created_at":"2012-06-29T15:38:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"},{"start":77,"end":89,"username":"DiabetesVic","id":"291459247"}],"hashtags":[{"start":48,"end":56,"tag":"WDC2013"}],"annotations":[{"start":57,"end":68,"probability":0.9968,"type":"Person","normalized_text":"Lewis Kaplan"}],"urls":{}},"source":"TweetDeck","conversation_id":"218729889925312512","referenced_tweets":[{"type":"retweeted","id":"218698364198465537"}],"text":"RT @IntDiabetesFed: Have you saved the date for #WDC2013?Lewis Kaplan,CEO of @DiabetesVic talks us through the preparations &amp; expect ...","id":"218729889925312512","lang":"en","created_at":"2012-06-29T15:37:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"urls":[{"start":71,"end":91,"url":"http://t.co/XskJekMk","expanded_url":"http://www.aemps.gob.es","display_url":"aemps.gob.es"}]},"source":"TweetDeck","conversation_id":"218729837869797378","referenced_tweets":[{"type":"retweeted","id":"218694575387185155"}],"text":"RT @AEMPSGOB: Estrategia frente a Medicamentos Falsificados 2012- 2015 http://t.co/XskJekMk","id":"218729837869797378","lang":"pt","created_at":"2012-06-29T15:37:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":{},"annotations":[{"start":13,"end":25,"probability":0.8325,"type":"Organization","normalized_text":"EU Commission"}],"urls":{}},"source":"TweetDeck","conversation_id":"218689947958378501","referenced_tweets":[{"type":"retweeted","id":"218685998064873472"}],"text":"RT @EPHA_EU: EU Commission launches prize to stimulate quality journalism that raises awareness of healthcare and patients’ rights:http: ...","id":"218689947958378501","lang":"en","created_at":"2012-06-29T12:58:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":82,"end":102,"url":"http://t.co/AS9n5hlL","expanded_url":"http://bit.ly/OIdSfq","display_url":"bit.ly/OIdSfq"}]},"source":"TweetDeck","conversation_id":"218678319531573248","referenced_tweets":[{"type":"retweeted","id":"218678173104218112"}],"text":"RT @LV_MPA: Märkning av läkemedelsförpackningar för minskad risk för förväxlingar http://t.co/AS9n5hlL","id":"218678319531573248","lang":"sv","created_at":"2012-06-29T12:12:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":55,"end":75,"url":"http://t.co/bqhawJNu","expanded_url":"http://bit.ly/NJA5nj","display_url":"bit.ly/NJA5nj"}]},"source":"TweetDeck","conversation_id":"218670210209689600","referenced_tweets":[{"type":"retweeted","id":"218670075660607488"}],"text":"RT @LV_MPA: Säkrare vård med bättre läkemedelssäkerhet http://t.co/bqhawJNu","id":"218670210209689600","lang":"sv","created_at":"2012-06-29T11:40:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":79,"end":87,"tag":"Olympic"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/ShgPrcZn","expanded_url":"http://bit.ly/MuWsAO","display_url":"bit.ly/MuWsAO"}]},"source":"bitly bitlink","conversation_id":"218663760708124672","referenced_tweets":{},"text":"Reminder to pharmaceutical companies: our activities are being affected by the #Olympic Games in July and August: http://t.co/ShgPrcZn","id":"218663760708124672","lang":"en","created_at":"2012-06-29T11:14:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":16,"end":24,"username":"kncvtbc","id":"222452977"},{"start":29,"end":37,"username":"TBVI_EU","id":"115401097"},{"start":120,"end":136,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":66,"end":79,"tag":"tuberculosis"},{"start":86,"end":97,"tag":"travellers"}],"annotations":{},"urls":[{"start":99,"end":119,"url":"http://t.co/c5KVloQj","expanded_url":"http://bit.ly/N1bawu","display_url":"bit.ly/N1bawu"}]},"source":"TweetDeck","conversation_id":"218659225784680448","referenced_tweets":[{"type":"retweeted","id":"218659107169767424"}],"text":"RT @ECDC_EU: RT @kncvtbc: MT @TBVI_EU: Significant increase cases #tuberculosis among #travellers: http://t.co/c5KVloQj @Eurosurveillanc","id":"218659225784680448","lang":"en","created_at":"2012-06-29T10:56:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":31,"end":40,"tag":"diabetes"},{"start":79,"end":94,"tag":"cardiovascular"}],"annotations":{},"urls":[{"start":103,"end":123,"url":"http://t.co/AjIPQ1uN","expanded_url":"http://bit.ly/KQBE6l","display_url":"bit.ly/KQBE6l"}]},"source":"bitly bitlink","conversation_id":"218652964980666371","referenced_tweets":{},"text":"We've updated our guideline on #diabetes medicines, including a new section on #cardiovascular safety: http://t.co/AjIPQ1uN","id":"218652964980666371","lang":"en","created_at":"2012-06-29T10:31:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EIP_AHA","id":"416925949"},{"start":100,"end":111,"username":"Innobasque","id":"16235927"},{"start":112,"end":128,"username":"WorldCafeEurope","id":"51714677"}],"hashtags":[{"start":88,"end":99,"tag":"evaabilbao"}],"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/46XI0lD4","expanded_url":"http://bit.ly/LkEeye","display_url":"bit.ly/LkEeye"}]},"source":"TweetDeck","conversation_id":"218628446291640320","referenced_tweets":[{"type":"retweeted","id":"218628406286364673"}],"text":"RT @EIP_AHA: Video: European Voices For Active Ageing Bilbao 2012: http://t.co/46XI0lD4 #evaabilbao @Innobasque @WorldCafeEurope","id":"218628446291640320","lang":"en","created_at":"2012-06-29T08:54:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":102,"end":111,"tag":"westnile"}],"annotations":[{"start":13,"end":21,"probability":0.4136,"type":"Place","normalized_text":"West Nile"}],"urls":[{"start":81,"end":101,"url":"http://t.co/VhqLw20S","expanded_url":"http://bit.ly/LIn3v2","display_url":"bit.ly/LIn3v2"}]},"source":"TweetDeck","conversation_id":"218624248380530688","referenced_tweets":[{"type":"retweeted","id":"218624212896722944"}],"text":"RT @ECDC_EU: West Nile fever weekly maps: No reported human cases so far in 2012 http://t.co/VhqLw20S #westnile","id":"218624248380530688","lang":"en","created_at":"2012-06-29T08:37:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":41,"end":49,"tag":"Egrifta"},{"start":51,"end":63,"tag":"tesamorelin"},{"start":68,"end":72,"tag":"HIV"}],"annotations":[{"start":0,"end":5,"probability":0.9321,"type":"Person","normalized_text":"Ferrer"}],"urls":[{"start":83,"end":103,"url":"http://t.co/JoTPKr1B","expanded_url":"http://bit.ly/NBgTIc","display_url":"bit.ly/NBgTIc"}]},"source":"Twitter Web Client","conversation_id":"218321255114350594","referenced_tweets":{},"text":"Ferrer has withdrawn its application for #Egrifta (#tesamorelin) in #HIV patients  http://t.co/JoTPKr1B","id":"218321255114350594","lang":"en","created_at":"2012-06-28T12:33:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":[{"start":43,"end":56,"probability":0.359,"type":"Organization","normalized_text":"IMI Newsletter"}],"urls":{}},"source":"TweetDeck","conversation_id":"218314847450963968","referenced_tweets":[{"type":"retweeted","id":"218305102623150081"}],"text":"RT @IMI_JU: Read the latest edition of the IMI Newsletter, featuring current and future Calls, news from the projects, and more… http:// ...","id":"218314847450963968","lang":"en","created_at":"2012-06-28T12:08:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":25,"end":43,"tag":"pharmacovigilance"},{"start":55,"end":59,"tag":"GVP"}],"annotations":{},"urls":[{"start":106,"end":126,"url":"http://t.co/yTJxh7Ts","expanded_url":"http://bit.ly/MA6WOq","display_url":"bit.ly/MA6WOq"}]},"source":"Twitter for iPhone","conversation_id":"218311622618394624","referenced_tweets":{},"text":"Two more modules on good #pharmacovigilance practices (#GVP) out for public consultation until 24 August: http://t.co/yTJxh7Ts","id":"218311622618394624","lang":"en","created_at":"2012-06-28T11:55:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":47,"end":65,"tag":"pharmacovigilance"},{"start":76,"end":80,"tag":"GVP"}],"annotations":{},"urls":[{"start":107,"end":127,"url":"http://t.co/yTJxh7Ts","expanded_url":"http://bit.ly/MA6WOq","display_url":"bit.ly/MA6WOq"}]},"source":"Twitter for iPhone","conversation_id":"218284696780554240","referenced_tweets":{},"text":"Yesterday we released two more modules on good #pharmacovigilance practice (#GVP) for public consultation: http://t.co/yTJxh7Ts","id":"218284696780554240","lang":"en","created_at":"2012-06-28T10:08:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"Cedefop","id":"118697276"}],"hashtags":[{"start":64,"end":73,"tag":"cy2012eu"}],"annotations":[{"start":13,"end":18,"probability":0.9758,"type":"Place","normalized_text":"Cyprus"},{"start":31,"end":40,"probability":0.6805,"type":"Organization","normalized_text":"EU Council"}],"urls":[{"start":74,"end":94,"url":"http://t.co/MhB9x7JC","expanded_url":"http://bit.ly/LHsJSr","display_url":"bit.ly/LHsJSr"}]},"source":"TweetDeck","conversation_id":"218283458391318528","referenced_tweets":[{"type":"retweeted","id":"218268935311732736"}],"text":"RT @Cedefop: Cyprus takes over EU Council presidency on 1 July  #cy2012eu http://t.co/MhB9x7JC","id":"218283458391318528","lang":"en","created_at":"2012-06-28T10:03:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/SGZqeAGG","expanded_url":"http://fb.me/13DIMp3tW","display_url":"fb.me/13DIMp3tW"}]},"source":"TweetDeck","conversation_id":"218283350648033281","referenced_tweets":[{"type":"retweeted","id":"218268435661066241"}],"text":"RT @cancereu: European Innovation Partnership: Strong stakeholder support for action on active and healthy ageing http://t.co/SGZqeAGG","id":"218283350648033281","lang":"en","created_at":"2012-06-28T10:03:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/SkryWOuL","expanded_url":"http://fb.me/Yr29XwNO","display_url":"fb.me/Yr29XwNO"}]},"source":"TweetDeck","conversation_id":"218283240010682368","referenced_tweets":[{"type":"retweeted","id":"218268414370791425"}],"text":"RT @cancereu: European Innovation Partnership: Strong stakeholder support for action on active and healthy ageing http://t.co/SkryWOuL","id":"218283240010682368","lang":"en","created_at":"2012-06-28T10:02:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":26,"end":34,"tag":"ESCAIDE"},{"start":100,"end":113,"tag":"epidemiology"}],"annotations":{},"urls":[{"start":79,"end":99,"url":"http://t.co/BHdNYksD","expanded_url":"http://bit.ly/MzrCEY","display_url":"bit.ly/MzrCEY"}]},"source":"TweetDeck","conversation_id":"218283100185174016","referenced_tweets":[{"type":"retweeted","id":"218264540520001536"}],"text":"RT @ECDC_EU: Register for #ESCAIDE 2012 – Early bird discount until 31 August! http://t.co/BHdNYksD #epidemiology","id":"218283100185174016","lang":"en","created_at":"2012-06-28T10:02:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":18,"end":26,"username":"EIP_AHA","id":"416925949"}],"hashtags":[{"start":114,"end":121,"tag":"ageing"}],"annotations":[{"start":57,"end":87,"probability":0.346,"type":"Organization","normalized_text":"European Innovation Partnership"}],"urls":{}},"source":"TweetDeck","conversation_id":"218013074035195906","referenced_tweets":[{"type":"retweeted","id":"218013030406029312"}],"text":"RT @EU_Health: RT @EIP_AHA 261 projects submitted to the European Innovation Partnership for active &amp; healthy #ageing! Read it here: ...","id":"218013074035195906","lang":"en","created_at":"2012-06-27T16:09:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.6437,"type":"Organization","normalized_text":"FDA"}],"urls":[{"start":115,"end":135,"url":"http://t.co/Flh2O7zS","expanded_url":"http://1.usa.gov/MUEaru","display_url":"1.usa.gov/MUEaru"}]},"source":"TweetDeck","conversation_id":"218008939718115328","referenced_tweets":[{"type":"retweeted","id":"218008490172624896"}],"text":"RT @US_FDA: FDA allows marketing of first test to identify certain bacteria associated with bloodstream infections http://t.co/Flh2O7zS","id":"218008939718115328","lang":"en","created_at":"2012-06-27T15:52:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":107,"end":120,"tag":"osteoporosis"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"218008908143394816","referenced_tweets":[{"type":"retweeted","id":"218008849741918208"}],"text":"RT @FDA_Drug_Info: #FDA: More investigation needed on long-term risks/benefits of bisphosphonates to treat #osteoporosis. http://t.co/t9 ...","id":"218008908143394816","lang":"en","created_at":"2012-06-27T15:52:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":40,"end":58,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/yTJxh7Ts","expanded_url":"http://bit.ly/MA6WOq","display_url":"bit.ly/MA6WOq"}]},"source":"bitly bitlink","conversation_id":"217988667325689857","referenced_tweets":{},"text":"We've released two more modules on good #pharmacovigilance practice for public consultation until 24 August: http://t.co/yTJxh7Ts","id":"217988667325689857","lang":"en","created_at":"2012-06-27T14:32:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":111,"end":127,"username":"Telethon_France","id":"46401677"}],"hashtags":[{"start":32,"end":44,"tag":"raredisease"},{"start":64,"end":76,"tag":"AFMTelethon"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217969175514198018","referenced_tweets":[{"type":"retweeted","id":"217969133969604610"}],"text":"RT @eurordis: Seeking cures for #raredisease through innovation #AFMTelethon english website is out. Please RT @Telethon_France http://t ...","id":"217969175514198018","lang":"en","created_at":"2012-06-27T13:14:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":81,"end":89,"tag":"Egrifta"}],"annotations":[{"start":0,"end":19,"probability":0.6517,"type":"Person","normalized_text":"Ferrer Internacional"}],"urls":[{"start":104,"end":124,"url":"http://t.co/JoTPKr1B","expanded_url":"http://bit.ly/NBgTIc","display_url":"bit.ly/NBgTIc"}]},"source":"bitly bitlink","conversation_id":"217963932609036288","referenced_tweets":{},"text":"Ferrer Internacional, S.A. withdraws its marketing authorisation application for #Egrifta (tesamorelin) http://t.co/JoTPKr1B","id":"217963932609036288","lang":"en","created_at":"2012-06-27T12:53:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":30,"end":41,"tag":"Innovation"},{"start":107,"end":115,"tag":"Healthy"},{"start":116,"end":123,"tag":"Ageing"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217931600715976704","referenced_tweets":[{"type":"retweeted","id":"217931505362665472"}],"text":"RT @innovationunion: European #Innovation Partnership: Strong stakeholder support for action on active and #Healthy #Ageing http://t.co/ ...","id":"217931600715976704","lang":"en","created_at":"2012-06-27T10:45:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":25,"end":36,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":38,"end":46,"tag":"eHealth"}],"annotations":[{"start":58,"end":63,"probability":0.97,"type":"Place","normalized_text":"Dublin"}],"urls":[{"start":82,"end":102,"url":"http://t.co/Vwyr0vdZ","expanded_url":"http://dlvr.it/1mm2kX","display_url":"dlvr.it/1mm2kX"}]},"source":"TweetDeck","conversation_id":"217931566322683905","referenced_tweets":[{"type":"retweeted","id":"217931498714710016"}],"text":"RT @innovationunion: via @EU_eHealth: #eHealth Week 2013, Dublin, dates confirmed http://t.co/Vwyr0vdZ","id":"217931566322683905","lang":"en","created_at":"2012-06-27T10:45:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":45,"end":48,"tag":"EU"},{"start":56,"end":63,"tag":"health"}],"annotations":{},"urls":[{"start":71,"end":91,"url":"http://t.co/mN8CDiC9","expanded_url":"http://bit.ly/EaDvV","display_url":"bit.ly/EaDvV"}]},"source":"TweetDeck","conversation_id":"217922461302407169","referenced_tweets":[{"type":"retweeted","id":"217912900931682304"}],"text":"RT @EU_Health: We are reviewing our official #EU public #health portal http://t.co/mN8CDiC9 and welcome your feedback http://t.co/yco7dd ...","id":"217922461302407169","lang":"en","created_at":"2012-06-27T10:08:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":88,"end":105,"tag":"farmacovigilanza"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/x2pHNFRA","expanded_url":"http://fb.me/1rEJ8kMLA","display_url":"fb.me/1rEJ8kMLA"}]},"source":"TweetDeck","conversation_id":"217633408904470528","referenced_tweets":[{"type":"retweeted","id":"217612297475076097"}],"text":"RT @Aifa_ufficiale: Regolamento di esecuzione (UE) per lo svolgimento delle attività di #farmacovigilanza... http://t.co/x2pHNFRA","id":"217633408904470528","lang":"it","created_at":"2012-06-26T15:00:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":5,"end":23,"tag":"pharmacovigilance"},{"start":35,"end":39,"tag":"GVP"}],"annotations":{},"urls":[{"start":94,"end":114,"url":"http://t.co/lrGxTYAe","expanded_url":"http://bit.ly/MnyANu","display_url":"bit.ly/MnyANu"}]},"source":"Twitter Web Client","conversation_id":"217574757565079552","referenced_tweets":{},"text":"Good #pharmacovigilance practices (#GVP): first seven modules of the guideline available now: http://t.co/lrGxTYAe","id":"217574757565079552","lang":"en","created_at":"2012-06-26T11:07:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":34,"end":44,"tag":"Revestive"},{"start":46,"end":58,"tag":"teduglutide"},{"start":69,"end":75,"tag":"short"},{"start":76,"end":82,"tag":"bowel"},{"start":83,"end":92,"tag":"syndrome"}],"annotations":{},"urls":[{"start":94,"end":114,"url":"http://t.co/5eJHiWTt","expanded_url":"http://bit.ly/KIffbm","display_url":"bit.ly/KIffbm"}]},"source":"Twitter Web Client","conversation_id":"217573800701739008","referenced_tweets":{},"text":"#CHMP adopts positive opinion for #Revestive (#teduglutide) to treat #short #bowel #syndrome: http://t.co/5eJHiWTt","id":"217573800701739008","lang":"en","created_at":"2012-06-26T11:03:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":24,"tag":"Meningitis"}],"annotations":[{"start":37,"end":43,"probability":0.9984,"type":"Place","normalized_text":"Romania"}],"urls":[{"start":77,"end":97,"url":"http://t.co/O7ORYPqI","expanded_url":"http://bit.ly/MqbIwG","display_url":"bit.ly/MqbIwG"}]},"source":"TweetDeck","conversation_id":"217562593273978880","referenced_tweets":[{"type":"retweeted","id":"217562555026116609"}],"text":"RT @ECDC_EU: #Meningitis outbreak in Romania: ECDC publishes risk assessment http://t.co/O7ORYPqI","id":"217562593273978880","lang":"en","created_at":"2012-06-26T10:18:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":33,"end":51,"tag":"pharmacovigilance"},{"start":63,"end":67,"tag":"GVP"}],"annotations":{},"urls":[{"start":107,"end":127,"url":"http://t.co/lrGxTYAe","expanded_url":"http://bit.ly/MnyANu","display_url":"bit.ly/MnyANu"}]},"source":"Twitter Web Client","conversation_id":"217560942005854208","referenced_tweets":{},"text":"The first set of modules on good #pharmacovigilance practices (#GVP) are now finalised and on our website: http://t.co/lrGxTYAe","id":"217560942005854208","lang":"en","created_at":"2012-06-26T10:12:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":79,"end":84,"tag":"Luca"},{"start":102,"end":119,"tag":"farmacovigilanza"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217551469036048384","referenced_tweets":[{"type":"retweeted","id":"217551435934597120"}],"text":"RT @Aifa_ufficiale: Il ruolo strategico dell'AIFA in Europa - intervista al DG #Luca Pani sulla nuova #farmacovigilanza europea... http: ...","id":"217551469036048384","lang":"it","created_at":"2012-06-26T09:34:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":107,"end":117,"username":"cgra_twit","id":"264697520"}],"hashtags":{},"annotations":{},"urls":[{"start":62,"end":82,"url":"http://t.co/13MTZf6X","expanded_url":"http://bit.ly/xFtNZv","display_url":"bit.ly/xFtNZv"},{"start":118,"end":138,"url":"http://t.co/nSNE6NNw","expanded_url":"http://dlvr.it/1mTRTj","display_url":"dlvr.it/1mTRTj"}]},"source":"TweetDeck","conversation_id":"217550807736922113","referenced_tweets":[{"type":"retweeted","id":"217522340253274112"}],"text":"RT @innovationunion: EU_eHealth: The EU eHealth Daily is out! http://t.co/13MTZf6X ▸ Top stories today via @cgra_twit http://t.co/nSNE6NNw","id":"217550807736922113","lang":"en","created_at":"2012-06-26T09:32:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":49,"end":67,"tag":"pharmacovigilance"},{"start":79,"end":83,"tag":"GVP"}],"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/lrGxTYAe","expanded_url":"http://bit.ly/MnyANu","display_url":"bit.ly/MnyANu"}]},"source":"bitly bitlink","conversation_id":"217292672904331264","referenced_tweets":{},"text":"We've finalised the first set of modules on good #pharmacovigilance practices (#GVP): http://t.co/lrGxTYAe","id":"217292672904331264","lang":"en","created_at":"2012-06-25T16:26:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"urls":[{"start":87,"end":107,"url":"http://t.co/XskJekMk","expanded_url":"http://www.aemps.gob.es","display_url":"aemps.gob.es"}]},"source":"TweetDeck","conversation_id":"217289291011850240","referenced_tweets":[{"type":"retweeted","id":"217289260955480064"}],"text":"RT @AEMPSGOB: Trimetazidina (Idaptan®, trimetazidina EFG): restricción de indicaciones http://t.co/XskJekMk","id":"217289291011850240","lang":"ca","created_at":"2012-06-25T16:12:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"urls":[{"start":103,"end":123,"url":"http://t.co/XskJekMk","expanded_url":"http://www.aemps.gob.es","display_url":"aemps.gob.es"}]},"source":"TweetDeck","conversation_id":"217288775154417664","referenced_tweets":[{"type":"retweeted","id":"217288739565735936"}],"text":"RT @AEMPSGOB: Doripenem (Doribax®): nuevas recomendaciones de uso en pacientes con neumonía nosocomial http://t.co/XskJekMk","id":"217288775154417664","lang":"es","created_at":"2012-06-25T16:10:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":10,"tag":"Revestive"},{"start":73,"end":79,"tag":"short"},{"start":80,"end":86,"tag":"bowel"},{"start":87,"end":96,"tag":"syndrome"}],"annotations":{},"urls":[{"start":98,"end":118,"url":"http://t.co/5eJHiWTt","expanded_url":"http://bit.ly/KIffbm","display_url":"bit.ly/KIffbm"}]},"source":"Twitter Web Client","conversation_id":"217275041161814016","referenced_tweets":{},"text":"#Revestive, novel peptide analogue, recommended for use in patients with #short #bowel #syndrome: http://t.co/5eJHiWTt","id":"217275041161814016","lang":"en","created_at":"2012-06-25T15:16:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":18,"end":32,"tag":"trimetazidine"}],"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/bSZwzBP1","expanded_url":"http://bit.ly/MAztBc","display_url":"bit.ly/MAztBc"}]},"source":"Twitter Web Client","conversation_id":"217273120774565888","referenced_tweets":{},"text":"Restricted use of #trimetazidine-containing medicines; doctors should review patients’ treatment at next appointment http://t.co/bSZwzBP1","id":"217273120774565888","lang":"en","created_at":"2012-06-25T15:08:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217272741156487169","referenced_tweets":[{"type":"retweeted","id":"217272540953972737"}],"text":"RT @MHRAGovUkPress: Trio convicted for involvement in online counterfeit medicines following successful criminal investigation by MHRA h ...","id":"217272741156487169","lang":"en","created_at":"2012-06-25T15:07:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":92,"end":107,"username":"joanguanyabens","id":"135495487"}],"hashtags":{},"annotations":[{"start":38,"end":43,"probability":0.9947,"type":"Place","normalized_text":"Europe"},{"start":76,"end":90,"probability":0.7019,"type":"Person","normalized_text":"President Ilves"}],"urls":[{"start":111,"end":131,"url":"http://t.co/xdfs909P","expanded_url":"http://dlvr.it/1mKHnd","display_url":"dlvr.it/1mKHnd"}]},"source":"TweetDeck","conversation_id":"217272718532427777","referenced_tweets":[{"type":"retweeted","id":"217272442194886656"}],"text":"RT @EU_eHealth: Redesigning health in Europe for 2020 video presentation by President Ilves @joanguanyabens... http://t.co/xdfs909P @Dig ...","id":"217272718532427777","lang":"en","created_at":"2012-06-25T15:07:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":30,"end":42,"tag":"tolperisone"},{"start":64,"end":75,"tag":"spasticity"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/3jY5u6yG","expanded_url":"http://bit.ly/MnMHU2","display_url":"bit.ly/MnMHU2"}]},"source":"Twitter Web Client","conversation_id":"217272119032156162","referenced_tweets":{},"text":"Doctors should be prescribing #tolperisone only for post-stroke #spasticity in adults; only oral use recommended. http://t.co/3jY5u6yG","id":"217272119032156162","lang":"en","created_at":"2012-06-25T15:04:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":70,"end":80,"tag":"pneumonia"},{"start":86,"end":94,"tag":"Doribax"}],"annotations":{},"urls":[{"start":96,"end":116,"url":"http://t.co/irqSiXju","expanded_url":"http://bit.ly/LLaYF1","display_url":"bit.ly/LLaYF1"}]},"source":"Twitter Web Client","conversation_id":"217270866050953216","referenced_tweets":{},"text":"We've given new advice for the treatment of patients with# nosocomial #pneumonia with #Doribax: http://t.co/irqSiXju","id":"217270866050953216","lang":"en","created_at":"2012-06-25T14:59:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":8,"tag":"Hexaxim"},{"start":21,"end":29,"tag":"vaccine"}],"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/vB7zT4CY","expanded_url":"http://bit.ly/Mz4SG0","display_url":"bit.ly/Mz4SG0"}]},"source":"Twitter Web Client","conversation_id":"217270244358627328","referenced_tweets":{},"text":"#Hexaxim, the 6-in-1 #vaccine recommended to be used outside the EU. http://t.co/vB7zT4CY","id":"217270244358627328","lang":"en","created_at":"2012-06-25T14:57:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":37,"tag":"Arzneimittelsicherheit"},{"start":38,"end":43,"tag":"BASG"},{"start":44,"end":49,"tag":"AGES"},{"start":64,"end":72,"tag":"Doribax"},{"start":84,"end":94,"tag":"Doripenem"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/jYg8XWOd","expanded_url":"http://www.basg.gv.at/news-center/news/sicherheitsinformationen-details/article/doribax-doripenem-neue-dosisempfehlung/","display_url":"basg.gv.at/news-center/ne…"}]},"source":"TweetDeck","conversation_id":"217247577614192641","referenced_tweets":[{"type":"retweeted","id":"217239296984367104"}],"text":"RT @agesnews: #Arzneimittelsicherheit #BASG #AGES informiert zu #Doribax Wirkstoff: #Doripenem - Neue Dosisempfehlung http://t.co/jYg8XWOd","id":"217247577614192641","lang":"de","created_at":"2012-06-25T13:27:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217247490376859651","referenced_tweets":[{"type":"retweeted","id":"217237424399585280"}],"text":"RT @LV_MPA: Nya rekommendationer för dos och behandlingstid med Doribax (doripenem) vid behandling av patienter med sjukhusf... http://t ...","id":"217247490376859651","lang":"sv","created_at":"2012-06-25T13:26:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":34,"end":41,"tag":"Cyprus"},{"start":129,"end":138,"tag":"cy2012eu"}],"annotations":[{"start":81,"end":86,"probability":0.9822,"type":"Place","normalized_text":"Cyprus"}],"urls":[{"start":108,"end":128,"url":"http://t.co/U8QWEHZ5","expanded_url":"http://www.cy2012.eu","display_url":"cy2012.eu"}]},"source":"TweetDeck","conversation_id":"217229900518662145","referenced_tweets":[{"type":"retweeted","id":"217228006895259648"}],"text":"RT @cy2012eu: Official website of #Cyprus Presidency presented to journalists in Cyprus today. Read more at http://t.co/U8QWEHZ5 #cy2012eu","id":"217229900518662145","lang":"en","created_at":"2012-06-25T12:16:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":84,"end":104,"url":"http://t.co/WIuZyZZE","expanded_url":"http://bit.ly/MLknZJ","display_url":"bit.ly/MLknZJ"}]},"source":"TweetDeck","conversation_id":"217229731400122369","referenced_tweets":[{"type":"retweeted","id":"217229642690600961"}],"text":"RT @LV_MPA: Europeisk utredning av brister i Roches system för säkerhetsövervakning http://t.co/WIuZyZZE","id":"217229731400122369","lang":"sv","created_at":"2012-06-25T12:16:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":18,"end":28,"tag":"Revestive"},{"start":72,"end":78,"tag":"short"},{"start":79,"end":85,"tag":"bowel"},{"start":86,"end":95,"tag":"syndrome"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/5eJHiWTt","expanded_url":"http://bit.ly/KIffbm","display_url":"bit.ly/KIffbm"}]},"source":"bitly bitlink","conversation_id":"217227667743834112","referenced_tweets":{},"text":"We've recommended #Revestive, first medical treatment for patients with #short #bowel #syndrome: http://t.co/5eJHiWTt","id":"217227667743834112","lang":"en","created_at":"2012-06-25T12:08:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":15,"end":23,"tag":"Hexaxim"}],"annotations":{},"urls":[{"start":52,"end":72,"url":"http://t.co/vB7zT4CY","expanded_url":"http://bit.ly/Mz4SG0","display_url":"bit.ly/Mz4SG0"}]},"source":"Twitter Web Client","conversation_id":"217226993400426497","referenced_tweets":{},"text":"We recommended #Hexaxim for the use outside the EU. http://t.co/vB7zT4CY","id":"217226993400426497","lang":"en","created_at":"2012-06-25T12:05:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":30,"end":42,"tag":"tolperisone"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/3jY5u6yG","expanded_url":"http://bit.ly/MnMHU2","display_url":"bit.ly/MnMHU2"}]},"source":"Twitter Web Client","conversation_id":"217225870367137793","referenced_tweets":{},"text":"Benefit-risk profile for oral #tolperisone considered positive only for adults with post-stroke spasticity.  http://t.co/3jY5u6yG","id":"217225870367137793","lang":"en","created_at":"2012-06-25T12:00:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":34,"end":42,"tag":"Doribax"}],"annotations":{},"urls":[{"start":80,"end":100,"url":"http://t.co/irqSiXju","expanded_url":"http://bit.ly/LLaYF1","display_url":"bit.ly/LLaYF1"}]},"source":"Twitter Web Client","conversation_id":"217225290387161089","referenced_tweets":{},"text":"Current dosing recommendations of #Doribax may not be enough for serious cases  http://t.co/irqSiXju","id":"217225290387161089","lang":"en","created_at":"2012-06-25T11:58:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":28,"end":42,"tag":"trimetazidine"},{"start":74,"end":83,"tag":"tinnitus"},{"start":85,"end":93,"tag":"vertigo"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/bSZwzBP1","expanded_url":"http://bit.ly/MAztBc","display_url":"bit.ly/MAztBc"}]},"source":"Twitter Web Client","conversation_id":"217224864912785410","referenced_tweets":{},"text":"Doctors shouldn't prescribe #trimetazidine for treatment of patients with #tinnitus, #vertigo or vision disturbances. http://t.co/bSZwzBP1","id":"217224864912785410","lang":"en","created_at":"2012-06-25T11:56:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217224610813456384","referenced_tweets":[{"type":"retweeted","id":"217204701320593408"}],"text":"RT @MHRAGovUkPress: MHRA tells surgeons to stop using R3 metal cup liner for MoM hip replacements and extends patient monitoring advice  ...","id":"217224610813456384","lang":"en","created_at":"2012-06-25T11:55:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":8,"tag":"Celgene"},{"start":53,"end":62,"tag":"multiple"},{"start":63,"end":71,"tag":"myeloma"},{"start":77,"end":86,"tag":"Revlimid"}],"annotations":{},"urls":[{"start":87,"end":107,"url":"http://t.co/U9PbKLs8","expanded_url":"http://bit.ly/KPmOOM","display_url":"bit.ly/KPmOOM"}]},"source":"Twitter Web Client","conversation_id":"217223797479194625","referenced_tweets":{},"text":"#Celgene withdraws its variation application for its #multiple #myeloma drug #Revlimid http://t.co/U9PbKLs8","id":"217223797479194625","lang":"en","created_at":"2012-06-25T11:52:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":36,"end":42,"tag":"Roche"}],"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/ANrQpBcJ","expanded_url":"http://bit.ly/M9sEay","display_url":"bit.ly/M9sEay"}]},"source":"Twitter Web Client","conversation_id":"217222963022409728","referenced_tweets":{},"text":"We will investigate deficiencies in #Roche medicine-safety reporting\nhttp://t.co/ANrQpBcJ","id":"217222963022409728","lang":"en","created_at":"2012-06-25T11:49:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":75,"end":84,"tag":"westnile"}],"annotations":{},"urls":[{"start":54,"end":74,"url":"http://t.co/lAZNBBCb","expanded_url":"http://bit.ly/KI2bCX","display_url":"bit.ly/KI2bCX"}]},"source":"TweetDeck","conversation_id":"217198954415267840","referenced_tweets":[{"type":"retweeted","id":"217198911855669248"}],"text":"RT @ECDC_EU: ECDC launches 2012 West Nile fever maps, http://t.co/lAZNBBCb #westnile","id":"217198954415267840","lang":"en","created_at":"2012-06-25T10:14:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":42,"end":46,"tag":"EMA"},{"start":103,"end":113,"tag":"doripenem"},{"start":114,"end":130,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"217196399954112512","referenced_tweets":[{"type":"retweeted","id":"217191855400562688"}],"text":"RT @Aifa_ufficiale: Nuove raccomandazioni #EMA per il trattamento di polmoniti nosocomiali con Doribax #doripenem #PilloledalMondo... ht ...","id":"217196399954112512","lang":"it","created_at":"2012-06-25T10:03:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":14,"end":28,"username":"HealthFirstEU","id":"216314816"}],"hashtags":[{"start":31,"end":40,"tag":"EUnetHTA"},{"start":113,"end":117,"tag":"HTA"}],"annotations":[{"start":121,"end":126,"probability":0.9834,"type":"Place","normalized_text":"Europe"}],"urls":{}},"source":"TweetDeck","conversation_id":"217169103528542210","referenced_tweets":[{"type":"retweeted","id":"217168957986185216"}],"text":"RT @EFPIA: RT @HealthFirstEU: \"#EUnetHTA Strategy 2012 and beyond\" released calling for greater collaboration on #HTA in Europe. http:// ...","id":"217169103528542210","lang":"en","created_at":"2012-06-25T08:15:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"216201646315802624","referenced_tweets":[{"type":"retweeted","id":"216193073963728896"}],"text":"RT @NICEcomms: We're looking for patients and carers to help us update our  type 1 diabetes in adults guideline. Interested? http://t.co ...","id":"216201646315802624","lang":"en","created_at":"2012-06-22T16:11:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":27,"end":35,"username":"YouTube","id":"10228272"}],"hashtags":{},"annotations":{},"urls":[{"start":55,"end":75,"url":"http://t.co/UNlTgcF2","expanded_url":"http://youtu.be/vwPgzpj7YQ8?a","display_url":"youtu.be/vwPgzpj7YQ8?a"}]},"source":"TweetDeck","conversation_id":"216174586243452928","referenced_tweets":[{"type":"retweeted","id":"216167657295183873"}],"text":"RT @agesnews: Ich habe ein @YouTube-Video hochgeladen. http://t.co/UNlTgcF2 100 + 2 Jahre AGES Mödling - das veterinärmediz","id":"216174586243452928","lang":"de","created_at":"2012-06-22T14:23:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eu2012dk","id":"289813776"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"216134007564406784","referenced_tweets":[{"type":"retweeted","id":"216133669943918593"}],"text":"RT @eu2012dk: EU Health Min commited to strengthen fight against antimicrobial resistance which is a serious &amp; increasing problem ht ...","id":"216134007564406784","lang":"en","created_at":"2012-06-22T11:42:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"216132675310858240","referenced_tweets":[{"type":"retweeted","id":"216129792360185856"}],"text":"RT @WHO_Europe: Have you seen our new home page design for our web site? It’s easier to navigate &amp; makes information more accessible ...","id":"216132675310858240","lang":"en","created_at":"2012-06-22T11:37:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"Hexaxim"}],"annotations":{},"urls":[{"start":74,"end":94,"url":"http://t.co/vB7zT4CY","expanded_url":"http://bit.ly/Mz4SG0","display_url":"bit.ly/Mz4SG0"}]},"source":"bitly bitlink","conversation_id":"216128901309665280","referenced_tweets":{},"text":"We've given first opinion for a vaccine for use outside the EU:  #Hexaxim http://t.co/vB7zT4CY","id":"216128901309665280","lang":"en","created_at":"2012-06-22T11:22:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":49,"end":60,"tag":"paediatric"},{"start":81,"end":85,"tag":"PIP"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/whqAT2LC","expanded_url":"http://bit.ly/KOQ6wU","display_url":"bit.ly/KOQ6wU"}]},"source":"Twitter Web Client","conversation_id":"216119895316893696","referenced_tweets":{},"text":"Pharma companies: if you have a deferral on your #paediatric investigation plan (#PIP) don't forget the annual reports! http://t.co/whqAT2LC","id":"216119895316893696","lang":"en","created_at":"2012-06-22T10:46:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":45,"end":48,"tag":"EU"},{"start":56,"end":63,"tag":"health"}],"annotations":{},"urls":[{"start":71,"end":91,"url":"http://t.co/mN8CDiC9","expanded_url":"http://bit.ly/EaDvV","display_url":"bit.ly/EaDvV"}]},"source":"TweetDeck","conversation_id":"216118344519131136","referenced_tweets":[{"type":"retweeted","id":"216115792075440129"}],"text":"RT @EU_Health: We are reviewing our official #EU public #health portal http://t.co/mN8CDiC9 and welcome your feedback http://t.co/yco7dd ...","id":"216118344519131136","lang":"en","created_at":"2012-06-22T10:40:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"216117678744674304","referenced_tweets":[{"type":"retweeted","id":"216090456973512706"}],"text":"RT @Legemiddelinfo: Godkjenningsfritak for legemidler til human bruk: Vi mottar mange henvendelser om godkjenningsfritak, og for å s...  ...","id":"216117678744674304","lang":"no","created_at":"2012-06-22T10:37:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":[{"start":78,"end":90,"probability":0.605,"type":"Organization","normalized_text":"The Economist"}],"urls":[{"start":92,"end":112,"url":"http://t.co/ZJvFlTHW","expanded_url":"http://fb.me/1nbTZWEBl","display_url":"fb.me/1nbTZWEBl"}]},"source":"TweetDeck","conversation_id":"216117220554702848","referenced_tweets":[{"type":"retweeted","id":"216087274931240960"}],"text":"RT @cancereu: Gene mutations predict which cancer will respond to treatment - The Economist http://t.co/ZJvFlTHW","id":"216117220554702848","lang":"en","created_at":"2012-06-22T10:35:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":9,"tag":"Revlimid"},{"start":63,"end":71,"tag":"Celgene"}],"annotations":{},"urls":[{"start":73,"end":93,"url":"http://t.co/U9PbKLs8","expanded_url":"http://bit.ly/KPmOOM","display_url":"bit.ly/KPmOOM"}]},"source":"Twitter Web Client","conversation_id":"216107379232743424","referenced_tweets":{},"text":"#Revlimid application for extension of indication withdrawn by #Celgene  http://t.co/U9PbKLs8","id":"216107379232743424","lang":"en","created_at":"2012-06-22T09:56:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":92,"end":98,"tag":"Roche"}],"annotations":{},"urls":[{"start":99,"end":119,"url":"http://t.co/ANrQpBcJ","expanded_url":"http://bit.ly/M9sEay","display_url":"bit.ly/M9sEay"}]},"source":"Twitter Web Client","conversation_id":"216106954995675136","referenced_tweets":{},"text":"We are looking at the impact of the deficiencies in the medicine-safety reporting system of #Roche http://t.co/ANrQpBcJ","id":"216106954995675136","lang":"en","created_at":"2012-06-22T09:54:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":37,"end":51,"tag":"trimetazidine"},{"start":93,"end":100,"tag":"angina"},{"start":101,"end":110,"tag":"pectoris"}],"annotations":{},"urls":[{"start":111,"end":131,"url":"http://t.co/bSZwzBP1","expanded_url":"http://bit.ly/MAztBc","display_url":"bit.ly/MAztBc"}]},"source":"bitly bitlink","conversation_id":"216106006483189760","referenced_tweets":{},"text":"We've recommended restricting use of #trimetazidine-containing medicines in the treatment of #angina #pectoris http://t.co/bSZwzBP1","id":"216106006483189760","lang":"en","created_at":"2012-06-22T09:51:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":40,"end":52,"tag":"tolperisone"}],"annotations":{},"urls":[{"start":63,"end":83,"url":"http://t.co/3jY5u6yG","expanded_url":"http://bit.ly/MnMHU2","display_url":"bit.ly/MnMHU2"}]},"source":"bitly bitlink","conversation_id":"216105409935708160","referenced_tweets":{},"text":"We recommended today restricting use of #tolperisone medicines http://t.co/3jY5u6yG","id":"216105409935708160","lang":"en","created_at":"2012-06-22T09:48:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":83,"end":91,"tag":"Doribax"}],"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/irqSiXju","expanded_url":"http://bit.ly/LLaYF1","display_url":"bit.ly/LLaYF1"}]},"source":"bitly bitlink","conversation_id":"216105091315417088","referenced_tweets":{},"text":"We've given new advice to doctors treating patients with nosocomial pneumonia with #Doribax http://t.co/irqSiXju","id":"216105091315417088","lang":"en","created_at":"2012-06-22T09:47:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"215831765540016128","referenced_tweets":[{"type":"retweeted","id":"215831683331657729"}],"text":"RT @cancereu: Agreement on pharmacovigilance will provide EU citizens with greater medicine safety - Danish Presidency 2012 http://t.co/ ...","id":"215831765540016128","lang":"en","created_at":"2012-06-21T15:41:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":8,"tag":"Celgene"},{"start":67,"end":76,"tag":"Revlimid"}],"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/U9PbKLs8","expanded_url":"http://bit.ly/KPmOOM","display_url":"bit.ly/KPmOOM"}]},"source":"bitly bitlink","conversation_id":"215825089722195969","referenced_tweets":{},"text":"#Celgene withdraws its application for extension of indication for #Revlimid http://t.co/U9PbKLs8","id":"215825089722195969","lang":"en","created_at":"2012-06-21T15:14:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":109,"end":115,"tag":"Roche"}],"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/ANrQpBcJ","expanded_url":"http://bit.ly/M9sEay","display_url":"bit.ly/M9sEay"}]},"source":"bitly bitlink","conversation_id":"215824754593120257","referenced_tweets":{},"text":"We are working with national agencies to investigate deficiencies in the medicine-safety reporting system of #Roche http://t.co/ANrQpBcJ","id":"215824754593120257","lang":"en","created_at":"2012-06-21T15:13:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":25,"end":36,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":68,"end":79,"tag":"MarieCurie"},{"start":122,"end":133,"tag":"Innovation"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"215819537516462080","referenced_tweets":[{"type":"retweeted","id":"215819500258467843"}],"text":"RT @innovationunion: via @EU_eHealth: Should I stay or should I go? #MarieCurie Actions shaping the European Research and #Innovation... ...","id":"215819537516462080","lang":"en","created_at":"2012-06-21T14:52:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":[{"start":14,"end":19,"probability":0.922,"type":"Place","normalized_text":"Europe"}],"urls":{}},"source":"TweetDeck","conversation_id":"215818626463301637","referenced_tweets":[{"type":"retweeted","id":"215816733842350081"}],"text":"RT @cancereu: Europe for patients - EMA finalises guidance on medicines containing monoclonal antibodies, used in some... http://t.co/Bd ...","id":"215818626463301637","lang":"en","created_at":"2012-06-21T14:49:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":121,"end":129,"tag":"DIA2012"}],"annotations":[{"start":18,"end":29,"probability":0.8191,"type":"Place","normalized_text":"Philadelphia"},{"start":37,"end":50,"probability":0.8142,"type":"Person","normalized_text":"Michael Nutter"}],"urls":[{"start":100,"end":120,"url":"http://t.co/xIjOPT6p","expanded_url":"http://bit.ly/KPgiHU","display_url":"bit.ly/KPgiHU"}]},"source":"TweetDeck","conversation_id":"215813032088059904","referenced_tweets":[{"type":"retweeted","id":"215812909870231554"}],"text":"RT @DrugInfoAssn: Philadelphia Mayor Michael Nutter to Open DIA 2012 48th Annual Meeting June 24-28 http://t.co/xIjOPT6p #DIA2012 http:/ ...","id":"215813032088059904","lang":"en","created_at":"2012-06-21T14:26:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":73,"end":85,"username":"gochujang81","id":"312747163"},{"start":86,"end":95,"username":"stashjem","id":"2172653268"}],"hashtags":{},"annotations":{},"urls":[{"start":98,"end":118,"url":"http://t.co/QyydGosF","expanded_url":"http://paper.li/DrugInfoAssn/1340067883","display_url":"paper.li/DrugInfoAssn/1…"}]},"source":"TweetDeck","conversation_id":"215812692420734977","referenced_tweets":[{"type":"retweeted","id":"215812152026595328"}],"text":"RT @DrugInfoAssn: Read DIA 2012 Annual Meeting ▸ today's top stories via @gochujang81 @stashjem ▸ http://t.co/QyydGosF","id":"215812692420734977","lang":"en","created_at":"2012-06-21T14:25:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":79,"end":90,"tag":"Innovation"},{"start":95,"end":103,"tag":"Science"},{"start":114,"end":120,"tag":"Women"}],"annotations":[{"start":21,"end":35,"probability":0.6576,"type":"Person","normalized_text":"Máire GEOGHEGAN"},{"start":37,"end":76,"probability":0.3164,"type":"Other","normalized_text":"QUINN European Commissioner for Research"}],"urls":{}},"source":"TweetDeck","conversation_id":"215802146703159296","referenced_tweets":[{"type":"retweeted","id":"215802073990701056"}],"text":"RT @innovationunion: Máire GEOGHEGAN-QUINN European Commissioner for Research, #Innovation and #Science Launch of #Women in Science... h ...","id":"215802146703159296","lang":"en","created_at":"2012-06-21T13:43:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"hashtags":[{"start":120,"end":126,"tag":"polio"}],"annotations":[{"start":25,"end":30,"probability":0.9836,"type":"Place","normalized_text":"Europe"}],"urls":{}},"source":"TweetDeck","conversation_id":"215784448103424002","referenced_tweets":[{"type":"retweeted","id":"215784388749832192"}],"text":"RT @WHO_Europe_VPI: What Europe does in the next 10 years will have a significant impact on whether we rid the world of #polio - WHO/Eur ...","id":"215784448103424002","lang":"en","created_at":"2012-06-21T12:33:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":81,"end":92,"tag":"paediatric"},{"start":113,"end":117,"tag":"PIP"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/whqAT2LC","expanded_url":"http://bit.ly/KOQ6wU","display_url":"bit.ly/KOQ6wU"}]},"source":"Twitter Web Client","conversation_id":"215776912310669312","referenced_tweets":{},"text":"Companies: don't forget to send us annual reports if you have a deferral on your #paediatric investigation plan (#PIP): http://t.co/whqAT2LC","id":"215776912310669312","lang":"en","created_at":"2012-06-21T12:03:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":39,"end":44,"tag":"fees"},{"start":49,"end":67,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":113,"end":133,"url":"http://t.co/VQ3xiI10","expanded_url":"http://bit.ly/KTOv4k","display_url":"bit.ly/KTOv4k"}]},"source":"Twitter Web Client","conversation_id":"215776770358657025","referenced_tweets":{},"text":"A European Commission concept paper on #fees for #pharmacovigilance is open for comments. Deadline 15 September: http://t.co/VQ3xiI10","id":"215776770358657025","lang":"en","created_at":"2012-06-21T12:02:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":104,"end":110,"tag":"polio"}],"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/21j1Fyv7","expanded_url":"http://bit.ly/KOWEM9","display_url":"bit.ly/KOWEM9"}]},"source":"TweetDeck","conversation_id":"215773211835641857","referenced_tweets":[{"type":"retweeted","id":"215767267311501312"}],"text":"RT @ECDC_EU: Today, the WHO European Region marks 10 years since it was certified free of poliomyelitis #polio. http://t.co/21j1Fyv7 htt ...","id":"215773211835641857","lang":"en","created_at":"2012-06-21T11:48:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":108,"end":129,"tag":"CommunicableDiseases"}],"annotations":[{"start":16,"end":17,"probability":0.6174,"type":"Organization","normalized_text":"EU"}],"urls":{}},"source":"TweetDeck","conversation_id":"215773184845291521","referenced_tweets":[{"type":"retweeted","id":"215765999797014528"}],"text":"RT @EPHA_EU: At EU &amp; EEA/EFTA,how health communication activities influence prevention &amp; control of #CommunicableDiseases?:http: ...","id":"215773184845291521","lang":"en","created_at":"2012-06-21T11:48:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":54,"end":65,"tag":"paediatric"},{"start":86,"end":90,"tag":"PIP"}],"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/whqAT2LC","expanded_url":"http://bit.ly/KOQ6wU","display_url":"bit.ly/KOQ6wU"}]},"source":"bitly bitlink","conversation_id":"215750786456616961","referenced_tweets":{},"text":"Reminder to companies: if you have a deferral on your #paediatric investigation plan (#PIP), send us an annual report: http://t.co/whqAT2LC","id":"215750786456616961","lang":"en","created_at":"2012-06-21T10:19:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":68,"end":86,"tag":"pharmacovigilance"},{"start":87,"end":92,"tag":"fees"}],"annotations":[{"start":14,"end":32,"probability":0.4733,"type":"Organization","normalized_text":"European Commission"}],"urls":[{"start":117,"end":137,"url":"http://t.co/VQ3xiI10","expanded_url":"http://bit.ly/KTOv4k","display_url":"bit.ly/KTOv4k"}]},"source":"Twitter Web Client","conversation_id":"215746450603261952","referenced_tweets":{},"text":"On Monday the European Commission launched a public consultation on #pharmacovigilance #fees. Deadline 15 September: http://t.co/VQ3xiI10","id":"215746450603261952","lang":"en","created_at":"2012-06-21T10:02:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":{},"annotations":[{"start":71,"end":76,"probability":0.5853,"type":"Place","normalized_text":"Europe"}],"urls":{}},"source":"TweetDeck","conversation_id":"215730653554163712","referenced_tweets":[{"type":"retweeted","id":"215730620607897600"}],"text":"RT @WHO_Europe: Today we launched our new home page design for the WHO/Europe web site. Check it out, and tell us what you think! http:/ ...","id":"215730653554163712","lang":"en","created_at":"2012-06-21T08:59:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eu2012dk","id":"289813776"}],"hashtags":[{"start":98,"end":107,"tag":"eu2012dk"}],"annotations":[{"start":14,"end":15,"probability":0.6541,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":108,"end":128,"url":"http://t.co/BW1aF51t","expanded_url":"http://bit.ly/L7aseo","display_url":"bit.ly/L7aseo"}]},"source":"TweetDeck","conversation_id":"215730470925766657","referenced_tweets":[{"type":"retweeted","id":"215728995327680512"}],"text":"RT @eu2012dk: EU’s Health Ministers discuss cross border health threats &amp; bacteria resistance #eu2012dk http://t.co/BW1aF51t","id":"215730470925766657","lang":"en","created_at":"2012-06-21T08:58:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":{},"annotations":[{"start":36,"end":50,"probability":0.4648,"type":"Person","normalized_text":"Marie Curie FP6"},{"start":64,"end":66,"probability":0.3523,"type":"Person","normalized_text":"TED"},{"start":72,"end":75,"probability":0.6574,"type":"Organization","normalized_text":"TEDx"}],"urls":{}},"source":"TweetDeck","conversation_id":"215725225772453888","referenced_tweets":[{"type":"retweeted","id":"215724514586267649"}],"text":"RT @innovationunion: Join the final Marie Curie FP6 conference! TED and TEDx speakers will alternate with research fellows and inspire y ...","id":"215725225772453888","lang":"en","created_at":"2012-06-21T08:37:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":62,"end":80,"tag":"pharmacovigilance"},{"start":81,"end":86,"tag":"fees"}],"annotations":[{"start":4,"end":22,"probability":0.5337,"type":"Organization","normalized_text":"European Commission"}],"urls":[{"start":88,"end":108,"url":"http://t.co/VQ3xiI10","expanded_url":"http://bit.ly/KTOv4k","display_url":"bit.ly/KTOv4k"}]},"source":"bitly bitlink","conversation_id":"215484875770306561","referenced_tweets":{},"text":"The European Commission has launched a public consultation on #pharmacovigilance #fees: http://t.co/VQ3xiI10","id":"215484875770306561","lang":"en","created_at":"2012-06-20T16:42:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"hashtags":[{"start":12,"end":30,"tag":"Pharmacovigilance"},{"start":91,"end":98,"tag":"eurlex"}],"annotations":{},"urls":[{"start":100,"end":120,"url":"http://t.co/LPLzJKR0","expanded_url":"http://owl.li/bI0d0","display_url":"owl.li/bI0d0"}]},"source":"TweetDeck","conversation_id":"215473070238990336","referenced_tweets":[{"type":"retweeted","id":"215473021958365184"}],"text":"RT @EURLex: #Pharmacovigilance: performance of pharmacovigilance activities. Regulation on #eurlex: http://t.co/LPLzJKR0","id":"215473070238990336","lang":"en","created_at":"2012-06-20T15:55:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":{},"annotations":[{"start":99,"end":104,"probability":0.5724,"type":"Place","normalized_text":"Europe"}],"urls":[{"start":116,"end":136,"url":"http://t.co/qOkI8m7C","expanded_url":"http://bit.ly/LwtcXD","display_url":"bit.ly/LwtcXD"}]},"source":"TweetDeck","conversation_id":"215464716762480641","referenced_tweets":[{"type":"retweeted","id":"215447666199506944"}],"text":"RT @WHO_Europe: Tomorrow we launch our new face to the world: the new home page design for the WHO/Europe web site! http://t.co/qOkI8m7C","id":"215464716762480641","lang":"en","created_at":"2012-06-20T15:22:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"215464552752627712","referenced_tweets":[{"type":"retweeted","id":"215449947800207362"}],"text":"RT @eurordis: Opportunity for patient group to work with screenwriter Welcome Trust launch prize to reward drama inspired by science htt ...","id":"215464552752627712","lang":"en","created_at":"2012-06-20T15:22:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":51,"end":62,"tag":"MarieCurie"},{"start":105,"end":116,"tag":"Innovation"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"215464482653212674","referenced_tweets":[{"type":"retweeted","id":"215450528518389761"}],"text":"RT @innovationunion: Should I stay or should I go? #MarieCurie Actions shaping the European Research and #Innovation Landscape http://t. ...","id":"215464482653212674","lang":"en","created_at":"2012-06-20T15:21:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":125,"end":136,"tag":"REGULATORY"}],"annotations":[{"start":85,"end":100,"probability":0.8763,"type":"Place","normalized_text":"Philadelphia, PA"}],"urls":[{"start":103,"end":123,"url":"http://t.co/l5goRtHB","expanded_url":"http://www.diahome.org/DIA2012","display_url":"diahome.org/DIA2012"}]},"source":"TweetDeck","conversation_id":"215464289027358720","referenced_tweets":[{"type":"retweeted","id":"215454709429968896"}],"text":"RT @DrugInfoAssn: DIA 2012 48th Annual Meeting: Collaborate to Innovate June 24-28 | Philadelphia, PA  http://t.co/l5goRtHB  #REGULATORY ...","id":"215464289027358720","lang":"en","created_at":"2012-06-20T15:21:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":21,"end":29,"tag":"eHealth"}],"annotations":[{"start":41,"end":46,"probability":0.9705,"type":"Place","normalized_text":"Dublin"}],"urls":[{"start":65,"end":85,"url":"http://t.co/w9J1eKkY","expanded_url":"http://dlvr.it/1lBWS1","display_url":"dlvr.it/1lBWS1"}]},"source":"TweetDeck","conversation_id":"215464143971557376","referenced_tweets":[{"type":"retweeted","id":"215459142289211393"}],"text":"RT @innovationunion: #eHealth Week 2013, Dublin, dates confirmed http://t.co/w9J1eKkY","id":"215464143971557376","lang":"en","created_at":"2012-06-20T15:20:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":25,"end":30,"tag":"EFSA"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/MN3mqmlD","expanded_url":"http://www.efsa.europa.eu/en/10thanniversary/timeline.htm","display_url":"efsa.europa.eu/en/10thanniver…"}]},"source":"TweetDeck","conversation_id":"215463901486268416","referenced_tweets":[{"type":"retweeted","id":"215460308083425282"}],"text":"RT @EFSA_EU: 10 years of #EFSA at a glance – take a look at the milestones of EFSA’s history in our new timeline: http://t.co/MN3mqmlD","id":"215463901486268416","lang":"en","created_at":"2012-06-20T15:19:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":28,"end":45,"tag":"protectourfuture"},{"start":59,"end":67,"tag":"WDD2012"}],"annotations":{},"urls":[{"start":76,"end":96,"url":"http://t.co/Pd2cI0cn","expanded_url":"http://bit.ly/rQA2mp","display_url":"bit.ly/rQA2mp"},{"start":97,"end":117,"url":"http://t.co/aHG5mI1X","expanded_url":"https://twitter.com/IntDiabetesFed/status/215439234843156481/photo/1","display_url":"pic.twitter.com/aHG5mI1X"}]},"source":"TweetDeck","conversation_id":"215439693200883714","referenced_tweets":[{"type":"retweeted","id":"215439234843156481"}],"text":"RT @IntDiabetesFed: Help us #protectourfuture! Retweet the #WDD2012 banners http://t.co/Pd2cI0cn http://t.co/aHG5mI1X","id":"215439693200883714","lang":"en","created_at":"2012-06-20T13:43:20.000Z","author_id":"116716199","attachments":{"media_keys":["3_215439234851545088"]}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":{},"annotations":{},"urls":[{"start":64,"end":84,"url":"http://t.co/DlKt5EKr","expanded_url":"http://bit.ly/KpPvjQ","display_url":"bit.ly/KpPvjQ"}]},"source":"TweetDeck","conversation_id":"215439650309935105","referenced_tweets":[{"type":"retweeted","id":"215439358315069441"}],"text":"RT @DrugInfoAssn: DIA 2012 Final Program Now Available Online   http://t.co/DlKt5EKr  # DIA2012 Start  Planning Today!","id":"215439650309935105","lang":"en","created_at":"2012-06-20T13:43:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":[{"start":132,"end":137,"tag":"ECPC"}],"annotations":[{"start":30,"end":37,"probability":0.493,"type":"Organization","normalized_text":"facebook"}],"urls":[{"start":111,"end":131,"url":"http://t.co/ii9C1R71","expanded_url":"http://on.fb.me/PrgfQi","display_url":"on.fb.me/PrgfQi"}]},"source":"TweetDeck","conversation_id":"215438168500088832","referenced_tweets":[{"type":"retweeted","id":"215438127756607489"}],"text":"RT @cancereu: We launched our facebook group for our members only a few hours ago and already have 19 members! http://t.co/ii9C1R71 #ECPC","id":"215438168500088832","lang":"en","created_at":"2012-06-20T13:37:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"annotations":[{"start":81,"end":99,"probability":0.577,"type":"Other","normalized_text":"World Hepatitis Day"}],"urls":{}},"source":"TweetDeck","conversation_id":"215418245317001217","referenced_tweets":[{"type":"retweeted","id":"215411047002148864"}],"text":"RT @Hep_Alliance: Reminder - we are developing a facebook application to support World Hepatitis Day 2012. The app will be found on... h ...","id":"215418245317001217","lang":"en","created_at":"2012-06-20T12:18:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eu2012dk","id":"289813776"}],"hashtags":[{"start":110,"end":119,"tag":"eu2012dk"}],"annotations":[{"start":58,"end":59,"probability":0.5419,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":120,"end":140,"url":"http://t.co/XJTX0bQt","expanded_url":"http://bit.ly/LB441G","display_url":"bit.ly/LB441G"}]},"source":"TweetDeck","conversation_id":"215418186689028097","referenced_tweets":[{"type":"retweeted","id":"215404339496366080"}],"text":"RT @eu2012dk: Good results: Increased medicine safety for EU citizens with new agreement on pharmacovigilance #eu2012dk\nhttp://t.co/XJTX0bQt","id":"215418186689028097","lang":"en","created_at":"2012-06-20T12:17:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/FuRHSiTM","expanded_url":"http://bit.ly/PqeqTP","display_url":"bit.ly/PqeqTP"}]},"source":"TweetDeck","conversation_id":"215368178384125952","referenced_tweets":[{"type":"retweeted","id":"215368021215166465"}],"text":"RT @LV_MPA: Ändrad policy för avgiftsbefrielse av klinisk prövning http://t.co/FuRHSiTM","id":"215368178384125952","lang":"sv","created_at":"2012-06-20T08:59:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":105,"end":113,"tag":"DIA2012"}],"annotations":{},"urls":[{"start":84,"end":104,"url":"http://t.co/tJ7OeO1w","expanded_url":"http://bit.ly/M2kpPJ","display_url":"bit.ly/M2kpPJ"}]},"source":"TweetDeck","conversation_id":"215083379513757696","referenced_tweets":[{"type":"retweeted","id":"215083261767073793"}],"text":"RT @DrugInfoAssn: Natural History Studies for Rare Diseases and Orphan Conditions   http://t.co/tJ7OeO1w #DIA2012","id":"215083379513757696","lang":"en","created_at":"2012-06-19T14:07:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"},{"start":69,"end":82,"tag":"counterfeits"}],"annotations":{},"urls":[{"start":48,"end":68,"url":"http://t.co/P1XoIEc7","expanded_url":"http://bit.ly/Lfe9Dm","display_url":"bit.ly/Lfe9Dm"}]},"source":"TweetDeck","conversation_id":"215080243684323329","referenced_tweets":[{"type":"retweeted","id":"215073519720079360"}],"text":"RT @EFPIA: Sale of fake #medicines on the rise: http://t.co/P1XoIEc7 #counterfeits","id":"215080243684323329","lang":"en","created_at":"2012-06-19T13:55:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":40,"end":48,"tag":"WDD2012"},{"start":62,"end":66,"tag":"WDD"}],"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/Pv9BqDLo","expanded_url":"http://bit.ly/MqyNvP","display_url":"bit.ly/MqyNvP"}]},"source":"TweetDeck","conversation_id":"215080080077107201","referenced_tweets":[{"type":"retweeted","id":"215035529392160768"}],"text":"RT @IntDiabetesFed: Only 5 months until #WDD2012! Get the new #WDD Campaign Materials http://t.co/Pv9BqDLo","id":"215080080077107201","lang":"en","created_at":"2012-06-19T13:54:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":25,"end":32,"tag":"orphan"},{"start":107,"end":116,"tag":"Kalydeco"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/QcCGQdm9","expanded_url":"http://bit.ly/NGL46C","display_url":"bit.ly/NGL46C"}]},"source":"Twitter Web Client","conversation_id":"215052005931102209","referenced_tweets":{},"text":"The June report from our #orphan committee is out: 9 new designations and maintenance of orphan status for #Kalydeco: http://t.co/QcCGQdm9","id":"215052005931102209","lang":"en","created_at":"2012-06-19T12:02:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"215038335431884801","referenced_tweets":[{"type":"retweeted","id":"215026978716262401"}],"text":"RT @Aifa_ufficiale: Identificati i meccanismi che permettono a un particolare ceppo di MRSA di resistere alla vancomicina #PilloledalMon ...","id":"215038335431884801","lang":"it","created_at":"2012-06-19T11:08:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":64,"end":73,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":43,"end":63,"url":"http://t.co/Ak32TauK","expanded_url":"http://bit.ly/MqZgti","display_url":"bit.ly/MqZgti"}]},"source":"Twitter Web Client","conversation_id":"215038232835010561","referenced_tweets":[{"type":"retweeted","id":"215017119744667648"}],"text":"RT @LV_MPA: Tjänst som Läkemedelsinspektör http://t.co/Ak32TauK #nyttjobb","id":"215038232835010561","lang":"sv","created_at":"2012-06-19T11:08:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":{},"annotations":[{"start":58,"end":76,"probability":0.3652,"type":"Organization","normalized_text":"Artic Light eHealth"},{"start":81,"end":85,"probability":0.8738,"type":"Place","normalized_text":"Lulea"},{"start":88,"end":93,"probability":0.5968,"type":"Place","normalized_text":"Sweden"}],"urls":{}},"source":"Twitter Web Client","conversation_id":"215037682265493504","referenced_tweets":[{"type":"retweeted","id":"215005081316241409"}],"text":"RT @eupatientsforum: Today starts the two days conference Artic Light eHealth in Lulea, Sweden. Leading politicians, business leaders,.. ...","id":"215037682265493504","lang":"en","created_at":"2012-06-19T11:05:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":45,"end":49,"tag":"low"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"215035660766154754","referenced_tweets":[{"type":"retweeted","id":"214983355450662913"}],"text":"RT @EFSA_EU: EFSA's Scientific Colloquium on #low-dose health effects - 100 scientists debated key issues for food risk assessment http: ...","id":"215035660766154754","lang":"en","created_at":"2012-06-19T10:57:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":24,"end":31,"tag":"orphan"},{"start":94,"end":99,"tag":"rare"},{"start":100,"end":108,"tag":"disease"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/QcCGQdm9","expanded_url":"http://bit.ly/NGL46C","display_url":"bit.ly/NGL46C"}]},"source":"Twitter Web Client","conversation_id":"215028445619564544","referenced_tweets":{},"text":"See the report from our #orphan committee: last week it recommended nine new designations for #rare #disease medicines: http://t.co/QcCGQdm9","id":"215028445619564544","lang":"en","created_at":"2012-06-19T10:29:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":106,"end":126,"url":"http://t.co/LUJglC9V","expanded_url":"http://bit.ly/KNe7Qg","display_url":"bit.ly/KNe7Qg"}]},"source":"Twitter Web Client","conversation_id":"215028036339372032","referenced_tweets":{},"text":"Our website showing suspected side effects of medicines is now available in all 23 official EU languages: http://t.co/LUJglC9V","id":"215028036339372032","lang":"en","created_at":"2012-06-19T10:27:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":54,"end":74,"url":"http://t.co/5rsnkt8q","expanded_url":"http://bit.ly/MkRzc4","display_url":"bit.ly/MkRzc4"}]},"source":"TweetDeck","conversation_id":"215027573913165825","referenced_tweets":[{"type":"retweeted","id":"214973576699314176"}],"text":"RT @LV_MPA: Nya vägledningsdokument för medicinteknik http://t.co/5rsnkt8q","id":"215027573913165825","lang":"sv","created_at":"2012-06-19T10:25:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":11,"tag":"orphan"},{"start":71,"end":80,"tag":"Kalydeco"},{"start":82,"end":92,"tag":"ivacaftor"},{"start":98,"end":105,"tag":"cystic"},{"start":106,"end":115,"tag":"fibrosis"}],"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/QcCGQdm9","expanded_url":"http://bit.ly/NGL46C","display_url":"bit.ly/NGL46C"}]},"source":"bitly bitlink","conversation_id":"214759706290429952","referenced_tweets":{},"text":"Our #orphan committee met last week. It confirmed the orphan status of #Kalydeco (#ivacaftor) for #cystic #fibrosis: http://t.co/QcCGQdm9","id":"214759706290429952","lang":"en","created_at":"2012-06-18T16:41:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":112,"end":120,"tag":"DIA2012"}],"annotations":{},"urls":[{"start":91,"end":111,"url":"http://t.co/l5goRtHB","expanded_url":"http://www.diahome.org/DIA2012","display_url":"diahome.org/DIA2012"}]},"source":"TweetDeck","conversation_id":"214757069801263104","referenced_tweets":[{"type":"retweeted","id":"214756862208380928"}],"text":"RT @DrugInfoAssn: Can’t Make All Four Days? Come for One Day. Register for a One-Day Pass. http://t.co/l5goRtHB #DIA2012","id":"214757069801263104","lang":"en","created_at":"2012-06-18T16:30:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":{},"annotations":{},"urls":[{"start":64,"end":84,"url":"http://t.co/DlKt5EKr","expanded_url":"http://bit.ly/KpPvjQ","display_url":"bit.ly/KpPvjQ"}]},"source":"TweetDeck","conversation_id":"214753349097111554","referenced_tweets":[{"type":"retweeted","id":"214753088202997761"}],"text":"RT @DrugInfoAssn: DIA 2012 Final Program Now Available Online   http://t.co/DlKt5EKr  # DIA2012 Start  Planning Today!","id":"214753349097111554","lang":"en","created_at":"2012-06-18T16:16:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"hashtags":[{"start":101,"end":108,"tag":"Makena"}],"annotations":[{"start":22,"end":24,"probability":0.5653,"type":"Organization","normalized_text":"FDA"}],"urls":{}},"source":"TweetDeck","conversation_id":"214717704844746752","referenced_tweets":[{"type":"retweeted","id":"214717648703991809"}],"text":"RT @FDAWomen: Updated FDA Statement on compounded hydroxyprogesterone caproate (active ingredient in #Makena) for preterm birth http://t ...","id":"214717704844746752","lang":"en","created_at":"2012-06-18T13:54:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/tQro8FvB","expanded_url":"http://bit.ly/Lr6suZ","display_url":"bit.ly/Lr6suZ"},{"start":112,"end":132,"url":"http://t.co/IQhZivad","expanded_url":"http://bit.ly/MmJyiG","display_url":"bit.ly/MmJyiG"}]},"source":"TweetDeck","conversation_id":"214699707082096641","referenced_tweets":[{"type":"retweeted","id":"214699534272561152"}],"text":"RT @LV_MPA: EMAs portal för biverkningsrapporter finns nu på svenska. http://t.co/tQro8FvB Läs mer om portalen: http://t.co/IQhZivad","id":"214699707082096641","lang":"sv","created_at":"2012-06-18T12:42:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"EuroParlPress","id":"199196447"}],"hashtags":[{"start":33,"end":38,"tag":"MEPs"},{"start":98,"end":101,"tag":"EP"}],"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/RvG3Jcoo","expanded_url":"http://bit.ly/Mlenqe","display_url":"bit.ly/Mlenqe"}]},"source":"TweetDeck","conversation_id":"214699665118081025","referenced_tweets":[{"type":"retweeted","id":"214699132491792384"}],"text":"RT @EuroParlPress: Horizon 2020: #MEPs debate plan to stimulate research and innovation at 3 p.m. #EP live: http://t.co/RvG3Jcoo","id":"214699665118081025","lang":"en","created_at":"2012-06-18T12:42:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"214696901445025793","referenced_tweets":[{"type":"retweeted","id":"214696828032122880"}],"text":"RT @EFSA_EU: EFSA new Scientific Committee &amp; Panels. Of members: 41% from universities 39% public institutes &amp; 15% government bo ...","id":"214696901445025793","lang":"en","created_at":"2012-06-18T12:31:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}],"annotations":{},"urls":[{"start":74,"end":94,"url":"http://t.co/worgzmBM","expanded_url":"http://bit.ly/LMYQSf","display_url":"bit.ly/LMYQSf"}]},"source":"Twitter Web Client","conversation_id":"214696555800829955","referenced_tweets":{},"text":"Our #veterinary committee (#CVMP) met last week. See the highlights here: http://t.co/worgzmBM","id":"214696555800829955","lang":"en","created_at":"2012-06-18T12:30:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":26,"end":37,"tag":"monoclonal"},{"start":38,"end":47,"tag":"antibody"},{"start":78,"end":90,"tag":"biosimilars"},{"start":102,"end":117,"tag":"immunogenicity"}],"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/mmSoCm7O","expanded_url":"http://bit.ly/Lg5bXG","display_url":"bit.ly/Lg5bXG"}]},"source":"Twitter Web Client","conversation_id":"214692129908330496","referenced_tweets":{},"text":"The final versions of our #monoclonal #antibody guidelines are online: one on #biosimilars and one on #immunogenicity: http://t.co/mmSoCm7O","id":"214692129908330496","lang":"en","created_at":"2012-06-18T12:12:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/LUJglC9V","expanded_url":"http://bit.ly/KNe7Qg","display_url":"bit.ly/KNe7Qg"}]},"source":"Twitter Web Client","conversation_id":"214691759454818305","referenced_tweets":{},"text":"We've updated our website showing suspected side effects of medicines: now available in all 23 official EU languages: http://t.co/LUJglC9V","id":"214691759454818305","lang":"en","created_at":"2012-06-18T12:11:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":118,"end":131,"tag":"epidemiology"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/4XKwpdDM","expanded_url":"http://bit.ly/Mmp21D","display_url":"bit.ly/Mmp21D"}]},"source":"TweetDeck","conversation_id":"214673581190287361","referenced_tweets":[{"type":"retweeted","id":"214673544322355200"}],"text":"RT @ECDC_EU: #ESCAIDE 2012: Check the guidelines for presentations and posters at the conference http://t.co/4XKwpdDM #epidemiology","id":"214673581190287361","lang":"en","created_at":"2012-06-18T10:59:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"EUCouncilPress","id":"198618575"}],"hashtags":[{"start":20,"end":30,"tag":"EUCouncil"},{"start":105,"end":114,"tag":"eu2012dk"},{"start":115,"end":120,"tag":"agri"}],"annotations":{},"urls":[{"start":84,"end":104,"url":"http://t.co/5OhRedSK","expanded_url":"http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/agricult/131032.pdf","display_url":"consilium.europa.eu/uedocs/cms_Dat…"}]},"source":"TweetDeck","conversation_id":"214669703241662464","referenced_tweets":[{"type":"retweeted","id":"214653272131248129"}],"text":"RT @EUCouncilPress: #EUCouncil conclusions on the protection and welfare of animals http://t.co/5OhRedSK #eu2012dk #agri","id":"214669703241662464","lang":"en","created_at":"2012-06-18T10:43:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":18,"end":29,"tag":"biosimilar"},{"start":30,"end":41,"tag":"monoclonal"},{"start":42,"end":53,"tag":"antibodies"},{"start":61,"end":76,"tag":"immunogenicity"},{"start":80,"end":85,"tag":"mAbs"}],"annotations":{},"urls":[{"start":105,"end":125,"url":"http://t.co/mmSoCm7O","expanded_url":"http://bit.ly/Lg5bXG","display_url":"bit.ly/Lg5bXG"}]},"source":"Twitter Web Client","conversation_id":"214649980827344896","referenced_tweets":{},"text":"Our guidelines on #biosimilar #monoclonal #antibodies and on #immunogenicity of #mAbs are now available: http://t.co/mmSoCm7O","id":"214649980827344896","lang":"en","created_at":"2012-06-18T09:25:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":95,"end":115,"url":"http://t.co/LUJglC9V","expanded_url":"http://bit.ly/KNe7Qg","display_url":"bit.ly/KNe7Qg"}]},"source":"bitly bitlink","conversation_id":"214642049872433152","referenced_tweets":{},"text":"Our website of suspected side-effect reports is now available in all 23 official EU languages: http://t.co/LUJglC9V","id":"214642049872433152","lang":"en","created_at":"2012-06-18T08:53:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":14,"end":25,"tag":"Veterinary"},{"start":37,"end":42,"tag":"CVMP"}],"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/worgzmBM","expanded_url":"http://bit.ly/LMYQSf","display_url":"bit.ly/LMYQSf"}]},"source":"bitly bitlink","conversation_id":"214615214291820545","referenced_tweets":{},"text":"Last week the #Veterinary Committee (#CVMP) met. Please see the report here: http://t.co/worgzmBM","id":"214615214291820545","lang":"en","created_at":"2012-06-18T07:07:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/w19JSZgF","expanded_url":"http://bit.ly/ORx06U","display_url":"bit.ly/ORx06U"}]},"source":"TweetDeck","conversation_id":"213666841749504000","referenced_tweets":[{"type":"retweeted","id":"213665375450169345"}],"text":"RT @LV_MPA: Översyn av kriterier för utbytbarhet av depotberedningar http://t.co/w19JSZgF","id":"213666841749504000","lang":"sv","created_at":"2012-06-15T16:18:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":44,"end":55,"tag":"veterinary"}],"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/worgzmBM","expanded_url":"http://bit.ly/LMYQSf","display_url":"bit.ly/LMYQSf"}]},"source":"bitly bitlink","conversation_id":"213665760466321408","referenced_tweets":{},"text":"We've published the outcomes of this week's #veterinary committee: http://t.co/worgzmBM","id":"213665760466321408","lang":"en","created_at":"2012-06-15T16:14:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":83,"end":96,"tag":"epidemiology"}],"annotations":{},"urls":[{"start":62,"end":82,"url":"http://t.co/9vidUpOR","expanded_url":"http://bit.ly/MbPw87","display_url":"bit.ly/MbPw87"}]},"source":"TweetDeck","conversation_id":"213664520634236928","referenced_tweets":[{"type":"retweeted","id":"213664222373085185"}],"text":"RT @ECDC_EU: #ESCAIDE 2012 provisional programme is now live: http://t.co/9vidUpOR #epidemiology","id":"213664520634236928","lang":"en","created_at":"2012-06-15T16:09:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":26,"tag":"Legionnaires"},{"start":58,"end":66,"tag":"anthrax"}],"annotations":[{"start":39,"end":47,"probability":0.997,"type":"Place","normalized_text":"Edinburgh"},{"start":70,"end":76,"probability":0.9967,"type":"Place","normalized_text":"Germany"},{"start":80,"end":81,"probability":0.4208,"type":"Organization","normalized_text":"EU"}],"urls":{}},"source":"TweetDeck","conversation_id":"213647371773550592","referenced_tweets":[{"type":"retweeted","id":"213646372572889089"}],"text":"RT @ECDC_EU: #Legionnaires' disease in Edinburgh, case of #anthrax in Germany - EU threats ECDC is monitoring. Read the CDTR http://t.co ...","id":"213647371773550592","lang":"en","created_at":"2012-06-15T15:01:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":60,"end":71,"tag":"monoclonal"},{"start":72,"end":83,"tag":"antibodies"},{"start":95,"end":107,"tag":"biosimilars"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/mmSoCm7O","expanded_url":"http://bit.ly/Lg5bXG","display_url":"bit.ly/Lg5bXG"}]},"source":"bitly bitlink","conversation_id":"213638107696861184","referenced_tweets":{},"text":"We've published guidance on developing medicines containing #monoclonal #antibodies, including #biosimilars: http://t.co/mmSoCm7O","id":"213638107696861184","lang":"en","created_at":"2012-06-15T14:24:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":27,"end":35,"username":"YouTube","id":"10228272"}],"hashtags":{},"annotations":{},"urls":[{"start":75,"end":95,"url":"http://t.co/1XfJVF5v","expanded_url":"http://youtu.be/XqYneauL0Zs?a","display_url":"youtu.be/XqYneauL0Zs?a"}]},"source":"TweetDeck","conversation_id":"213633520868925441","referenced_tweets":[{"type":"retweeted","id":"213633050242859008"}],"text":"RT @agesnews: Ich habe ein @YouTube-Video zu meinen Favoriten hinzugefügt. http://t.co/1XfJVF5v 100 + 2 Jahre AGES Mödling","id":"213633520868925441","lang":"de","created_at":"2012-06-15T14:06:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":22,"tag":"Syphilis"},{"start":24,"end":35,"tag":"gonorrhoea"},{"start":37,"end":47,"tag":"chlamydia"},{"start":58,"end":62,"tag":"STI"},{"start":119,"end":126,"tag":"Europe"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213619722615390208","referenced_tweets":[{"type":"retweeted","id":"213619688658309121"}],"text":"RT @ECDC_EU: #Syphilis, #gonorrhoea, #chlamydia and other #STI: latest surveillance maps give overview of situation in #Europe http://t. ...","id":"213619722615390208","lang":"en","created_at":"2012-06-15T13:11:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":103,"end":119,"username":"antoniotajanieu","id":"3029538799"},{"start":120,"end":134,"username":"EU_enterprise","id":"2562735307"}],"hashtags":[{"start":19,"end":24,"tag":"SMEs"},{"start":64,"end":81,"tag":"entrepreneurship"}],"annotations":{},"urls":[{"start":82,"end":102,"url":"http://t.co/uijhrheo","expanded_url":"http://bit.ly/KyJ6V0","display_url":"bit.ly/KyJ6V0"}]},"source":"TweetDeck","conversation_id":"213610853004615680","referenced_tweets":[{"type":"retweeted","id":"213610810411454465"}],"text":"RT @EU_Commission: #SMEs: Better access to finance and boosting #entrepreneurship http://t.co/uijhrheo @AntonioTajaniEU @EU_Enterprise","id":"213610853004615680","lang":"en","created_at":"2012-06-15T12:36:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":117,"end":133,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213609552426434563","referenced_tweets":[{"type":"retweeted","id":"213609063316074497"}],"text":"RT @Aifa_ufficiale: Un nuovo modello computerizzato capace di prevedere gli effetti collaterali negativi dei farmaci #PilloledalMondo... ...","id":"213609552426434563","lang":"it","created_at":"2012-06-15T12:31:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"}],"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":68,"end":75,"tag":"Health"},{"start":97,"end":101,"tag":"ICT"},{"start":102,"end":106,"tag":"FP7"},{"start":107,"end":117,"tag":"EUScience"},{"start":118,"end":126,"tag":"eHealth"},{"start":127,"end":132,"tag":"tech"}],"annotations":{},"urls":[{"start":76,"end":96,"url":"http://t.co/LHjZL8fi","expanded_url":"http://ow.ly/bxZtt","display_url":"ow.ly/bxZtt"}]},"source":"TweetDeck","conversation_id":"213609475750371328","referenced_tweets":[{"type":"retweeted","id":"213609391184805888"}],"text":"RT @DigitalAgendaEU: #EU research projects delivering High-Tech for #Health http://t.co/LHjZL8fi #ICT #FP7 #EUScience #eHealth #tech","id":"213609475750371328","lang":"en","created_at":"2012-06-15T12:30:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":45,"end":48,"tag":"EU"},{"start":56,"end":63,"tag":"health"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/yco7dd4Z","expanded_url":"http://svy.mk/LhFSQe","display_url":"svy.mk/LhFSQe"}]},"source":"TweetDeck","conversation_id":"213606760022421504","referenced_tweets":[{"type":"retweeted","id":"213605602058973184"}],"text":"RT @EU_Health: We are reviewing our official #EU public #health portal and welcome your feedback http://t.co/yco7dd4Z. Thank you!","id":"213606760022421504","lang":"en","created_at":"2012-06-15T12:19:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":54,"end":64,"username":"TheLancet","id":"27013292"}],"hashtags":[{"start":13,"end":24,"tag":"Gonorrhoea"}],"annotations":{},"urls":[{"start":65,"end":85,"url":"http://t.co/mUTvwaHO","expanded_url":"http://bit.ly/Lftqp5","display_url":"bit.ly/Lftqp5"}]},"source":"TweetDeck","conversation_id":"213593163330359296","referenced_tweets":[{"type":"retweeted","id":"213593135622791169"}],"text":"RT @ECDC_EU: #Gonorrhoea—old disease, new threat from @TheLancet http://t.co/mUTvwaHO","id":"213593163330359296","lang":"en","created_at":"2012-06-15T11:25:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213584044661809152","referenced_tweets":[{"type":"retweeted","id":"213571479936307200"}],"text":"RT @Hep_Alliance: What's the difference between a curable and incurable HBV or other viral infection? Looks like it might only be a... h ...","id":"213584044661809152","lang":"en","created_at":"2012-06-15T10:49:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"annotations":{},"urls":[{"start":95,"end":115,"url":"http://t.co/LNQkbGi2","expanded_url":"http://fb.me/19nki2iek","display_url":"fb.me/19nki2iek"}]},"source":"TweetDeck","conversation_id":"213584006833385472","referenced_tweets":[{"type":"retweeted","id":"213571282153914368"}],"text":"RT @Hep_Alliance: Scientists Show Lack of Single Protein Results in Persistent Viral Infection http://t.co/LNQkbGi2","id":"213584006833385472","lang":"en","created_at":"2012-06-15T10:49:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":28,"end":38,"username":"TheLancet","id":"27013292"}],"hashtags":[{"start":75,"end":89,"tag":"antimicrobial"},{"start":90,"end":96,"tag":"drugs"}],"annotations":[{"start":40,"end":45,"probability":0.9861,"type":"Place","normalized_text":"Europe"}],"urls":[{"start":97,"end":117,"url":"http://t.co/2iNs3tr2","expanded_url":"http://bit.ly/LYN8RO","display_url":"bit.ly/LYN8RO"}]},"source":"TweetDeck","conversation_id":"213563545407852544","referenced_tweets":[{"type":"retweeted","id":"213553656656691200"}],"text":"RT @IMI_JU: IMI featured in @TheLancet: Europe to boost development of new #antimicrobial #drugs http://t.co/2iNs3tr2","id":"213563545407852544","lang":"en","created_at":"2012-06-15T09:28:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":75,"end":82,"tag":"animal"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213563408719675392","referenced_tweets":[{"type":"retweeted","id":"213557823295070209"}],"text":"RT @EFSA_EU: #EFSA: establishing a framework for future scientific work on #animal-based measures to assess the welfare of animals: http ...","id":"213563408719675392","lang":"en","created_at":"2012-06-15T09:27:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":0,"end":8,"username":"kerfors","id":"144624330"},{"start":9,"end":23,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213347187873169409","referenced_tweets":[{"type":"replied_to","id":"213347187873169409"}],"text":"@kerfors @FDA_Drug_Info Thank you for your tweet. Please forward your request to info@ema.europa.eu so that we can respond to you directly.","id":"213545799068565505","lang":"en","created_at":"2012-06-15T08:17:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"144624330"},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":36,"end":40,"tag":"DIA"}],"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/coflzQBW","expanded_url":"http://bit.ly/DIA2012preview","display_url":"bit.ly/DIA2012preview"}]},"source":"TweetDeck","conversation_id":"213275639128670209","referenced_tweets":[{"type":"retweeted","id":"213275602168451073"}],"text":"RT @DrugInfoAssn: Are you ready for #DIA 2012? Check out this podcast http://t.co/coflzQBW","id":"213275639128670209","lang":"en","created_at":"2012-06-14T14:24:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":[{"start":73,"end":78,"tag":"NICE"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213248853980348416","referenced_tweets":[{"type":"retweeted","id":"213248801371209728"}],"text":"RT @NICEcomms: We're reviewing our technology appraisal 'manual' aka the #NICE methods guide. Draft for consultation here:  http://t.co/ ...","id":"213248853980348416","lang":"en","created_at":"2012-06-14T12:37:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":{},"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/B1WFEPXW","expanded_url":"http://bit.ly/fm4MvN","display_url":"bit.ly/fm4MvN"}]},"source":"TweetDeck","conversation_id":"213245858282614784","referenced_tweets":[{"type":"retweeted","id":"213245715210715136"}],"text":"RT @euparkinsons: Move 4 Change Part III, survey open 11 April - 28 Oct 2012, please don't forget 2 fill in our survey: http://t.co/B1WFEPXW","id":"213245858282614784","lang":"en","created_at":"2012-06-14T12:25:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":41,"end":49,"tag":"WDD2012"},{"start":51,"end":68,"tag":"protectourfuture"},{"start":90,"end":94,"tag":"WDD"}],"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/BS9Q1MPN","expanded_url":"http://bit.ly/mRYAjo","display_url":"bit.ly/mRYAjo"}]},"source":"TweetDeck","conversation_id":"213239397582258176","referenced_tweets":[{"type":"retweeted","id":"213239367404224512"}],"text":"RT @IntDiabetesFed: Only 5 months before #WDD2012! #protectourfuture http://t.co/BS9Q1MPN #WDD","id":"213239397582258176","lang":"en","created_at":"2012-06-14T12:00:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":42,"end":56,"tag":"Schmallenberg"}],"annotations":[{"start":126,"end":127,"probability":0.5237,"type":"Place","normalized_text":"EU"}],"urls":{}},"source":"TweetDeck","conversation_id":"213220915721416704","referenced_tweets":[{"type":"retweeted","id":"213212687025438721"}],"text":"RT @EFSA_EU: #EFSA's impact assessment of #Schmallenberg virus on animal health/production/welfare. 3745 holdings affected in EU the htt ...","id":"213220915721416704","lang":"en","created_at":"2012-06-14T10:46:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"hashtags":[{"start":16,"end":20,"tag":"WDD"},{"start":21,"end":38,"tag":"protectourfuture"},{"start":59,"end":64,"tag":"blue"},{"start":92,"end":101,"tag":"diabetes"}],"annotations":{},"urls":[{"start":71,"end":91,"url":"http://t.co/6G0HWjVE","expanded_url":"http://bit.ly/JIiN8n","display_url":"bit.ly/JIiN8n"}]},"source":"TweetDeck","conversation_id":"213220897031585793","referenced_tweets":[{"type":"retweeted","id":"213211143613849600"}],"text":"RT @WDD: RT our #WDD #protectourfuture video to spread the #blue word! http://t.co/6G0HWjVE #diabetes","id":"213220897031585793","lang":"en","created_at":"2012-06-14T10:46:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"213207003005333504","referenced_tweets":[{"type":"retweeted","id":"213206156045320192"}],"text":"RT @Legemiddelinfo: Endring i lovverk for legemiddelovervåking: I juli oppdateres gjeldende lovverk for legemiddelovervåking. Det gj...  ...","id":"213207003005333504","lang":"no","created_at":"2012-06-14T09:51:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":[{"start":63,"end":71,"tag":"Barroso"}],"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/gI2zhzRq","expanded_url":"http://bit.ly/LZI95A","display_url":"bit.ly/LZI95A"}]},"source":"TweetDeck","conversation_id":"213200570410999808","referenced_tweets":[{"type":"retweeted","id":"213191997970857984"}],"text":"RT @beuctweet: BEUC 50 years - Check our website for president #Barroso video message http://t.co/gI2zhzRq","id":"213200570410999808","lang":"en","created_at":"2012-06-14T09:25:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":118,"end":124,"tag":"lvsme"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/c2ba4K3u","expanded_url":"http://tinyurl.com/c6boekn","display_url":"tinyurl.com/c6boekn"}]},"source":"TweetDeck","conversation_id":"213200409915961344","referenced_tweets":[{"type":"retweeted","id":"213191662413950976"}],"text":"RT @LV_MPA: Presentationer ifrån gårdagens möte om vetenskaplig rådgivning är nu publicerade här http://t.co/c2ba4K3u #lvsme","id":"213200409915961344","lang":"sv","created_at":"2012-06-14T09:25:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"annotations":[{"start":93,"end":101,"probability":0.9955,"type":"Place","normalized_text":"Edinburgh"},{"start":104,"end":111,"probability":0.7468,"type":"Place","normalized_text":"Scotland"}],"urls":[{"start":114,"end":134,"url":"http://t.co/RQyaKfcy","expanded_url":"http://bit.ly/MQgXXA","display_url":"bit.ly/MQgXXA"}]},"source":"TweetDeck","conversation_id":"213200250796646400","referenced_tweets":[{"type":"retweeted","id":"213188863445839872"}],"text":"RT @ECDC_EU: Legionnaires' diseaase: ECDC assesses risk related to the community oubtreak in Edinburgh, Scotland. http://t.co/RQyaKfcy # ...","id":"213200250796646400","lang":"en","created_at":"2012-06-14T09:24:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":22,"end":32,"tag":"gonorrhea"},{"start":50,"end":57,"tag":"Europe"}],"annotations":{},"urls":[{"start":58,"end":78,"url":"http://t.co/kAesObUp","expanded_url":"http://reut.rs/KnYOSF","display_url":"reut.rs/KnYOSF"}]},"source":"TweetDeck","conversation_id":"212947086533070849","referenced_tweets":[{"type":"retweeted","id":"212926598582779905"}],"text":"RT @EPHA_EU: Superbug #gonorrhea spreading across #Europe:http://t.co/kAesObUp→ “It may become untreatable in the near future” #Antimicr ...","id":"212947086533070849","lang":"en","created_at":"2012-06-13T16:38:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":66,"end":76,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":88,"end":108,"url":"http://t.co/IVZNiXae","expanded_url":"http://bit.ly/LChYkD","display_url":"bit.ly/LChYkD"}]},"source":"TweetDeck","conversation_id":"212947009596964865","referenced_tweets":[{"type":"retweeted","id":"212922308594110467"}],"text":"RT @euparkinsons: A molecular signature in blood identifies early #Parkinson's disease: http://t.co/IVZNiXae","id":"212947009596964865","lang":"en","created_at":"2012-06-13T16:38:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"annotations":{},"urls":[{"start":103,"end":123,"url":"http://t.co/rB7a0J9d","expanded_url":"http://bit.ly/Nyax0P","display_url":"bit.ly/Nyax0P"}]},"source":"TweetDeck","conversation_id":"212946900343726080","referenced_tweets":[{"type":"retweeted","id":"212919194604404738"}],"text":"RT @ECDC_EU: ECDC publishes Directors annual report, detailing ECDC's work and challenges during 2011. http://t.co/rB7a0J9d","id":"212946900343726080","lang":"en","created_at":"2012-06-13T16:37:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":17,"tag":"Low"},{"start":34,"end":45,"tag":"toxicology"},{"start":47,"end":52,"tag":"EFSA"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212883154657226752","referenced_tweets":[{"type":"retweeted","id":"212880483535687680"}],"text":"RT @EFSA_EU: #Low-dose effects in #toxicology: #EFSA’s international scientific debate on key issues for risk assessment in the EU: http ...","id":"212883154657226752","lang":"en","created_at":"2012-06-13T12:24:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{},"urls":[{"start":76,"end":96,"url":"http://t.co/H28iGIlU","expanded_url":"http://bit.ly/MrqOSZ","display_url":"bit.ly/MrqOSZ"}]},"source":"TweetDeck","conversation_id":"212881278729588736","referenced_tweets":[{"type":"retweeted","id":"212878045269331968"}],"text":"RT @NICEcomms: Want to work at NICE? We have vacancies for a medical writer http://t.co/H28iGIlU and a a technical advisor http://t.co/q ...","id":"212881278729588736","lang":"en","created_at":"2012-06-13T12:17:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":96,"end":102,"tag":"lvsme"}],"annotations":{},"urls":[{"start":75,"end":95,"url":"http://t.co/ncFCCDON","expanded_url":"http://j.mp/MDE4Bm","display_url":"j.mp/MDE4Bm"}]},"source":"TweetDeck","conversation_id":"212880434923708417","referenced_tweets":[{"type":"retweeted","id":"212871101779419136"}],"text":"RT @LV_MPA: SME-guiden är till hjälp för företag, forskare och innovatörer http://t.co/ncFCCDON #lvsme","id":"212880434923708417","lang":"sv","created_at":"2012-06-13T12:13:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":103,"end":109,"tag":"lvsme"}],"annotations":{},"urls":[{"start":82,"end":102,"url":"http://t.co/TTC8EpXw","expanded_url":"http://j.mp/MDGeRq","display_url":"j.mp/MDGeRq"}]},"source":"TweetDeck","conversation_id":"212880350156816384","referenced_tweets":[{"type":"retweeted","id":"212873362786091008"}],"text":"RT @LV_MPA: ATMP-klassificering går att göra utan kostnad för SME-företag hos EMA http://t.co/TTC8EpXw #lvsme","id":"212880350156816384","lang":"sv","created_at":"2012-06-13T12:13:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":76,"end":82,"tag":"lvsme"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212850385671561216","referenced_tweets":[{"type":"retweeted","id":"212823007033438208"}],"text":"RT @LV_MPA: SME-företag får 90% rabatt vid vetenskaplig rådgivning från EMA #lvsme","id":"212850385671561216","lang":"sv","created_at":"2012-06-13T10:14:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":108,"end":124,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212850279698268160","referenced_tweets":[{"type":"retweeted","id":"212827521870348289"}],"text":"RT @Aifa_ufficiale: L’OMS lancia l’allarme per la diffusione di una forma di gonorrea resistente ai farmaci #PilloledalMondo... http://t ...","id":"212850279698268160","lang":"it","created_at":"2012-06-13T10:13:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":74,"end":77,"tag":"EU"},{"start":87,"end":99,"tag":"RareDisease"}],"annotations":[{"start":103,"end":110,"probability":0.9813,"type":"Place","normalized_text":"Brussels"}],"urls":[{"start":113,"end":133,"url":"http://t.co/VHcXwf1V","expanded_url":"http://bit.ly/L2yjjH","display_url":"bit.ly/L2yjjH"}]},"source":"TweetDeck","conversation_id":"212563693584650240","referenced_tweets":[{"type":"retweeted","id":"212563660177031169"}],"text":"RT @eurordis: New video playlist from the opening session of last months' #EU conf. on #RareDisease in Brussels. http://t.co/VHcXwf1V","id":"212563693584650240","lang":"en","created_at":"2012-06-12T15:15:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":28,"end":32,"tag":"WDD"},{"start":33,"end":50,"tag":"protectourfuture"}],"annotations":{},"urls":[{"start":81,"end":101,"url":"http://t.co/bpgaHddj","expanded_url":"http://bit.ly/JIiN8n","display_url":"bit.ly/JIiN8n"}]},"source":"TweetDeck","conversation_id":"212525133351489538","referenced_tweets":[{"type":"retweeted","id":"212521650737000449"}],"text":"RT @IntDiabetesFed: The new #WDD #protectourfuture video is out! Do you like it? http://t.co/bpgaHddj","id":"212525133351489538","lang":"en","created_at":"2012-06-12T12:41:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212524888324448256","referenced_tweets":[{"type":"retweeted","id":"212515671022645248"}],"text":"RT @Legemiddelinfo: Ny europeisk webside for bivirkningsrapporter: Den europeiske legemiddelmyndigheten (EMA) lanserte nylig en nett...  ...","id":"212524888324448256","lang":"no","created_at":"2012-06-12T12:40:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"hashtags":{},"annotations":{},"urls":[{"start":113,"end":133,"url":"http://t.co/sLBwvKSY","expanded_url":"http://www.alz.co.uk/research/world-report-2012","display_url":"alz.co.uk/research/world…"}]},"source":"TweetDeck","conversation_id":"212512050629455873","referenced_tweets":[{"type":"retweeted","id":"212506388096753665"}],"text":"RT @AlzDisInt: Looking for people with dementia and carers to answer our survey on stigma - just a few days left http://t.co/sLBwvKSY","id":"212512050629455873","lang":"en","created_at":"2012-06-12T11:49:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":103,"end":119,"username":"PharmTechnology","id":"48667276"},{"start":120,"end":126,"username":"PhRMA","id":"116748080"}],"hashtags":{},"annotations":[{"start":49,"end":78,"probability":0.6457,"type":"Organization","normalized_text":"Anticounterfeiting Initiatives"}],"urls":[{"start":82,"end":102,"url":"http://t.co/O72NDN3X","expanded_url":"http://bit.ly/KzH14r","display_url":"bit.ly/KzH14r"}]},"source":"TweetDeck","conversation_id":"212501469809737728","referenced_tweets":[{"type":"retweeted","id":"212475001910210562"}],"text":"RT @EFPIA: Pharma Associations Provide Update on Anticounterfeiting Initiatives - http://t.co/O72NDN3X @PharmTechnology @PhRMA @GIRPBrus ...","id":"212501469809737728","lang":"en","created_at":"2012-06-12T11:07:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212465720536219649","referenced_tweets":[{"type":"retweeted","id":"212465667075608576"}],"text":"RT @Aifa_ufficiale: FDA ha approvato il farmaco pertuzumab, nuovo trattamento contro il tumore del seno Her2-positivo in stadio... http: ...","id":"212465720536219649","lang":"it","created_at":"2012-06-12T08:45:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"urls":[{"start":61,"end":81,"url":"http://t.co/XskJekMk","expanded_url":"http://www.aemps.gob.es","display_url":"aemps.gob.es"}]},"source":"TweetDeck","conversation_id":"212222554889388032","referenced_tweets":[{"type":"retweeted","id":"212222508437479425"}],"text":"RT @AEMPSGOB: Boletín anual de Farmacovigilancia Veterinaria http://t.co/XskJekMk","id":"212222554889388032","lang":"und","created_at":"2012-06-11T16:39:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":{},"annotations":[{"start":19,"end":21,"probability":0.8988,"type":"Organization","normalized_text":"FDA"}],"urls":[{"start":78,"end":98,"url":"http://t.co/hep5bmzj","expanded_url":"http://1.usa.gov/Perjeta","display_url":"1.usa.gov/Perjeta"}]},"source":"TweetDeck","conversation_id":"212214140499017728","referenced_tweets":[{"type":"retweeted","id":"212212269713588225"}],"text":"RT @FDA_Drug_Info: FDA approves Perjeta for type of late-stage breast cancer. http://t.co/hep5bmzj","id":"212214140499017728","lang":"en","created_at":"2012-06-11T16:06:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"hashtags":[{"start":12,"end":22,"tag":"Marketing"},{"start":114,"end":121,"tag":"eurlex"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212200678880321537","referenced_tweets":[{"type":"retweeted","id":"212198873060491264"}],"text":"RT @EURLex: #Marketing authorisations: financial penalties for infringement of certain obligations in connection. #eurlex: http://t.co/c ...","id":"212200678880321537","lang":"fr","created_at":"2012-06-11T15:12:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":18,"tag":"ECDC"},{"start":108,"end":119,"tag":"gonorrhoea"},{"start":123,"end":130,"tag":"Europe"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212167023655006209","referenced_tweets":[{"type":"retweeted","id":"212157430459678721"}],"text":"RT @ECDC_EU: #ECDC launches Plan with recommendations and strategies in response to increasingly resistant  #gonorrhoea in #Europe  http ...","id":"212167023655006209","lang":"en","created_at":"2012-06-11T12:58:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":58,"end":66,"tag":"measles"},{"start":68,"end":76,"tag":"rubella"},{"start":107,"end":116,"tag":"euro2012"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212166997654503424","referenced_tweets":[{"type":"retweeted","id":"212156286983348224"}],"text":"RT @WHO_Europe: Get your questions answered about crowds, #measles, #rubella and other health concerns for #euro2012 here: http://t.co/O ...","id":"212166997654503424","lang":"en","created_at":"2012-06-11T12:58:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":24,"tag":"Gonorrhoea"},{"start":73,"end":80,"tag":"Europe"},{"start":128,"end":132,"tag":"AMR"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212166955136847872","referenced_tweets":[{"type":"retweeted","id":"212156157110915072"}],"text":"RT @ECDC_EU: #Gonorrhoea: increasing number of treatment failures across #Europe indicate risk of disease becoming untreatable. #AMR htt ...","id":"212166955136847872","lang":"en","created_at":"2012-06-11T12:58:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":{},"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/SjzfpRIv","expanded_url":"http://goo.gl/tWw6f","display_url":"goo.gl/tWw6f"}]},"source":"TweetDeck","conversation_id":"212166924484886528","referenced_tweets":[{"type":"retweeted","id":"212154502562840576"}],"text":"RT @DrugInfoAssn: DIA 2012 Final Program is Now Available Online!  http://t.co/SjzfpRIv","id":"212166924484886528","lang":"en","created_at":"2012-06-11T12:58:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"UNAIDS","id":"19177501"}],"hashtags":[{"start":63,"end":67,"tag":"hiv"},{"start":80,"end":92,"tag":"infographic"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212166746189205506","referenced_tweets":[{"type":"retweeted","id":"212149711916908544"}],"text":"RT @UNAIDS: Every minute, a young woman is newly infected with #hiv. Our latest #infographic shares more info on young women &amp; hiv:  ...","id":"212166746189205506","lang":"en","created_at":"2012-06-11T12:57:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"annotations":[{"start":113,"end":127,"probability":0.413,"type":"Place","normalized_text":"World Hepatitis"}],"urls":{}},"source":"TweetDeck","conversation_id":"212166706964086785","referenced_tweets":[{"type":"retweeted","id":"212146855352610816"}],"text":"RT @Hep_Alliance: Like last year, the Alliance is producing a campaign video to raise awareness in the run-up to World Hepatitis... http ...","id":"212166706964086785","lang":"en","created_at":"2012-06-11T12:57:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212131661859663873","referenced_tweets":[{"type":"retweeted","id":"212131337820307457"}],"text":"RT @eupatientsforum: EPF President participates at the “HOSPAGE” two days conference: “Ageing Health Workforce - Ageing patients:... htt ...","id":"212131661859663873","lang":"en","created_at":"2012-06-11T10:38:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":102,"end":117,"username":"MeaslesRubella","id":"351342476"},{"start":128,"end":135,"username":"UNICEF","id":"33933259"}],"hashtags":[{"start":86,"end":91,"tag":"blog"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212121904037900288","referenced_tweets":[{"type":"retweeted","id":"212121857854414849"}],"text":"RT @ECDC_EU: Measles mortality reduction: A successful global public health strategy; #blog entry fr  @MeaslesRubella website;  @UNICEF","id":"212121904037900288","lang":"en","created_at":"2012-06-11T09:59:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212116093911842817","referenced_tweets":[{"type":"retweeted","id":"212115829502902272"}],"text":"RT @nice_intl: Draft PAHO report recommends incorporation of HTA into health systems to help ensure high quality, affordaable care http: ...","id":"212116093911842817","lang":"en","created_at":"2012-06-11T09:36:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":[{"start":73,"end":75,"probability":0.8309,"type":"Organization","normalized_text":"NHS"}],"urls":{}},"source":"TweetDeck","conversation_id":"212110229310156801","referenced_tweets":[{"type":"retweeted","id":"212109467800698880"}],"text":"RT @NICEcomms: We're looking for a GP to join our committee advising the NHS on Medical Technologies and help influence health policy ht ...","id":"212110229310156801","lang":"en","created_at":"2012-06-11T09:13:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":72,"end":85,"tag":"microbiology"},{"start":90,"end":103,"tag":"epidemiology"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"212100660936712193","referenced_tweets":[{"type":"retweeted","id":"212100629068394496"}],"text":"RT @ECDC_EU: #ESCAIDE 2012: Abstracts that highlight the interaction of #microbiology and #epidemiology are particularly welcomed http:/ ...","id":"212100660936712193","lang":"en","created_at":"2012-06-11T08:35:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":53,"end":61,"username":"EIP_AHA","id":"416925949"}],"hashtags":[{"start":31,"end":37,"tag":"Dalli"},{"start":112,"end":119,"tag":"ageing"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/LGVg1olA","expanded_url":"http://bit.ly/Mh0UOR","display_url":"bit.ly/Mh0UOR"}]},"source":"TweetDeck","conversation_id":"212098331860680704","referenced_tweets":[{"type":"retweeted","id":"212098256568729600"}],"text":"RT @EU_Consumer: Read on Cssr. #Dalli's blog about   @EIP_AHA stakeholders commitments for active &amp; healthy #ageing http://t.co/LGVg1olA","id":"212098331860680704","lang":"en","created_at":"2012-06-11T08:25:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"EUCouncilPress","id":"198618575"}],"hashtags":[{"start":36,"end":48,"tag":"traineeship"},{"start":56,"end":66,"tag":"EUCouncil"},{"start":109,"end":114,"tag":"euco"}],"annotations":{},"urls":[{"start":87,"end":108,"url":"https://t.co/jTWrqaxZ","expanded_url":"https://www.facebook.com/photo.php?fbid=380966661952995&set=a.182018825181114.45940.147547541961576&type=1&ref=nf","display_url":"facebook.com/photo.php?fbid…"}]},"source":"TweetDeck","conversation_id":"211112201526845444","referenced_tweets":[{"type":"retweeted","id":"211110059470622720"}],"text":"RT @EUCouncilPress: Interested in a #traineeship at the #EUCouncil? Apply by 31 August https://t.co/jTWrqaxZ #euco","id":"211112201526845444","lang":"en","created_at":"2012-06-08T15:07:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":15,"end":24,"tag":"FDAVoice"}],"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/yZavar5l","expanded_url":"http://blogs.fda.gov/fdavoice/index.php/2012/06/fda-inaugurates-annual-patient-network-meeting/","display_url":"blogs.fda.gov/fdavoice/index…"}]},"source":"TweetDeck","conversation_id":"211092315228483584","referenced_tweets":[{"type":"retweeted","id":"211092214904913920"}],"text":"RT @US_FDA: On #FDAVoice blog: Learn about our Patient Network initiatives and our 1st annual Patient Network Meeting. http://t.co/yZavar5l","id":"211092315228483584","lang":"en","created_at":"2012-06-08T13:48:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":36,"end":44,"tag":"ESCAIDE"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/rVcN4iGG","expanded_url":"http://bit.ly/L8Cp8f","display_url":"bit.ly/L8Cp8f"}]},"source":"TweetDeck","conversation_id":"211091616843309056","referenced_tweets":[{"type":"retweeted","id":"211090049624846336"}],"text":"RT @ECDC_EU: Call for abstracts for #ESCAIDE 2012 is now open. Deadline: 13 July. More info on the conference at: http://t.co/rVcN4iGG # ...","id":"211091616843309056","lang":"en","created_at":"2012-06-08T13:45:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":57,"end":77,"url":"http://t.co/alSI1OJw","expanded_url":"http://bit.ly/K4WdM1","display_url":"bit.ly/K4WdM1"}]},"source":"TweetDeck","conversation_id":"211088286737903617","referenced_tweets":[{"type":"retweeted","id":"211088146597806080"}],"text":"RT @LV_MPA: Månadsrapport från CHMP och PhVWP (maj 2012) http://t.co/alSI1OJw","id":"211088286737903617","lang":"sv","created_at":"2012-06-08T13:32:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":20,"end":24,"tag":"EMA"},{"start":85,"end":93,"tag":"fibrosi"},{"start":94,"end":102,"tag":"cistica"},{"start":103,"end":119,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"211087632464232448","referenced_tweets":[{"type":"retweeted","id":"211084856174723073"}],"text":"RT @Aifa_ufficiale: #EMA raccomanda farmaco di prima classe per il trattamento della #fibrosi #cistica #PilloledalMondo... http://t.co/E ...","id":"211087632464232448","lang":"it","created_at":"2012-06-08T13:29:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":42,"end":50,"tag":"WDD2012"},{"start":78,"end":87,"tag":"diabetes"},{"start":99,"end":116,"tag":"protectourfuture"}],"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/bpgaHddj","expanded_url":"http://bit.ly/JIiN8n","display_url":"bit.ly/JIiN8n"}]},"source":"TweetDeck","conversation_id":"211087537014448129","referenced_tweets":[{"type":"retweeted","id":"211082977504014337"}],"text":"RT @IntDiabetesFed: Retweet our video for #WDD2012! We need you to spread the #diabetes awareness! #protectourfuture http://t.co/bpgaHddj","id":"211087537014448129","lang":"en","created_at":"2012-06-08T13:29:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":19,"end":26,"tag":"orphan"},{"start":58,"end":63,"tag":"rare"},{"start":64,"end":73,"tag":"diseases"}],"annotations":{},"urls":[{"start":103,"end":123,"url":"http://t.co/4i9jzgl3","expanded_url":"http://bit.ly/LAqr6n","display_url":"bit.ly/LAqr6n"}]},"source":"Twitter Web Client","conversation_id":"211080577451966465","referenced_tweets":{},"text":"We've reached 1000 #orphan designations for medicines for #rare #diseases: 70 medicines on the market: http://t.co/4i9jzgl3","id":"211080577451966465","lang":"en","created_at":"2012-06-08T13:01:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EIP_AHA","id":"416925949"}],"hashtags":{},"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/MOjKqx2K","expanded_url":"http://bit.ly/KD7ynI","display_url":"bit.ly/KD7ynI"}]},"source":"TweetDeck","conversation_id":"211079815787331584","referenced_tweets":[{"type":"retweeted","id":"211078514747785218"}],"text":"RT @EIP_AHA: Detecting Alzheimer's in its early stages: an EU-funded nanoscope will soon rise to the challenge! http://t.co/MOjKqx2K #Co ...","id":"211079815787331584","lang":"en","created_at":"2012-06-08T12:58:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":{},"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/B1WFEPXW","expanded_url":"http://bit.ly/fm4MvN","display_url":"bit.ly/fm4MvN"}]},"source":"TweetDeck","conversation_id":"211079577517301760","referenced_tweets":[{"type":"retweeted","id":"211076891799584768"}],"text":"RT @euparkinsons: Move 4 Change Part III, survey open 11 April - 28 Oct 2012, please don't forget 2 fill in our survey: http://t.co/B1WFEPXW","id":"211079577517301760","lang":"en","created_at":"2012-06-08T12:57:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":111,"end":121,"username":"SandorMax","id":"18693966"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"211079483812347904","referenced_tweets":[{"type":"retweeted","id":"211076353032855553"}],"text":"RT @DrugInfoAssn: Be Sure to Join Our Chat Today @ 12pm ET on social media &amp;&amp; patient engagement. Join @sandormax  @raresideases ...","id":"211079483812347904","lang":"en","created_at":"2012-06-08T12:57:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"hashtags":[{"start":13,"end":17,"tag":"WDD"},{"start":25,"end":34,"tag":"Diabetes"},{"start":36,"end":53,"tag":"protectourfuture"}],"annotations":{},"urls":[{"start":87,"end":107,"url":"http://t.co/N9zHb9YY","expanded_url":"http://bit.ly/L9Kiul","display_url":"bit.ly/L9Kiul"}]},"source":"TweetDeck","conversation_id":"211079395778113538","referenced_tweets":[{"type":"retweeted","id":"211066051780284416"}],"text":"RT @WDD: New #WDD video! #Diabetes: #protectourfuture! Share it to increase awareness! http://t.co/N9zHb9YY","id":"211079395778113538","lang":"en","created_at":"2012-06-08T12:57:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":0,"end":15,"probability":0.4779,"type":"Organization","normalized_text":"Management Board"}],"urls":[{"start":90,"end":110,"url":"http://t.co/tYe7o9EK","expanded_url":"http://bit.ly/KCUezF","display_url":"bit.ly/KCUezF"}]},"source":"bitly bitlink","conversation_id":"211051877574516736","referenced_tweets":{},"text":"Management Board completes the framework on dealing with potential conflicts of interests http://t.co/tYe7o9EK","id":"211051877574516736","lang":"en","created_at":"2012-06-08T11:07:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":111,"end":127,"username":"wordpressdotcom","id":"823905"}],"hashtags":{},"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/ENSLEJo5","expanded_url":"http://wp.me/p1UXPA-bL","display_url":"wp.me/p1UXPA-bL"}]},"source":"Twitter Web Client","conversation_id":"211041143008407552","referenced_tweets":[{"type":"retweeted","id":"211034773165051905"}],"text":"RT @ECDC_EU: Working with the world’s pediatricians to eliminate measles and rubella  http://t.co/ENSLEJo5 via @wordpressdotcom","id":"211041143008407552","lang":"en","created_at":"2012-06-08T10:25:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":89,"end":109,"url":"http://t.co/4DzNPB7e","expanded_url":"http://bit.ly/Mppdtw","display_url":"bit.ly/Mppdtw"}]},"source":"Twitter Web Client","conversation_id":"211022267184979968","referenced_tweets":{},"text":"We have moved towards paper-less forms for submission of plasma master file applications http://t.co/4DzNPB7e","id":"211022267184979968","lang":"en","created_at":"2012-06-08T09:10:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":5,"end":12,"tag":"orphan"},{"start":47,"end":52,"tag":"rare"},{"start":53,"end":62,"tag":"diseases"}],"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/4i9jzgl3","expanded_url":"http://bit.ly/LAqr6n","display_url":"bit.ly/LAqr6n"}]},"source":"Twitter Web Client","conversation_id":"211020942070120448","referenced_tweets":{},"text":"1000 #orphan designations are now approved for #rare #diseases: 70 medicines are now on the market as a result: http://t.co/4i9jzgl3","id":"211020942070120448","lang":"en","created_at":"2012-06-08T09:04:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":22,"end":29,"tag":"orphan"},{"start":61,"end":66,"tag":"rare"},{"start":67,"end":76,"tag":"diseases"}],"annotations":[{"start":98,"end":116,"probability":0.5565,"type":"Organization","normalized_text":"European Commission"}],"urls":[{"start":119,"end":139,"url":"http://t.co/4i9jzgl3","expanded_url":"http://bit.ly/LAqr6n","display_url":"bit.ly/LAqr6n"}]},"source":"bitly bitlink","conversation_id":"210729537984659457","referenced_tweets":{},"text":"We welcome the 1000th #orphan designation for a medicine for #rare #diseases, issued today by the European Commission: http://t.co/4i9jzgl3","id":"210729537984659457","lang":"en","created_at":"2012-06-07T13:46:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":94,"end":114,"url":"http://t.co/HVUqotB1","expanded_url":"http://bit.ly/M8lFfG","display_url":"bit.ly/M8lFfG"}]},"source":"Twitter Web Client","conversation_id":"210725552426975232","referenced_tweets":{},"text":"Read our 2011 annual report: we increased our levels of transparency significantly last year: http://t.co/HVUqotB1","id":"210725552426975232","lang":"en","created_at":"2012-06-07T13:31:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EIP_AHA","id":"416925949"}],"hashtags":{},"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210725102063587328","referenced_tweets":[{"type":"retweeted","id":"210720758035521537"}],"text":"RT @EIP_AHA: Fantastic response on Active and Healthy Ageing call: 300 commitments to action and 60 potential Reference Sites! http://t. ...","id":"210725102063587328","lang":"en","created_at":"2012-06-07T13:29:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":26,"end":45,"tag":"anticounterfeiting"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210725061005557761","referenced_tweets":[{"type":"retweeted","id":"210719499199070209"}],"text":"RT @EFPIA: Today is world #anticounterfeiting day: Did you know that over 50% of cases, medicines purchased online have been found to be ...","id":"210725061005557761","lang":"en","created_at":"2012-06-07T13:29:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":41,"end":49,"username":"EIP_AHA","id":"416925949"},{"start":107,"end":121,"username":"NeelieKroesEU","id":"159950527"}],"hashtags":[{"start":95,"end":102,"tag":"Ageing"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210725029594411009","referenced_tweets":[{"type":"retweeted","id":"210718819990241280"}],"text":"RT @EU_Consumer: Read the results of the @EIP_AHA call for commitments on Healthy &amp; Active #Ageing  on @NeelieKroesEU blog! http://t ...","id":"210725029594411009","lang":"en","created_at":"2012-06-07T13:28:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":86,"end":101,"tag":"Pharmaceutical"},{"start":131,"end":137,"tag":"Dalli"}],"annotations":{},"urls":[{"start":110,"end":130,"url":"http://t.co/MtyiYCFK","expanded_url":"http://bit.ly/MdJt5h","display_url":"bit.ly/MdJt5h"}]},"source":"Twitter Web Client","conversation_id":"210724939928580096","referenced_tweets":[{"type":"retweeted","id":"210717471701868544"}],"text":"RT @EFPIA: Read Health Commissionner speech: The European Commission Strategy\nfor the #Pharmaceutical Sector: http://t.co/MtyiYCFK #Dalli","id":"210724939928580096","lang":"en","created_at":"2012-06-07T13:28:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":55,"end":64,"tag":"diabetes"},{"start":69,"end":74,"tag":"NCDs"}],"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/pL02DOOF","expanded_url":"http://bit.ly/odVaMJ","display_url":"bit.ly/odVaMJ"}]},"source":"Twitter Web Client","conversation_id":"210724754909442048","referenced_tweets":[{"type":"retweeted","id":"210709835560402945"}],"text":"RT @IntDiabetesFed: Let’s make 2012 a turning point in #diabetes and #NCDs. Check out what needs to be done http://t.co/pL02DOOF","id":"210724754909442048","lang":"en","created_at":"2012-06-07T13:27:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"annotations":[{"start":46,"end":64,"probability":0.8194,"type":"Other","normalized_text":"World Hepatitis Day"}],"urls":{}},"source":"Twitter Web Client","conversation_id":"210724659270926336","referenced_tweets":[{"type":"retweeted","id":"210709704387723267"}],"text":"RT @Hep_Alliance: There are 50 days left till World Hepatitis Day on Saturday, 28 July 2012! Download the campaign materials for... http ...","id":"210724659270926336","lang":"en","created_at":"2012-06-07T13:27:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210724585006579714","referenced_tweets":[{"type":"retweeted","id":"210708271198248960"}],"text":"RT @IMI_JU: Sign up for IMI’s webinar on clinical development aspects of the antimicrobial resistance Call on 12/6 at 13:00 CEST http:// ...","id":"210724585006579714","lang":"en","created_at":"2012-06-07T13:27:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":82,"end":102,"url":"http://t.co/4DzNPB7e","expanded_url":"http://bit.ly/Mppdtw","display_url":"bit.ly/Mppdtw"}]},"source":"bitly bitlink","conversation_id":"210721904447852544","referenced_tweets":{},"text":"We launched new electronic form for submission of plasma master file applications http://t.co/4DzNPB7e","id":"210721904447852544","lang":"en","created_at":"2012-06-07T13:16:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/w36bQHL9","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON155607","display_url":"mhra.gov.uk/NewsCentre/CON…"}]},"source":"Twitter Web Client","conversation_id":"210702879449808896","referenced_tweets":[{"type":"retweeted","id":"210688169153282048"}],"text":"RT @MHRAGovUkPress: 'Youth friendly' message on medicines for kids http://t.co/w36bQHL9","id":"210702879449808896","lang":"en","created_at":"2012-06-07T12:00:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"hashtags":{},"annotations":{},"urls":[{"start":101,"end":121,"url":"http://t.co/a5OcI8Tn","expanded_url":"http://international.drugabuse.gov/meetings/international-forum","display_url":"international.drugabuse.gov/meetings/inter…"}]},"source":"Twitter Web Client","conversation_id":"210702842548338689","referenced_tweets":[{"type":"retweeted","id":"210689275631644672"}],"text":"RT @EMCDDA: Second interdisciplinary forum on new and emerging psychoactive substances, EMCDDA–NIDA:\nhttp://t.co/a5OcI8Tn","id":"210702842548338689","lang":"en","created_at":"2012-06-07T12:00:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":68,"end":88,"url":"http://t.co/gpV2saK1","expanded_url":"http://bit.ly/Lu5wnI","display_url":"bit.ly/Lu5wnI"}]},"source":"Twitter Web Client","conversation_id":"210674183909294080","referenced_tweets":[{"type":"retweeted","id":"210669347105030145"}],"text":"RT @LV_MPA: Första studien om rådgivning kring receptfria läkemedel http://t.co/gpV2saK1","id":"210674183909294080","lang":"da","created_at":"2012-06-07T10:06:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/HVUqotB1","expanded_url":"http://bit.ly/M8lFfG","display_url":"bit.ly/M8lFfG"}]},"source":"Twitter Web Client","conversation_id":"210657771866177536","referenced_tweets":{},"text":"Our 2011 annual report is out. We released more than a million pages in access-to-documents requests last year: http://t.co/HVUqotB1","id":"210657771866177536","lang":"en","created_at":"2012-06-07T09:01:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":18,"end":22,"tag":"EMA"}],"annotations":[{"start":30,"end":31,"probability":0.6028,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":104,"end":124,"url":"http://t.co/rs5h8bBT","expanded_url":"http://bit.ly/MeOMS0","display_url":"bit.ly/MeOMS0"}]},"source":"Twitter Web Client","conversation_id":"210650174589116416","referenced_tweets":[{"type":"retweeted","id":"210648543524962304"}],"text":"RT @euparkinsons: #EMA boosts EU transparency with online publication of suspected side effect reports: http://t.co/rs5h8bBT","id":"210650174589116416","lang":"en","created_at":"2012-06-07T08:31:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":26,"end":45,"tag":"anticounterfeiting"},{"start":103,"end":115,"tag":"Counterfeit"},{"start":116,"end":126,"tag":"Medicines"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210650096923181056","referenced_tweets":[{"type":"retweeted","id":"210645657466318848"}],"text":"RT @EFPIA: Today is World #anticounterfeiting day: ESM Progress seek to protect European Patients from #Counterfeit #Medicines: http://t ...","id":"210650096923181056","lang":"en","created_at":"2012-06-07T08:31:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210644522504425472","referenced_tweets":[{"type":"retweeted","id":"210642949762068480"}],"text":"RT @LV_MPA: Det finns fortfarande plats på seminariet om rådgivning för forskare och företag, den 13 juni hos oss i Uppsala http://t.co/ ...","id":"210644522504425472","lang":"sv","created_at":"2012-06-07T08:09:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"hashtags":{},"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210391077079891970","referenced_tweets":[{"type":"retweeted","id":"210385878814687234"}],"text":"RT @FDAWomen: Find out how grapefruit juice can interfere with the action of some prescription &amp; non-prescription drugs: http://t.co ...","id":"210391077079891970","lang":"en","created_at":"2012-06-06T15:21:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/HVUqotB1","expanded_url":"http://bit.ly/M8lFfG","display_url":"bit.ly/M8lFfG"}]},"source":"bitly bitlink","conversation_id":"210390523905708032","referenced_tweets":{},"text":"We've published our annual report for 2011: it shows a continuous high level of activities: http://t.co/HVUqotB1","id":"210390523905708032","lang":"en","created_at":"2012-06-06T15:19:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":116,"end":132,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210369038004662274","referenced_tweets":[{"type":"retweeted","id":"210354124288573440"}],"text":"RT @Aifa_ufficiale: L’EMA promuove la trasparenza in UE: pubblicazione online delle segnalazioni delle sospette ADR #PilloledalMondo...  ...","id":"210369038004662274","lang":"it","created_at":"2012-06-06T13:54:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":173,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":52,"end":63,"tag":"antibiotic"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210342944283176960","referenced_tweets":[{"type":"retweeted","id":"210318198761984001"}],"text":"RT @WHO: Not taking the full course of a prescribed #antibiotic or the use of poor quality antibiotics can lead to antimicrobial resistance","id":"210342944283176960","lang":"en","created_at":"2012-06-06T12:10:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":27,"end":32,"tag":"EPDA"},{"start":66,"end":76,"tag":"Parkinson"}],"annotations":[{"start":99,"end":107,"probability":0.941,"type":"Place","normalized_text":"Amsterdam"}],"urls":{}},"source":"Twitter Web Client","conversation_id":"210342701319725057","referenced_tweets":[{"type":"retweeted","id":"210310067432599552"}],"text":"RT @euparkinsons: Join the #EPDA 4 our 1st European Unity Walk, 4 #Parkinson's, on Sept 28 2012 in Amsterdam - register @ http://t.co/m5 ...","id":"210342701319725057","lang":"en","created_at":"2012-06-06T12:09:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":76,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":33,"end":44,"tag":"gonorrhoea"},{"start":128,"end":133,"tag":"STIs"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210342651109715968","referenced_tweets":[{"type":"retweeted","id":"210306737880834049"}],"text":"RT @WHO: Millions of people with #gonorrhoea may be at risk of running out of treatment options due to antimicrobial resistance #STIs","id":"210342651109715968","lang":"en","created_at":"2012-06-06T12:09:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":47,"end":57,"tag":"Parkinson"}],"annotations":{},"urls":[{"start":102,"end":122,"url":"http://t.co/XBiQyUp4","expanded_url":"http://bit.ly/JVOvRS","display_url":"bit.ly/JVOvRS"}]},"source":"Twitter Web Client","conversation_id":"210342581178073088","referenced_tweets":[{"type":"retweeted","id":"210299993272238080"}],"text":"RT @euparkinsons: The possibilities 4 treating #Parkinson’s is becoming increasingly better with time http://t.co/XBiQyUp4","id":"210342581178073088","lang":"en","created_at":"2012-06-06T12:09:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":45,"end":55,"tag":"Parkinson"}],"annotations":[{"start":33,"end":38,"probability":0.9966,"type":"Place","normalized_text":"Europe"},{"start":74,"end":80,"probability":0.9117,"type":"Place","normalized_text":"Germany"},{"start":91,"end":95,"probability":0.6542,"type":"Place","normalized_text":"Italy"},{"start":105,"end":109,"probability":0.8802,"type":"Place","normalized_text":"Spain"},{"start":130,"end":135,"probability":0.7525,"type":"Place","normalized_text":"France"}],"urls":{}},"source":"Twitter Web Client","conversation_id":"210342427339403264","referenced_tweets":[{"type":"retweeted","id":"210294959474081792"}],"text":"RT @euparkinsons: 1.2m people in Europe have #Parkinson’s: approx 260,000=Germany 200,000= Italy 150,000=Spain 120,000=UK 117,000=France ...","id":"210342427339403264","lang":"en","created_at":"2012-06-06T12:08:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":37,"tag":"Arzneimittelsicherheit"},{"start":40,"end":45,"tag":"BASG"},{"start":46,"end":51,"tag":"AGES"},{"start":89,"end":103,"tag":"Antibabypille"},{"start":118,"end":130,"tag":"Drospirenon"}],"annotations":{},"urls":{}},"source":"Twitter Web Client","conversation_id":"210342284359778306","referenced_tweets":[{"type":"retweeted","id":"210284581599985665"}],"text":"RT @agesnews: #Arzneimittelsicherheit - #BASG #AGES informiert über Thromboserisiken bei #Antibabypille mit Wirkstoff #Drospirenon http: ...","id":"210342284359778306","lang":"de","created_at":"2012-06-06T12:08:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":55,"end":64,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":34,"end":54,"url":"http://t.co/8guoSvNT","expanded_url":"http://bit.ly/MxqFjO","display_url":"bit.ly/MxqFjO"}]},"source":"TweetDeck","conversation_id":"210005160225816576","referenced_tweets":[{"type":"retweeted","id":"209989666877870080"}],"text":"RT @LV_MPA: Medicinsk epidemiolog http://t.co/8guoSvNT #nyttjobb","id":"210005160225816576","lang":"es","created_at":"2012-06-05T13:48:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":50,"end":59,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":29,"end":49,"url":"http://t.co/kCkHaZqi","expanded_url":"http://bit.ly/M3CJDu","display_url":"bit.ly/M3CJDu"}]},"source":"TweetDeck","conversation_id":"210005143498928128","referenced_tweets":[{"type":"retweeted","id":"209989665531498498"}],"text":"RT @LV_MPA: Specialistläkare http://t.co/kCkHaZqi #nyttjobb","id":"210005143498928128","lang":"sv","created_at":"2012-06-05T13:48:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":44,"end":53,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":23,"end":43,"url":"http://t.co/ZmhdOJnt","expanded_url":"http://bit.ly/M3CJDm","display_url":"bit.ly/M3CJDm"}]},"source":"TweetDeck","conversation_id":"210005124863623170","referenced_tweets":[{"type":"retweeted","id":"209989664852029441"}],"text":"RT @LV_MPA: Barnläkare http://t.co/ZmhdOJnt #nyttjobb","id":"210005124863623170","lang":"sv","created_at":"2012-06-05T13:48:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209950769133273088","referenced_tweets":[{"type":"retweeted","id":"209950536957575169"}],"text":"RT @IMI_JU: IMI future Calls: draft outlines of indicative 7th Call topics &amp; indicative titles for 8th &amp; 9th Calls now online ht ...","id":"209950769133273088","lang":"en","created_at":"2012-06-05T10:12:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":77,"end":88,"username":"New_Europe","id":"20840441"},{"start":89,"end":102,"username":"GIRPBrussels","id":"78244075"},{"start":103,"end":108,"username":"PGEU","id":"459292439"}],"hashtags":[{"start":109,"end":122,"tag":"counterfeits"},{"start":123,"end":132,"tag":"medicine"}],"annotations":{},"urls":[{"start":56,"end":76,"url":"http://t.co/LdzC9qh2","expanded_url":"http://bit.ly/KAlEFX","display_url":"bit.ly/KAlEFX"}]},"source":"TweetDeck","conversation_id":"209948434898227202","referenced_tweets":[{"type":"retweeted","id":"209947678312902656"}],"text":"RT @EFPIA: Pharma companies begin verified supply chain http://t.co/LdzC9qh2 @New_Europe @GIRPBrussels @PGEU #counterfeits #medicine","id":"209948434898227202","lang":"en","created_at":"2012-06-05T10:03:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":{},"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/B1WFEPXW","expanded_url":"http://bit.ly/fm4MvN","display_url":"bit.ly/fm4MvN"}]},"source":"TweetDeck","conversation_id":"209947838354948096","referenced_tweets":[{"type":"retweeted","id":"209947675339145216"}],"text":"RT @euparkinsons: Move 4 Change Part III, survey open 11 April - 28 Oct 2012, please don't forget 2 fill in our survey: http://t.co/B1WFEPXW","id":"209947838354948096","lang":"en","created_at":"2012-06-05T10:00:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":120,"end":133,"tag":"EPHAConf2012"}],"annotations":[{"start":82,"end":88,"probability":0.4626,"type":"Organization","normalized_text":"Twitter"}],"urls":[{"start":99,"end":119,"url":"http://t.co/LmMYpuXI","expanded_url":"http://bit.ly/M7MaoM","display_url":"bit.ly/M7MaoM"}]},"source":"TweetDeck","conversation_id":"209933570314207232","referenced_tweets":[{"type":"retweeted","id":"209933376453492736"}],"text":"RT @EPHA_EU: Possibilities to feed into the debates on austerity&amp;health and  thru Twitter tmw! http://t.co/LmMYpuXI #EPHAConf2012","id":"209933570314207232","lang":"en","created_at":"2012-06-05T09:03:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":74,"end":84,"tag":"Parkinson"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209932951784402944","referenced_tweets":[{"type":"retweeted","id":"209932588163407873"}],"text":"RT @euparkinsons: Statistic: It is estimated that 6.3 million people have #Parkinson’s worldwide, affecting all races &amp; cultures. ht ...","id":"209932951784402944","lang":"en","created_at":"2012-06-05T09:01:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":56,"end":65,"username":"EURACTIV","id":"14808226"}],"hashtags":[{"start":11,"end":23,"tag":"Antibiotics"}],"annotations":{},"urls":[{"start":67,"end":87,"url":"http://t.co/zTZvzFHQ","expanded_url":"http://www.euractiv.com/health/antibiotics-preserving-precious-analysis-513112#.T821ECdjpKQ.twitter","display_url":"euractiv.com/health/antibio…"}]},"source":"TweetDeck","conversation_id":"209932846142468096","referenced_tweets":[{"type":"retweeted","id":"209932578348728320"}],"text":"RT @EFPIA: #Antibiotics: Preserving a precious resource @EurActiv: http://t.co/zTZvzFHQ","id":"209932846142468096","lang":"en","created_at":"2012-06-05T09:01:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"UNLibrary","id":"109720244"},{"start":87,"end":91,"username":"WHO","id":"14499829"}],"hashtags":[{"start":74,"end":82,"tag":"malaria"}],"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/qMTex8M0","expanded_url":"http://ow.ly/blqxH","display_url":"ow.ly/blqxH"}]},"source":"TweetDeck","conversation_id":"209655009590259713","referenced_tweets":[{"type":"retweeted","id":"209654957048209409"}],"text":"RT @UNLibrary: check out the map of countries and territories affected by #malaria via @WHO http://t.co/qMTex8M0","id":"209655009590259713","lang":"en","created_at":"2012-06-04T14:37:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":16,"end":32,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":62,"end":74,"tag":"vaccination"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209653638006710272","referenced_tweets":[{"type":"retweeted","id":"209653532922621952"}],"text":"RT @ECDC_EU: MT @Eurosurveillanc: Mandatory &amp; recommended #vaccination: survey results on national vaccination programmes: http://t. ...","id":"209653638006710272","lang":"en","created_at":"2012-06-04T14:31:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":53,"end":66,"tag":"Legionnaires"},{"start":88,"end":94,"tag":"Spain"}],"annotations":{},"urls":[{"start":95,"end":115,"url":"http://t.co/PoE9g8n7","expanded_url":"http://bit.ly/KXJXL1","display_url":"bit.ly/KXJXL1"}]},"source":"TweetDeck","conversation_id":"209648154826649600","referenced_tweets":[{"type":"retweeted","id":"209644244560920577"}],"text":"RT @ECDC_EU: ECDC updates its risk assessment on the #Legionnaires’ disease outbreak in #Spain http://t.co/PoE9g8n7","id":"209648154826649600","lang":"en","created_at":"2012-06-04T14:09:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":25,"end":30,"tag":"EFSA"},{"start":114,"end":119,"tag":"bees"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/nHEsXOJ9","expanded_url":"http://bit.ly/JWYLg2","display_url":"bit.ly/JWYLg2"}]},"source":"TweetDeck","conversation_id":"209633094557372416","referenced_tweets":[{"type":"retweeted","id":"205929765356568576"}],"text":"RT @EFSA_EU: Bee health: #EFSA published state-of-the-art scientific review of risks posed by pesticides to honey #bees http://t.co/nHEsXOJ9","id":"209633094557372416","lang":"en","created_at":"2012-06-04T13:09:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":37,"tag":"Arzneimittelsicherheit"},{"start":38,"end":61,"tag":"Nebenwirkungsmeldungen"},{"start":64,"end":68,"tag":"EMA"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/9BFxelw6","expanded_url":"http://www.basg.gv.at/news-center/news/news-detail/article/ema-macht-sicherheitsdaten-oeffentlich-zugaenglich/","display_url":"basg.gv.at/news-center/ne…"}]},"source":"TweetDeck","conversation_id":"209631164418367489","referenced_tweets":{},"text":"RT @agesnews: #Arzneimittelsicherheit #Nebenwirkungsmeldungen - #EMA macht Sicherheitsdaten öffentlich zugänglich http://t.co/9BFxelw6","id":"209631164418367489","lang":"de","created_at":"2012-06-04T13:02:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":[{"start":14,"end":37,"tag":"Arzneimittelsicherheit"},{"start":38,"end":43,"tag":"BASG"},{"start":44,"end":49,"tag":"AGES"},{"start":70,"end":78,"tag":"Pradaxa"},{"start":90,"end":101,"tag":"Dabigatran"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209601625298444288","referenced_tweets":[{"type":"retweeted","id":"209601476006395905"}],"text":"RT @agesnews: #Arzneimittelsicherheit #BASG #AGES - Aktualisierung zu #Pradaxa Wirkstoff: #Dabigatran bzüglich letaler Blutungen http:// ...","id":"209601625298444288","lang":"de","created_at":"2012-06-04T11:04:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209580004831535106","referenced_tweets":[{"type":"retweeted","id":"209579723662176256"}],"text":"RT @cancereu: Innovative study asks kidney cancer patients about their preference between two therapies, tracking impact on... http://t. ...","id":"209580004831535106","lang":"en","created_at":"2012-06-04T09:39:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"209579971692335105","referenced_tweets":[{"type":"retweeted","id":"209579410720952320"}],"text":"RT @cancereu: Lower-income patients are less likely to participate in clinical trials, raising concerns about equal access http://t.co/Y ...","id":"209579971692335105","lang":"en","created_at":"2012-06-04T09:38:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":62,"end":82,"url":"http://t.co/Z2KsFJbs","expanded_url":"http://fb.me/1QS2pUiXA","display_url":"fb.me/1QS2pUiXA"}]},"source":"TweetDeck","conversation_id":"209579945863806976","referenced_tweets":[{"type":"retweeted","id":"209578678387085312"}],"text":"RT @cancereu: eCancerNews brings you the latest from ASCO2012 http://t.co/Z2KsFJbs","id":"209579945863806976","lang":"en","created_at":"2012-06-04T09:38:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/pSU4WF13","expanded_url":"http://fb.me/AKRkrPyr","display_url":"fb.me/AKRkrPyr"}]},"source":"TweetDeck","conversation_id":"209579902763143168","referenced_tweets":[{"type":"retweeted","id":"209575486043598849"}],"text":"RT @cancereu: Why does chemotherapy fail? Scientists show why leukaemia often returns http://t.co/pSU4WF13","id":"209579902763143168","lang":"en","created_at":"2012-06-04T09:38:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":[{"start":86,"end":106,"url":"http://t.co/PJaG7ACL","expanded_url":"http://fb.me/1WdXvAkfl","display_url":"fb.me/1WdXvAkfl"}]},"source":"TweetDeck","conversation_id":"209579881682579456","referenced_tweets":[{"type":"retweeted","id":"209575466158391297"}],"text":"RT @cancereu: Why does chemotherapy fail? Scientists show why leukaemia often returns http://t.co/PJaG7ACL","id":"209579881682579456","lang":"en","created_at":"2012-06-04T09:38:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":44,"end":55,"tag":"biosimilar"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/ycZQMg1F","expanded_url":"http://bit.ly/N0WtMX","display_url":"bit.ly/N0WtMX"}]},"source":"Twitter Web Client","conversation_id":"208589456935104512","referenced_tweets":{},"text":"Our revised guideline on quality aspects of #biosimilar medicines is open for public consultation until November: http://t.co/ycZQMg1F","id":"208589456935104512","lang":"en","created_at":"2012-06-01T16:02:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":37,"end":57,"url":"http://t.co/r4cHmQbu","expanded_url":"http://bit.ly/Km2ZNN","display_url":"bit.ly/Km2ZNN"}]},"source":"TweetDeck","conversation_id":"208578185191899137","referenced_tweets":[{"type":"retweeted","id":"208577972574228481"}],"text":"RT @LV_MPA: Pandemrix och narkolepsi http://t.co/r4cHmQbu","id":"208578185191899137","lang":"pl","created_at":"2012-06-01T15:18:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/LFaFsqj9","expanded_url":"http://bit.ly/LOhc1s","display_url":"bit.ly/LOhc1s"}]},"source":"TweetDeck","conversation_id":"208567677898330114","referenced_tweets":[{"type":"retweeted","id":"208567117900038145"}],"text":"RT @Legemiddelinfo: Nye registreringsgebyrer for søknad om markedsføringstillatelse m.v.: Gjelder fra 15. juni. http://t.co/LFaFsqj9","id":"208567677898330114","lang":"no","created_at":"2012-06-01T14:36:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":76,"end":79,"tag":"EU"},{"start":80,"end":89,"tag":"consumer"},{"start":113,"end":122,"tag":"EURO2012"}],"annotations":[{"start":17,"end":29,"probability":0.5237,"type":"Organization","normalized_text":"Europe Direct"}],"urls":{}},"source":"TweetDeck","conversation_id":"208553261966430208","referenced_tweets":[{"type":"retweeted","id":"208548717043789825"}],"text":"RT @EU_Consumer: Europe Direct is ready to answer online queries on general #EU #consumer rights in 23 languages #EURO2012 http://t.co/i ...","id":"208553261966430208","lang":"en","created_at":"2012-06-01T13:39:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":70,"end":84,"tag":"neonicotinoid"},{"start":85,"end":96,"tag":"pesticides"},{"start":100,"end":104,"tag":"bee"}],"annotations":{},"urls":[{"start":115,"end":135,"url":"http://t.co/A19TGkFl","expanded_url":"http://www.efsa.europa.eu/en/press/news/120601.htm","display_url":"efsa.europa.eu/en/press/news/…"}]},"source":"TweetDeck","conversation_id":"208500010743119872","referenced_tweets":[{"type":"retweeted","id":"208495872437268480"}],"text":"RT @EFSA_EU: #EFSA assesses innovative studies pointing at effects of #neonicotinoid #pesticides on #bee colonies: http://t.co/A19TGkFl","id":"208500010743119872","lang":"en","created_at":"2012-06-01T10:07:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"hashtags":[{"start":37,"end":46,"tag":"diabetes"}],"annotations":{},"urls":[{"start":79,"end":99,"url":"http://t.co/QW51lhWA","expanded_url":"http://bit.ly/JQMmUx","display_url":"bit.ly/JQMmUx"}]},"source":"TweetDeck","conversation_id":"208499980053385216","referenced_tweets":[{"type":"retweeted","id":"208495836911517696"}],"text":"RT @WDD: Today we’re reading: Type 1 #diabetes complex to understand and treat http://t.co/QW51lhWA","id":"208499980053385216","lang":"en","created_at":"2012-06-01T10:07:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/DtQZT9dS","expanded_url":"http://bit.ly/LM5yHY","display_url":"bit.ly/LM5yHY"}]},"source":"Twitter Web Client","conversation_id":"208486175420334080","referenced_tweets":{},"text":"Yesterday we opened the database of suspected side effects reports to public http://t.co/DtQZT9dS","id":"208486175420334080","lang":"en","created_at":"2012-06-01T09:12:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":76,"end":87,"tag":"biosimilar"}],"annotations":{},"urls":[{"start":99,"end":119,"url":"http://t.co/ycZQMg1F","expanded_url":"http://bit.ly/N0WtMX","display_url":"bit.ly/N0WtMX"}]},"source":"Twitter Web Client","conversation_id":"208483298102620160","referenced_tweets":{},"text":"Please send us your comments on our revised guideline on quality aspects of #biosimilar medicines: http://t.co/ycZQMg1F","id":"208483298102620160","lang":"en","created_at":"2012-06-01T09:01:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":{},"annotations":[{"start":77,"end":83,"probability":0.5907,"type":"Organization","normalized_text":"YouTube"}],"urls":{}},"source":"TweetDeck","conversation_id":"208476953437671424","referenced_tweets":[{"type":"retweeted","id":"208476529607450624"}],"text":"RT @eupatientsforum: Look at the videos about the project Renewing Health on YouTube channel! This project is an opportunity for EPF...  ...","id":"208476953437671424","lang":"en","created_at":"2012-06-01T08:35:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":73,"end":84,"tag":"biosimilar"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/ycZQMg1F","expanded_url":"http://bit.ly/N0WtMX","display_url":"bit.ly/N0WtMX"}]},"source":"bitly bitlink","conversation_id":"208232921390268417","referenced_tweets":{},"text":"We've started a public consultation on a guideline on quality aspects of #biosimilar medicines. Deadline: 30/11/2012: http://t.co/ycZQMg1F","id":"208232921390268417","lang":"en","created_at":"2012-05-31T16:26:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":83,"end":103,"url":"http://t.co/DtQZT9dS","expanded_url":"http://bit.ly/LM5yHY","display_url":"bit.ly/LM5yHY"}]},"source":"Twitter Web Client","conversation_id":"208225730297995264","referenced_tweets":{},"text":"Today we launched a new website where you can search suspected side effect reports http://t.co/DtQZT9dS","id":"208225730297995264","lang":"en","created_at":"2012-05-31T15:57:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"208197943721865216","referenced_tweets":[{"type":"retweeted","id":"208197892182249472"}],"text":"RT @ECDC_EU: ECDC publishes report reviewing the evidence on the effectiveness of interventions to improve health literacy http://t.co/9 ...","id":"208197943721865216","lang":"en","created_at":"2012-05-31T14:07:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":[{"start":48,"end":68,"probability":0.5178,"type":"Organization","normalized_text":"IMI Stakeholder Forum"}],"urls":[{"start":117,"end":137,"url":"http://t.co/Af3SjOWt","expanded_url":"http://bit.ly/IDu5JK","display_url":"bit.ly/IDu5JK"}]},"source":"TweetDeck","conversation_id":"208192715232522240","referenced_tweets":[{"type":"retweeted","id":"208142240663601152"}],"text":"RT @IMI_JU: Thanks to all who came along to the IMI Stakeholder Forum yesterday. The presentations are now online at http://t.co/Af3SjOWt","id":"208192715232522240","lang":"en","created_at":"2012-05-31T13:46:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"ehnheart","id":"407008173"}],"hashtags":{},"annotations":[{"start":14,"end":15,"probability":0.5875,"type":"Organization","normalized_text":"EU"}],"urls":{}},"source":"TweetDeck","conversation_id":"208169200026517504","referenced_tweets":[{"type":"retweeted","id":"208160585391673346"}],"text":"RT @ehnheart: EU website for adverse drug reaction reporting is live! Direct patient reporting is an effective way 2 safer medicines! ht ...","id":"208169200026517504","lang":"en","created_at":"2012-05-31T12:12:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":57,"end":77,"url":"http://t.co/DtQZT9dS","expanded_url":"http://bit.ly/LM5yHY","display_url":"bit.ly/LM5yHY"}]},"source":"bitly bitlink","conversation_id":"208124001883668480","referenced_tweets":{},"text":"We start to publish suspected side effect reports today. http://t.co/DtQZT9dS","id":"208124001883668480","lang":"en","created_at":"2012-05-31T09:13:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":49,"end":58,"tag":"diabetes"}],"annotations":{},"urls":[{"start":96,"end":116,"url":"http://t.co/efO788fe","expanded_url":"https://twitter.com/IntDiabetesFed/status/207816876808609795/photo/1","display_url":"pic.twitter.com/efO788fe"}]},"source":"TweetDeck","conversation_id":"207830705856720898","referenced_tweets":[{"type":"retweeted","id":"207816876808609795"}],"text":"RT @IntDiabetesFed: 2011 was a turning point for #diabetes. Read about it in our Annual Report! http://t.co/efO788fe","id":"207830705856720898","lang":"en","created_at":"2012-05-30T13:47:56.000Z","author_id":"116716199","attachments":{"media_keys":["3_207816876816998400"]}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207790938892935168","referenced_tweets":[{"type":"retweeted","id":"207790769594052608"}],"text":"RT @Legemiddelinfo: Refusjonsvurdering for Pradaxa (dabigatran) oversendt Helse- og omsorgsdepartementet: Legemiddelverket anser de ...  ...","id":"207790938892935168","lang":"no","created_at":"2012-05-30T11:09:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":66,"end":75,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":49,"end":61,"tag":"RareDisease"}],"annotations":[{"start":37,"end":43,"probability":0.3644,"type":"Organization","normalized_text":"EU Conf"},{"start":103,"end":110,"probability":0.9767,"type":"Place","normalized_text":"Brussels"}],"urls":[{"start":112,"end":132,"url":"http://t.co/MAqsYm1K","expanded_url":"http://bit.ly/KbOxYT","display_url":"bit.ly/KbOxYT"}]},"source":"TweetDeck","conversation_id":"207778858978648065","referenced_tweets":[{"type":"retweeted","id":"207778823192850432"}],"text":"RT @eurordis: Photos from last weeks EU Conf. on #RareDisease and @eurordis Membership Meeting held in Brussels http://t.co/MAqsYm1K","id":"207778858978648065","lang":"en","created_at":"2012-05-30T10:21:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"hashtags":{},"annotations":[{"start":32,"end":56,"probability":0.3471,"type":"Other","normalized_text":"EUnetHTA Plenary Assembly"}],"urls":[{"start":71,"end":91,"url":"http://t.co/z5Hl9ZTd","expanded_url":"http://www.eunethta.eu","display_url":"eunethta.eu"}]},"source":"TweetDeck","conversation_id":"207770796335169536","referenced_tweets":[{"type":"retweeted","id":"207770765209239552"}],"text":"RT @EUnetHTA: Highlights of the EUnetHTA Plenary Assembly available on http://t.co/z5Hl9ZTd","id":"207770796335169536","lang":"en","created_at":"2012-05-30T09:49:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":[{"start":125,"end":137,"tag":"medisininfo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207761453355241472","referenced_tweets":[{"type":"retweeted","id":"207761219409559552"}],"text":"RT @Legemiddelinfo: Kunnskap etter Pandemrix er viktig for hvordan vi forholder oss til vaksiner i fremtiden. Steinar Madsen #medisininfo","id":"207761453355241472","lang":"no","created_at":"2012-05-30T09:12:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":[{"start":93,"end":105,"tag":"medisininfo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207761299973742593","referenced_tweets":[{"type":"retweeted","id":"207759549728428032"}],"text":"RT @Legemiddelinfo: Pandemrix - vaksinerte hadde lavere risiko for fosterdød. Steinar Madsen #medisininfo","id":"207761299973742593","lang":"no","created_at":"2012-05-30T09:12:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/V6rZFQhc","expanded_url":"http://fb.me/1IfVSG0is","display_url":"fb.me/1IfVSG0is"}]},"source":"TweetDeck","conversation_id":"207749565519114240","referenced_tweets":[{"type":"retweeted","id":"207745862695264256"}],"text":"RT @Aifa_ufficiale: Rapporto AIFA sulle ispezioni di farmacovigilanza http://t.co/V6rZFQhc","id":"207749565519114240","lang":"it","created_at":"2012-05-30T08:25:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":[{"start":88,"end":108,"url":"http://t.co/k9xqoWHD","expanded_url":"http://fb.me/U5iV87XZ","display_url":"fb.me/U5iV87XZ"}]},"source":"TweetDeck","conversation_id":"207749546913185792","referenced_tweets":[{"type":"retweeted","id":"207745637658275840"}],"text":"RT @Aifa_ufficiale: Pharma Retail sul rapporto AIFA sulle ispezioni di farmacovigilanza http://t.co/k9xqoWHD","id":"207749546913185792","lang":"it","created_at":"2012-05-30T08:25:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":110,"end":126,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207749411420372992","referenced_tweets":[{"type":"retweeted","id":"207745247495720960"}],"text":"RT @Aifa_ufficiale: Esito positivo della revisione dell’EMA sulla qualità dell’anticorpo monoclonale MabThera #PilloledalMondo... http:/ ...","id":"207749411420372992","lang":"it","created_at":"2012-05-30T08:24:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":90,"end":98,"username":"kevinmd","id":"11274452"}],"hashtags":[{"start":11,"end":19,"tag":"Twitter"},{"start":34,"end":41,"tag":"health"},{"start":55,"end":64,"tag":"patients"}],"annotations":{},"urls":[{"start":65,"end":85,"url":"http://t.co/qYB02f95","expanded_url":"http://www.kevinmd.com/blog/2012/05/twitter-valuable-health-resource-patients.html","display_url":"kevinmd.com/blog/2012/05/t…"}]},"source":"TweetDeck","conversation_id":"207749268222648320","referenced_tweets":[{"type":"retweeted","id":"207743151207759874"}],"text":"RT @EFPIA: #Twitter is a valuable #health resource for #patients http://t.co/qYB02f95 via @kevinmd","id":"207749268222648320","lang":"en","created_at":"2012-05-30T08:24:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":44,"end":57,"tag":"RareDiseases"}],"annotations":[{"start":32,"end":38,"probability":0.3321,"type":"Organization","normalized_text":"EU Conf"}],"urls":{}},"source":"TweetDeck","conversation_id":"207503487372763137","referenced_tweets":[{"type":"retweeted","id":"207475594164830208"}],"text":"RT @eurordis: Missed last weeks EU Conf. on #RareDiseases? Updates coming all week, here is the press release after Day 1 http://t.co/aS ...","id":"207503487372763137","lang":"en","created_at":"2012-05-29T16:07:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207503089035513857","referenced_tweets":[{"type":"retweeted","id":"207466879747493890"}],"text":"RT @WHO_Europe_VPI: Get updated on measles and rubella outbreaks around the European Region in the new issue of WHO Epi Brief http://t.c ...","id":"207503089035513857","lang":"en","created_at":"2012-05-29T16:06:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":118,"end":128,"tag":"hepatitis"}],"annotations":{},"urls":[{"start":97,"end":117,"url":"http://t.co/OQjoDlHI","expanded_url":"http://bit.ly/LAf4xG","display_url":"bit.ly/LAf4xG"}]},"source":"TweetDeck","conversation_id":"207435968758820864","referenced_tweets":[{"type":"retweeted","id":"207435870893113345"}],"text":"RT @Hep_Alliance: Our Annual Activity Report 2011 is now available for download from our website http://t.co/OQjoDlHI #hepatitis #worldh ...","id":"207435968758820864","lang":"en","created_at":"2012-05-29T11:39:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":48,"end":53,"tag":"NCDs"},{"start":69,"end":73,"tag":"WHO"}],"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/yfCuRpXE","expanded_url":"http://bit.ly/Jr7q4y","display_url":"bit.ly/Jr7q4y"}]},"source":"TweetDeck","conversation_id":"207413805662216192","referenced_tweets":[{"type":"retweeted","id":"207412808458055680"}],"text":"RT @IntDiabetesFed: First ever global target on #NCDs was adopted by #WHO member states on Saturday. Exciting news! http://t.co/yfCuRpXE ...","id":"207413805662216192","lang":"en","created_at":"2012-05-29T10:11:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":106,"end":126,"url":"http://t.co/p8Z4E5Bw","expanded_url":"http://bit.ly/K7cT61","display_url":"bit.ly/K7cT61"}]},"source":"TweetDeck","conversation_id":"207413321945722880","referenced_tweets":[{"type":"retweeted","id":"207384599045750787"}],"text":"RT @LV_MPA: Pradaxa – tydligare information till patienter och förskrivare för att minska blödningsrisken http://t.co/p8Z4E5Bw","id":"207413321945722880","lang":"sv","created_at":"2012-05-29T10:09:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":17,"end":23,"tag":"Dalli"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"207413275883864064","referenced_tweets":[{"type":"retweeted","id":"207380478167228416"}],"text":"RT @EU_Consumer: #Dalli underlines that \"active participation of confident &amp; empowered consumers in the market is essential\" #ECS201 ...","id":"207413275883864064","lang":"en","created_at":"2012-05-29T10:09:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":17,"end":23,"tag":"Dalli"},{"start":41,"end":44,"tag":"EU"},{"start":95,"end":103,"tag":"ECS2012"}],"annotations":{},"urls":[{"start":104,"end":124,"url":"http://t.co/HiHseKwV","expanded_url":"http://bit.ly/MinSad","display_url":"bit.ly/MinSad"}]},"source":"TweetDeck","conversation_id":"207413252274143232","referenced_tweets":[{"type":"retweeted","id":"207380101254483968"}],"text":"RT @EU_Consumer: #Dalli: \"We want to put #EU consumers at the very heart of the Single Market\" #ECS2012 http://t.co/HiHseKwV","id":"207413252274143232","lang":"en","created_at":"2012-05-29T10:09:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"}],"annotations":{},"urls":[{"start":53,"end":73,"url":"http://t.co/dIuZHei9","expanded_url":"http://bit.ly/JBBHDR","display_url":"bit.ly/JBBHDR"}]},"source":"Twitter Web Client","conversation_id":"206045677631967233","referenced_tweets":{},"text":"Check the #CHMP decisions from May 2012 meeting here http://t.co/dIuZHei9","id":"206045677631967233","lang":"en","created_at":"2012-05-25T15:34:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":9,"tag":"Kalydeco"},{"start":57,"end":64,"tag":"cystic"},{"start":65,"end":74,"tag":"fibrosis"}],"annotations":{},"urls":[{"start":75,"end":95,"url":"http://t.co/L5rkPEZY","expanded_url":"http://bit.ly/JhlqxM","display_url":"bit.ly/JhlqxM"}]},"source":"Twitter Web Client","conversation_id":"206045330167431168","referenced_tweets":{},"text":"#Kalydeco offers therapeutic innovation for treatment of #cystic #fibrosis http://t.co/L5rkPEZY","id":"206045330167431168","lang":"en","created_at":"2012-05-25T15:33:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":0,"end":9,"tag":"MabThera"}],"annotations":[{"start":35,"end":43,"probability":0.4214,"type":"Place","normalized_text":"Vacaville"}],"urls":[{"start":99,"end":119,"url":"http://t.co/ReYjxQcW","expanded_url":"http://bit.ly/K3l7uq","display_url":"bit.ly/K3l7uq"}]},"source":"Twitter Web Client","conversation_id":"206044937970659329","referenced_tweets":{},"text":"#MabThera batches produced  at the Vacaville manufacturing site do not pose risk to public health  http://t.co/ReYjxQcW","id":"206044937970659329","lang":"en","created_at":"2012-05-25T15:31:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":50,"end":58,"tag":"Pradaxa"}],"annotations":{},"urls":[{"start":101,"end":121,"url":"http://t.co/9CZhfAp2","expanded_url":"http://bit.ly/JIubAw","display_url":"bit.ly/JIubAw"}]},"source":"Twitter Web Client","conversation_id":"206044577688330241","referenced_tweets":{},"text":"We've confirmed positive benefit-risk balance for #Pradaxa but changes to product information needed http://t.co/9CZhfAp2","id":"206044577688330241","lang":"en","created_at":"2012-05-25T15:30:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":17,"end":22,"tag":"CHMP"}],"annotations":{},"urls":[{"start":31,"end":51,"url":"http://t.co/dIuZHei9","expanded_url":"http://bit.ly/JBBHDR","display_url":"bit.ly/JBBHDR"}]},"source":"bitly bitlink","conversation_id":"205987308292419585","referenced_tweets":{},"text":"Latest news from #CHMP meeting http://t.co/dIuZHei9","id":"205987308292419585","lang":"en","created_at":"2012-05-25T11:42:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":59,"end":66,"tag":"cystic"},{"start":67,"end":76,"tag":"fibrosis"}],"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/L5rkPEZY","expanded_url":"http://bit.ly/JhlqxM","display_url":"bit.ly/JhlqxM"}]},"source":"bitly bitlink","conversation_id":"205986114635440131","referenced_tweets":{},"text":"We've recommended first-in-class medicine for treatment of #cystic #fibrosis http://t.co/L5rkPEZY","id":"205986114635440131","lang":"en","created_at":"2012-05-25T11:38:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":44,"end":53,"tag":"MabThera"}],"annotations":{},"urls":[{"start":55,"end":75,"url":"http://t.co/ReYjxQcW","expanded_url":"http://bit.ly/K3l7uq","display_url":"bit.ly/K3l7uq"}]},"source":"bitly bitlink","conversation_id":"205949595275104257","referenced_tweets":{},"text":"We confirm positive benefit-risk balance of #MabThera\n http://t.co/ReYjxQcW","id":"205949595275104257","lang":"en","created_at":"2012-05-25T09:13:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":53,"end":61,"tag":"Pradaxa"}],"annotations":{},"urls":[{"start":63,"end":83,"url":"http://t.co/9CZhfAp2","expanded_url":"http://bit.ly/JIubAw","display_url":"bit.ly/JIubAw"}]},"source":"bitly bitlink","conversation_id":"205949141522726912","referenced_tweets":{},"text":"We've updated patient and prescriber information for #Pradaxa  http://t.co/9CZhfAp2","id":"205949141522726912","lang":"en","created_at":"2012-05-25T09:11:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":80,"end":100,"url":"http://t.co/k13acv4v","expanded_url":"http://bit.ly/MsXTgl","display_url":"bit.ly/MsXTgl"}]},"source":"Twitter Web Client","conversation_id":"205946500965076992","referenced_tweets":{},"text":"We are closed on Monday 28 May. We have an emergency out-of-hours phone number: http://t.co/k13acv4v","id":"205946500965076992","lang":"en","created_at":"2012-05-25T09:00:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":89,"end":109,"url":"http://t.co/k13acv4v","expanded_url":"http://bit.ly/MsXTgl","display_url":"bit.ly/MsXTgl"}]},"source":"Twitter Web Client","conversation_id":"205660075644297217","referenced_tweets":{},"text":"Our offices are closed on Monday 28 May. We have an emergency out-of-hours phone number: http://t.co/k13acv4v","id":"205660075644297217","lang":"en","created_at":"2012-05-24T14:02:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":86,"end":104,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/zi1FgVyB","expanded_url":"http://bit.ly/KyU6u9","display_url":"bit.ly/KyU6u9"}]},"source":"Twitter Web Client","conversation_id":"205659917959430144","referenced_tweets":{},"text":"Yesterday we published guidance for pharmaceutical companies on initial phases of the #pharmacovigilance legislation: http://t.co/zi1FgVyB","id":"205659917959430144","lang":"en","created_at":"2012-05-24T14:02:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205651580480004097","referenced_tweets":[{"type":"retweeted","id":"205639587790454784"}],"text":"RT @FDA_Drug_Info: Registration Open: FDA Small Business Regulatory Education for Industry (REdI) Conference Spring 2012. http://t.co/5L ...","id":"205651580480004097","lang":"en","created_at":"2012-05-24T13:28:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205638555211530242","referenced_tweets":[{"type":"retweeted","id":"205638483870621696"}],"text":"RT @eurordis: Future developments for EMA &amp; orphan medicines:transparency of outcomes, data mining, support int'l research, analyze  ...","id":"205638555211530242","lang":"en","created_at":"2012-05-24T12:37:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":31,"end":51,"url":"http://t.co/k13acv4v","expanded_url":"http://bit.ly/MsXTgl","display_url":"bit.ly/MsXTgl"}]},"source":"bitly bitlink","conversation_id":"205637355300851713","referenced_tweets":{},"text":"We're closed on Monday 28 May: http://t.co/k13acv4v","id":"205637355300851713","lang":"en","created_at":"2012-05-24T12:32:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"hashtags":{},"annotations":[{"start":53,"end":77,"probability":0.4282,"type":"Organization","normalized_text":"EUnetHTA Plenary Assembly"},{"start":122,"end":128,"probability":0.9736,"type":"Place","normalized_text":"Croatia"}],"urls":{}},"source":"TweetDeck","conversation_id":"205634639908442112","referenced_tweets":[{"type":"retweeted","id":"205634605196378114"}],"text":"RT @EUnetHTA: 52 participants are taking part in the EUnetHTA Plenary Assembly meeting, representing 24 EU member states, Croatia, Norwa ...","id":"205634639908442112","lang":"en","created_at":"2012-05-24T12:21:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":20,"end":35,"tag":"IntDiabetesFed"},{"start":91,"end":100,"tag":"diabetes"},{"start":105,"end":113,"tag":"climate"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205633359056076801","referenced_tweets":[{"type":"retweeted","id":"205625557604503552"}],"text":"RT @IntDiabetesFed: #IntDiabetesFed news: Unique expert dialogue makes connections between #diabetes and #climate change  http://t.co/cC ...","id":"205633359056076801","lang":"en","created_at":"2012-05-24T12:16:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":35,"end":46,"tag":"interferon"},{"start":52,"end":56,"tag":"HCV"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/oqCkuWcz","expanded_url":"http://bit.ly/Jts991","display_url":"bit.ly/Jts991"}]},"source":"TweetDeck","conversation_id":"205633118156234752","referenced_tweets":[{"type":"retweeted","id":"205627895673135104"}],"text":"RT @Hep_Alliance: Will there be an #interferon-free #HCV therapy for all: upcoming reality or just a vision? http://t.co/oqCkuWcz","id":"205633118156234752","lang":"en","created_at":"2012-05-24T12:15:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":82,"end":86,"tag":"WHO"},{"start":108,"end":114,"tag":"WHA65"}],"annotations":[{"start":16,"end":31,"probability":0.9295,"type":"Person","normalized_text":"Dr Margaret Chan"}],"urls":[{"start":87,"end":107,"url":"http://t.co/ZEbry7SK","expanded_url":"http://bit.ly/Kh7WV0","display_url":"bit.ly/Kh7WV0"}]},"source":"TweetDeck","conversation_id":"205632945338335232","referenced_tweets":[{"type":"retweeted","id":"205628120512999425"}],"text":"RT @WHO_Europe: Dr Margaret Chan appointed for second term as Director-General of #WHO http://t.co/ZEbry7SK #WHA65","id":"205632945338335232","lang":"en","created_at":"2012-05-24T12:14:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":80,"end":92,"username":"stenstovall","id":"23584208"},{"start":111,"end":115,"username":"GSK","id":"5383942"},{"start":116,"end":128,"username":"AstraZeneca","id":"62465691"}],"hashtags":[{"start":46,"end":58,"tag":"Antibiotics"},{"start":93,"end":110,"tag":"NewDrugs4BadBugs"}],"annotations":[{"start":11,"end":12,"probability":0.6213,"type":"Organization","normalized_text":"EU"}],"urls":[{"start":59,"end":79,"url":"http://t.co/3XUD8BBJ","expanded_url":"http://on.wsj.com/JUwTt7","display_url":"on.wsj.com/JUwTt7"}]},"source":"TweetDeck","conversation_id":"205632849804660736","referenced_tweets":[{"type":"retweeted","id":"205632684788158466"}],"text":"RT @EFPIA: EU Joins Widening Push To Find New #Antibiotics http://t.co/3XUD8BBJ @stenstovall #NewDrugs4BadBugs @GSK @Astrazeneca #Basile ...","id":"205632849804660736","lang":"en","created_at":"2012-05-24T12:14:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205621281117310976","referenced_tweets":[{"type":"retweeted","id":"205617787035594753"}],"text":"RT @AEMPSGOB: Uno de cada cuatro medicamentos debe incluir un pictograma para alertar de su interacción con la conducción http://t.co/Xs ...","id":"205621281117310976","lang":"es","created_at":"2012-05-24T11:28:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"hashtags":{},"annotations":[{"start":14,"end":38,"probability":0.5759,"type":"Organization","normalized_text":"EUnetHTA Plenary Assembly"},{"start":59,"end":64,"probability":0.9878,"type":"Place","normalized_text":"Lisbon"}],"urls":{}},"source":"TweetDeck","conversation_id":"205621190008639489","referenced_tweets":[{"type":"retweeted","id":"205621047389724672"}],"text":"RT @EUnetHTA: EUnetHTA Plenary Assembly is taking place in Lisbon, May 24-25, 2012","id":"205621190008639489","lang":"en","created_at":"2012-05-24T11:28:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205621172237381632","referenced_tweets":[{"type":"retweeted","id":"205620961851084800"}],"text":"RT @sanidadgob: Uno de cada 4 medicamentos debe incluir en sus envases un distintivo para alertar de su interacción con la conducción ht ...","id":"205621172237381632","lang":"es","created_at":"2012-05-24T11:28:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"hashtags":{},"annotations":[{"start":122,"end":127,"probability":0.9974,"type":"Place","normalized_text":"Europe"}],"urls":{}},"source":"TweetDeck","conversation_id":"205609396447875072","referenced_tweets":[{"type":"retweeted","id":"205609322611343361"}],"text":"RT @EMCDDA: Just published: profiles of the national early warning systems on new psychoactive substances in operation in Europe: http:/ ...","id":"205609396447875072","lang":"en","created_at":"2012-05-24T10:41:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"},{"start":110,"end":121,"username":"TheBrowser","id":"21251300"}],"hashtags":{},"annotations":[{"start":12,"end":26,"probability":0.9877,"type":"Person","normalized_text":"Louise Foxcroft"}],"urls":[{"start":85,"end":105,"url":"http://t.co/N7VSXwux","expanded_url":"http://thebrowser.com/interviews/louise-foxcroft-on-history-medicine-and-addiction?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A+Fivebooks+%2528The+Browser+%257C+FiveBooks%2529","display_url":"thebrowser.com/interviews/lou…"}]},"source":"TweetDeck","conversation_id":"205606941500780545","referenced_tweets":[{"type":"retweeted","id":"205606870084366336"}],"text":"RT @EMCDDA: Louise Foxcroft on the history of medicine and addiction in the Browser: http://t.co/N7VSXwux via @TheBrowser","id":"205606941500780545","lang":"en","created_at":"2012-05-24T10:31:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":114,"end":118,"username":"GSK","id":"5383942"},{"start":119,"end":131,"username":"AstraZeneca","id":"62465691"},{"start":132,"end":139,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":15,"end":19,"tag":"IMI"},{"start":69,"end":80,"tag":"antibiotic"},{"start":81,"end":92,"tag":"resistance"}],"annotations":{},"urls":[{"start":93,"end":113,"url":"http://t.co/hSFoFeZq","expanded_url":"http://bit.ly/sNRyWr","display_url":"bit.ly/sNRyWr"}]},"source":"TweetDeck","conversation_id":"205592041269362688","referenced_tweets":[{"type":"retweeted","id":"205589351718068224"}],"text":"RT @EFPIA: RT: #IMI launches €223.7 million programme for combatting #antibiotic #resistance http://t.co/hSFoFeZq @GSK @AstraZeneca @IMI_JU","id":"205592041269362688","lang":"en","created_at":"2012-05-24T09:32:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205591988354035712","referenced_tweets":[{"type":"retweeted","id":"205590254109982720"}],"text":"RT @Aifa_ufficiale: Per combattere il fenomeno della resistenza agli antibiotici l'IMI (Innovative Medicines Initiative), la più... http ...","id":"205591988354035712","lang":"it","created_at":"2012-05-24T09:32:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":113,"end":117,"username":"GSK","id":"5383942"},{"start":118,"end":130,"username":"AstraZeneca","id":"62465691"}],"hashtags":[{"start":11,"end":22,"tag":"Innovative"}],"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/tBfFirUb","expanded_url":"http://bit.ly/JU28nS","display_url":"bit.ly/JU28nS"}]},"source":"TweetDeck","conversation_id":"205580990347882496","referenced_tweets":[{"type":"retweeted","id":"205580915173359617"}],"text":"RT @EFPIA: #Innovative public-private collaboration launches to tackle antibiotic research: http://t.co/tBfFirUb @GSK @AstraZeneca @IMI_ ...","id":"205580990347882496","lang":"en","created_at":"2012-05-24T08:48:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":15,"end":21,"username":"EFPIA","id":"52084584"},{"start":37,"end":51,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":57,"end":61,"tag":"IMI"},{"start":101,"end":112,"tag":"antibiotic"},{"start":124,"end":131,"tag":"pharma"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205570754304151552","referenced_tweets":[{"type":"retweeted","id":"205568956960997376"}],"text":"RT @EFPIA: RT: @EFPIA companies plus @EU_Commission thru #IMI launch €223M R&amp;D program to tackle #antibiotic resistance #pharma #bio ...","id":"205570754304151552","lang":"en","created_at":"2012-05-24T08:07:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":68,"end":86,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/zi1FgVyB","expanded_url":"http://bit.ly/KyU6u9","display_url":"bit.ly/KyU6u9"}]},"source":"Twitter Web Client","conversation_id":"205569257071853568","referenced_tweets":{},"text":"Frequently asked questions and answers on the initial phases of the #pharmacovigilance legislation are on our website: http://t.co/zi1FgVyB","id":"205569257071853568","lang":"en","created_at":"2012-05-24T08:01:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":83,"end":101,"tag":"pharmacovigilance"}],"annotations":{},"urls":[{"start":115,"end":135,"url":"http://t.co/zi1FgVyB","expanded_url":"http://bit.ly/KyU6u9","display_url":"bit.ly/KyU6u9"}]},"source":"bitly bitlink","conversation_id":"205350883440082944","referenced_tweets":{},"text":"We've published some practical guidance for companies on the initial phases of the #pharmacovigilance legislation: http://t.co/zi1FgVyB","id":"205350883440082944","lang":"en","created_at":"2012-05-23T17:34:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":67,"end":75,"tag":"measles"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205321134512668673","referenced_tweets":[{"type":"retweeted","id":"205318115209383936"}],"text":"RT @ECDC_EU: In the period 1 January -30 March 2012, 2283 cases of #measles were reported by 29 EU/EEA countries. See monthly report htt ...","id":"205321134512668673","lang":"en","created_at":"2012-05-23T15:35:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":119,"end":125,"tag":"WHA65"}],"annotations":[{"start":26,"end":41,"probability":0.8614,"type":"Person","normalized_text":"Dr Margaret Chan"}],"urls":[{"start":98,"end":118,"url":"http://t.co/S8STXRB4","expanded_url":"http://goo.gl/Z4aJJ","display_url":"goo.gl/Z4aJJ"}]},"source":"TweetDeck","conversation_id":"205313812818169856","referenced_tweets":[{"type":"retweeted","id":"205313747705806848"}],"text":"RT @WHO: Media release on Dr Margaret Chan's appointment to a second term as WHO Director-General http://t.co/S8STXRB4 #WHA65","id":"205313812818169856","lang":"en","created_at":"2012-05-23T15:06:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":78,"end":84,"tag":"WHA65"}],"annotations":[{"start":30,"end":36,"probability":0.9936,"type":"Person","normalized_text":"Dr Chan"}],"urls":[{"start":85,"end":105,"url":"http://t.co/An6htND0","expanded_url":"http://instagr.am/p/K-SOyfqM2V/","display_url":"instagr.am/p/K-SOyfqM2V/"}]},"source":"TweetDeck","conversation_id":"205310995118292992","referenced_tweets":[{"type":"retweeted","id":"205310709297455106"}],"text":"RT @WHO: Media interview with Dr Chan, newly reappointed WHO Director-General #WHA65 http://t.co/An6htND0","id":"205310995118292992","lang":"en","created_at":"2012-05-23T14:55:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":20,"end":31,"tag":"veterinary"}],"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/8IVsINwB","expanded_url":"http://bit.ly/KSz3F9","display_url":"bit.ly/KSz3F9"}]},"source":"Twitter Web Client","conversation_id":"205298163358248960","referenced_tweets":{},"text":"We've published our #veterinary committee's May outcomes, including positive opinions for 2 new medicines for dogs: http://t.co/8IVsINwB","id":"205298163358248960","lang":"en","created_at":"2012-05-23T14:04:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":18,"end":25,"tag":"orphan"},{"start":70,"end":74,"tag":"HUS"},{"start":79,"end":83,"tag":"PML"}],"annotations":{},"urls":[{"start":85,"end":105,"url":"http://t.co/HJGdrecM","expanded_url":"http://bit.ly/K7YzII","display_url":"bit.ly/K7YzII"}]},"source":"Twitter Web Client","conversation_id":"205297789054361601","referenced_tweets":{},"text":"We've recommended #orphan designation for 16 medicines, including for #HUS and #PML: http://t.co/HJGdrecM","id":"205297789054361601","lang":"en","created_at":"2012-05-23T14:03:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":70,"end":74,"tag":"FP7"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/BCPI9fWq","expanded_url":"http://bit.ly/KwCh1d","display_url":"bit.ly/KwCh1d"}]},"source":"Twitter Web Client","conversation_id":"205297394378747904","referenced_tweets":{},"text":"Supplementary info on funding for medicine safety studies through the #FP7 programme is available on our website: http://t.co/BCPI9fWq","id":"205297394378747904","lang":"en","created_at":"2012-05-23T14:01:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":23,"end":32,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":98,"end":110,"tag":"raredisease"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"205269346577170433","referenced_tweets":[{"type":"retweeted","id":"205238356584579072"}],"text":"RT @eurordis: The 2012 @eurordis Membership Meeting off to a fast start with many of our over 500 #raredisease members in attendance htt ...","id":"205269346577170433","lang":"en","created_at":"2012-05-23T12:10:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"}],"annotations":{},"urls":[{"start":89,"end":109,"url":"http://t.co/8IVsINwB","expanded_url":"http://bit.ly/KSz3F9","display_url":"bit.ly/KSz3F9"}]},"source":"Twitter Web Client","conversation_id":"205268913347502080","referenced_tweets":{},"text":"Our #veterinary committee has recommended the authorisation of 2 new medicines for dogs: http://t.co/8IVsINwB","id":"205268913347502080","lang":"en","created_at":"2012-05-23T12:08:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":4,"end":11,"tag":"orphan"},{"start":12,"end":21,"tag":"medicine"}],"annotations":[{"start":115,"end":117,"probability":0.3598,"type":"Person","normalized_text":"PML"}],"urls":[{"start":120,"end":140,"url":"http://t.co/HJGdrecM","expanded_url":"http://bit.ly/K7YzII","display_url":"bit.ly/K7YzII"}]},"source":"Twitter Web Client","conversation_id":"205268485830492163","referenced_tweets":{},"text":"Our #orphan #medicine committee has recommended 16 designations for medicines for rare diseases, including HUS and PML: http://t.co/HJGdrecM","id":"205268485830492163","lang":"en","created_at":"2012-05-23T12:06:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":61,"end":65,"tag":"FP7"}],"annotations":{},"urls":[{"start":120,"end":140,"url":"http://t.co/BCPI9fWq","expanded_url":"http://bit.ly/KwCh1d","display_url":"bit.ly/KwCh1d"}]},"source":"Twitter Web Client","conversation_id":"205267804683907072","referenced_tweets":{},"text":"Funding for medicine safety studies is available through the #FP7 programme. We've published supplementary information: http://t.co/BCPI9fWq","id":"205267804683907072","lang":"en","created_at":"2012-05-23T12:03:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":55,"end":66,"tag":"veterinary"}],"annotations":{},"urls":[{"start":78,"end":98,"url":"http://t.co/8IVsINwB","expanded_url":"http://bit.ly/KSz3F9","display_url":"bit.ly/KSz3F9"}]},"source":"bitly bitlink","conversation_id":"205226073301073920","referenced_tweets":{},"text":"We've published the outcomes of the May meeting of our #veterinary committee: http://t.co/8IVsINwB","id":"205226073301073920","lang":"en","created_at":"2012-05-23T09:18:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":38,"end":80,"probability":0.2953,"type":"Other","normalized_text":"May Committee for Orphan Medicinal Products"}],"urls":[{"start":98,"end":118,"url":"http://t.co/HJGdrecM","expanded_url":"http://bit.ly/K7YzII","display_url":"bit.ly/K7YzII"}]},"source":"bitly bitlink","conversation_id":"204967194973585412","referenced_tweets":{},"text":"We've published the highlights of the May Committee for Orphan Medicinal Products (COMP) meeting: http://t.co/HJGdrecM","id":"204967194973585412","lang":"en","created_at":"2012-05-22T16:09:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204962638961184768","referenced_tweets":[{"type":"retweeted","id":"204962566538133504"}],"text":"RT @beuctweet: EU Consumer Agenda published.Impressive list of initiatives.Consumers expect swift follow-up of promises.See BEUC PR http ...","id":"204962638961184768","lang":"en","created_at":"2012-05-22T15:51:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":45,"end":49,"tag":"FP7"}],"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/BCPI9fWq","expanded_url":"http://bit.ly/KwCh1d","display_url":"bit.ly/KwCh1d"}]},"source":"bitly bitlink","conversation_id":"204956513863876610","referenced_tweets":{},"text":"We've published supplementary information on #FP7 funding for studies into medicine safety: http://t.co/BCPI9fWq","id":"204956513863876610","lang":"en","created_at":"2012-05-22T15:26:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":82,"end":97,"tag":"consumeragenda"}],"annotations":{},"urls":[{"start":100,"end":120,"url":"http://t.co/KYzuEzev","expanded_url":"http://bit.ly/Jh0mZm","display_url":"bit.ly/Jh0mZm"}]},"source":"TweetDeck","conversation_id":"204948033790672898","referenced_tweets":[{"type":"retweeted","id":"204947999250583552"}],"text":"RT @EU_Consumer: Consumer agenda covers also animal welfare – concrete actions on #consumeragenda – http://t.co/KYzuEzev","id":"204948033790672898","lang":"en","created_at":"2012-05-22T14:53:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":35,"end":41,"tag":"WHA65"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204942330573242368","referenced_tweets":[{"type":"retweeted","id":"204876267160481792"}],"text":"RT @WHO: 1st resolution EB130.R6 @ #WHA65 has been passed, awaiting adoption: Strengthening noncommunicable disease policies to promote  ...","id":"204942330573242368","lang":"en","created_at":"2012-05-22T14:30:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":17,"end":32,"tag":"Consumeragenda"},{"start":85,"end":88,"tag":"EU"}],"annotations":{},"urls":[{"start":110,"end":130,"url":"http://t.co/KYzuEzev","expanded_url":"http://bit.ly/Jh0mZm","display_url":"bit.ly/Jh0mZm"}]},"source":"TweetDeck","conversation_id":"204942127841554436","referenced_tweets":[{"type":"retweeted","id":"204933722758328321"}],"text":"RT @EU_Consumer: #Consumeragenda only relevant within EU? Countries exporting to the #EU are also concerned – http://t.co/KYzuEzev","id":"204942127841554436","lang":"en","created_at":"2012-05-22T14:29:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":32,"end":39,"tag":"safety"},{"start":66,"end":76,"tag":"consumers"},{"start":90,"end":93,"tag":"EU"},{"start":116,"end":131,"tag":"consumeragenda"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204941985092612096","referenced_tweets":[{"type":"retweeted","id":"204929163373715456"}],"text":"RT @EU_Consumer: Making product #safety laws work even better for #consumers all over the #EU – concrete actions on #consumeragenda – ht ...","id":"204941985092612096","lang":"en","created_at":"2012-05-22T14:29:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204928263221547008","referenced_tweets":[{"type":"retweeted","id":"204927303082459136"}],"text":"RT @cancereu: Check out the Eurobarometer report on patient involvement - do you feel involved enough in your own treatment?... http://t ...","id":"204928263221547008","lang":"en","created_at":"2012-05-22T13:34:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":21,"end":36,"tag":"consumeragenda"}],"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/uFBxeLu4","expanded_url":"http://bit.ly/JlySlv","display_url":"bit.ly/JlySlv"}]},"source":"TweetDeck","conversation_id":"204928109936508928","referenced_tweets":[{"type":"retweeted","id":"204924498770792449"}],"text":"RT @EU_Consumer: New #consumeragenda 2012-2014 \"to put consumer at the heart of the Single Market\" is adopted today http://t.co/uFBxeLu4","id":"204928109936508928","lang":"en","created_at":"2012-05-22T13:34:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":78,"end":84,"tag":"WHA65"}],"annotations":[{"start":35,"end":55,"probability":0.4016,"type":"Other","normalized_text":"World Health Assembly"}],"urls":[{"start":57,"end":77,"url":"http://t.co/zQ3n2CaM","expanded_url":"http://goo.gl/ZoPpF","display_url":"goo.gl/ZoPpF"}]},"source":"TweetDeck","conversation_id":"204857321883570177","referenced_tweets":[{"type":"retweeted","id":"204687302662959105"}],"text":"RT @WHO: Here's recap from day one World Health Assembly http://t.co/zQ3n2CaM #WHA65","id":"204857321883570177","lang":"en","created_at":"2012-05-22T08:52:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":46,"end":57,"tag":"pesticides"},{"start":108,"end":113,"tag":"EFSA"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204610539618439170","referenced_tweets":[{"type":"retweeted","id":"204584095035031553"}],"text":"RT @EFSA_EU: Understanding science - What are #pesticides and how do they get into our food? Take a look at #EFSA’s new video: \nhttp://t ...","id":"204610539618439170","lang":"en","created_at":"2012-05-21T16:32:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"UNLibrary","id":"109720244"},{"start":15,"end":22,"username":"UNAIDS","id":"19177501"},{"start":69,"end":79,"username":"reliefweb","id":"19993545"}],"hashtags":[{"start":52,"end":56,"tag":"HIV"}],"annotations":{},"urls":[{"start":80,"end":100,"url":"http://t.co/fobhrVcc","expanded_url":"http://ow.ly/b2NT7","display_url":"ow.ly/b2NT7"}]},"source":"TweetDeck","conversation_id":"204584777272143873","referenced_tweets":[{"type":"retweeted","id":"204574651488276482"}],"text":"RT @UNLibrary: @UNAIDS  reports on the quest for an #HIV vaccine via @reliefweb http://t.co/fobhrVcc","id":"204584777272143873","lang":"en","created_at":"2012-05-21T14:49:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":27,"end":36,"tag":"Clinical"},{"start":37,"end":44,"tag":"Trials"}],"annotations":{},"urls":[{"start":60,"end":80,"url":"http://t.co/CtSeG9xg","expanded_url":"http://bit.ly/L6SW9T","display_url":"bit.ly/L6SW9T"}]},"source":"Twitter Web Client","conversation_id":"204583164105068544","referenced_tweets":{},"text":"We supported International #Clinical #Trials Day yesterday: http://t.co/CtSeG9xg","id":"204583164105068544","lang":"en","created_at":"2012-05-21T14:43:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":19,"end":32,"tag":"Hypertension"}],"annotations":{},"urls":[{"start":52,"end":72,"url":"http://t.co/CxdQlaVN","expanded_url":"http://bit.ly/KmgRTW","display_url":"bit.ly/KmgRTW"}]},"source":"Twitter Web Client","conversation_id":"204583088418848768","referenced_tweets":{},"text":"We supported World #Hypertension Day last Thursday: http://t.co/CxdQlaVN","id":"204583088418848768","lang":"en","created_at":"2012-05-21T14:43:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":118,"end":124,"tag":"WHA65"}],"annotations":[{"start":23,"end":29,"probability":0.9739,"type":"Person","normalized_text":"Dr Chan"},{"start":65,"end":90,"probability":0.5867,"type":"Other","normalized_text":"65th World Health Assembly"}],"urls":[{"start":97,"end":117,"url":"http://t.co/vBYdsuEo","expanded_url":"http://goo.gl/fg5xT","display_url":"goo.gl/fg5xT"}]},"source":"TweetDeck","conversation_id":"204582755995103233","referenced_tweets":[{"type":"retweeted","id":"204581967193325569"}],"text":"RT @WHO: You will find Dr Chan's complete opening address to the 65th World Health Assembly here http://t.co/vBYdsuEo #WHA65","id":"204582755995103233","lang":"en","created_at":"2012-05-21T14:41:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":133,"end":139,"tag":"WHA65"}],"annotations":[{"start":40,"end":60,"probability":0.8236,"type":"Organization","normalized_text":"World Health Assembly"}],"urls":{}},"source":"TweetDeck","conversation_id":"204537111293071361","referenced_tweets":[{"type":"retweeted","id":"204520630832472064"}],"text":"RT @WHO: 100 entry badges to attend the World Health Assembly are available to the general public everyday. First come, first serve. #WHA65","id":"204537111293071361","lang":"en","created_at":"2012-05-21T11:40:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":18,"end":36,"tag":"WorldHepatitisDay"}],"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/CwycW8A8","expanded_url":"http://www.worldhepatitisday.info","display_url":"worldhepatitisday.info"}]},"source":"TweetDeck","conversation_id":"204537044914016257","referenced_tweets":[{"type":"retweeted","id":"204532687564840960"}],"text":"RT @Hep_Alliance: #WorldHepatitisDay landing page has been launched! http://t.co/CwycW8A8","id":"204537044914016257","lang":"en","created_at":"2012-05-21T11:40:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"},{"start":96,"end":100,"username":"WHO","id":"14499829"}],"hashtags":[{"start":88,"end":92,"tag":"NCD"},{"start":122,"end":129,"tag":"Stat12"}],"annotations":[{"start":20,"end":51,"probability":0.2622,"type":"Other","normalized_text":"The World Health Statistics 2012"}],"urls":[{"start":101,"end":121,"url":"http://t.co/8THZuh6y","expanded_url":"http://bit.ly/K6AUp0","display_url":"bit.ly/K6AUp0"}]},"source":"TweetDeck","conversation_id":"204537004531261440","referenced_tweets":[{"type":"retweeted","id":"204536945701953536"}],"text":"RT @IntDiabetesFed: The World Health Statistics 2012 report is out! Read the section on #NCD’s! @WHO http://t.co/8THZuh6y #Stat12","id":"204537004531261440","lang":"en","created_at":"2012-05-21T11:39:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":99,"end":108,"tag":"nyttjobb"}],"annotations":{},"urls":[{"start":109,"end":129,"url":"http://t.co/YM0Tdqb0","expanded_url":"http://tinyurl.com/7kw9lvu","display_url":"tinyurl.com/7kw9lvu"}]},"source":"TweetDeck","conversation_id":"204514111428628480","referenced_tweets":[{"type":"retweeted","id":"204513495948083200"}],"text":"RT @LV_MPA: Lediga tjänster på Läkemedelsverket: Kommunikationsansvarig, kliniker och farmacevter  #nyttjobb http://t.co/YM0Tdqb0","id":"204514111428628480","lang":"sv","created_at":"2012-05-21T10:08:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204510480675520512","referenced_tweets":[{"type":"retweeted","id":"204510035626295296"}],"text":"RT @Aifa_ufficiale: L’UE ha autorizzato il pixantrone dimaleato come terapia per pazienti con linfomi non-Hodgkin (Lnh) a cellule B... h ...","id":"204510480675520512","lang":"it","created_at":"2012-05-21T09:54:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"},{"start":77,"end":81,"username":"WHO","id":"14499829"}],"hashtags":[{"start":94,"end":100,"tag":"WHA65"}],"annotations":[{"start":34,"end":67,"probability":0.5904,"type":"Other","normalized_text":"65th session World Health Assembly"}],"urls":{}},"source":"TweetDeck","conversation_id":"204490970316816384","referenced_tweets":[{"type":"retweeted","id":"204490895175847938"}],"text":"RT @WHO: For conversations on the 65th session World Health Assembly, follow @WHO and hashtag #WHA65","id":"204490970316816384","lang":"en","created_at":"2012-05-21T08:37:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":98,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":6,"username":"UN","id":"14159148"},{"start":112,"end":116,"username":"WHO","id":"14499829"}],"hashtags":[{"start":24,"end":33,"tag":"diabetes"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"204485820864937984","referenced_tweets":[{"type":"retweeted","id":"204149608329383937"}],"text":"RT @UN: Left untreated, #diabetes can lead to heart attacks, strokes, blindness &amp; kidney failure. More from @WHO: http://t.co/q6T9i0 ...","id":"204485820864937984","lang":"en","created_at":"2012-05-21T08:16:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":25,"end":34,"tag":"Clinical"},{"start":35,"end":42,"tag":"Trials"}],"annotations":{},"urls":[{"start":76,"end":96,"url":"http://t.co/CtSeG9xg","expanded_url":"http://bit.ly/L6SW9T","display_url":"bit.ly/L6SW9T"}]},"source":"Twitter Web Client","conversation_id":"204484425973628928","referenced_tweets":{},"text":"We support International #Clinical #Trials Day, which took place yesterday: http://t.co/CtSeG9xg","id":"204484425973628928","lang":"en","created_at":"2012-05-21T08:11:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":17,"end":30,"tag":"Hypertension"}],"annotations":{},"urls":[{"start":68,"end":88,"url":"http://t.co/CxdQlaVN","expanded_url":"http://bit.ly/KmgRTW","display_url":"bit.ly/KmgRTW"}]},"source":"Twitter Web Client","conversation_id":"204484323875889152","referenced_tweets":{},"text":"We support World #Hypertension Day, which took place last Thursday: http://t.co/CxdQlaVN","id":"204484323875889152","lang":"en","created_at":"2012-05-21T08:10:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/px6fdNjs","expanded_url":"http://bit.ly/K7HWKa","display_url":"bit.ly/K7HWKa"}]},"source":"Twitter Web Client","conversation_id":"204484158238621696","referenced_tweets":{},"text":"Last week we launched an e-learning course on Article 57 (2) requirements on submission of information on medicines: http://t.co/px6fdNjs","id":"204484158238621696","lang":"en","created_at":"2012-05-21T08:09:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":124,"end":130,"tag":"WHA65"}],"annotations":[{"start":41,"end":66,"probability":0.4377,"type":"Other","normalized_text":"65th World Health Assembly"}],"urls":[{"start":103,"end":123,"url":"http://t.co/yXRRnc3g","expanded_url":"http://bit.ly/KV4xwG","display_url":"bit.ly/KV4xwG"}]},"source":"TweetDeck","conversation_id":"204483879275462656","referenced_tweets":[{"type":"retweeted","id":"204482293757255680"}],"text":"RT @WHO_Europe: Opening session of WHO's 65th World Health Assembly (annual global meeting) just began http://t.co/yXRRnc3g #WHA65 #publ ...","id":"204483879275462656","lang":"en","created_at":"2012-05-21T08:08:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":31,"end":40,"tag":"Clinical"},{"start":41,"end":48,"tag":"Trials"}],"annotations":{},"urls":[{"start":54,"end":74,"url":"http://t.co/CtSeG9xg","expanded_url":"http://bit.ly/L6SW9T","display_url":"bit.ly/L6SW9T"}]},"source":"bitly bitlink","conversation_id":"202807529636503554","referenced_tweets":{},"text":"We're supporting International #Clinical #Trials Day: http://t.co/CtSeG9xg","id":"202807529636503554","lang":"en","created_at":"2012-05-16T17:07:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":23,"end":36,"tag":"Hypertension"}],"annotations":{},"urls":[{"start":42,"end":62,"url":"http://t.co/CxdQlaVN","expanded_url":"http://bit.ly/KmgRTW","display_url":"bit.ly/KmgRTW"}]},"source":"bitly bitlink","conversation_id":"202780077111525377","referenced_tweets":{},"text":"We're supporting World #Hypertension Day: http://t.co/CxdQlaVN","id":"202780077111525377","lang":"en","created_at":"2012-05-16T15:18:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":105,"end":125,"url":"http://t.co/QwWp4ymN","expanded_url":"http://bit.ly/JFu4ZV","display_url":"bit.ly/JFu4ZV"}]},"source":"Twitter Web Client","conversation_id":"202777224569556992","referenced_tweets":{},"text":"We are closed tomorrow and Friday. We have an emergency out-of-hours phone number for medicine problems: http://t.co/QwWp4ymN","id":"202777224569556992","lang":"en","created_at":"2012-05-16T15:07:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":106,"end":126,"url":"http://t.co/px6fdNjs","expanded_url":"http://bit.ly/K7HWKa","display_url":"bit.ly/K7HWKa"}]},"source":"Twitter Web Client","conversation_id":"202777130122215426","referenced_tweets":{},"text":"Take our new e-learning course for Article 57 (2) requirements on submission of information on medicines: http://t.co/px6fdNjs","id":"202777130122215426","lang":"en","created_at":"2012-05-16T15:06:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":127,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":129,"end":136,"tag":"Stat12"}],"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/Y9ftdUM2","expanded_url":"http://goo.gl/ijK66","display_url":"goo.gl/ijK66"}]},"source":"TweetDeck","conversation_id":"202766804693696512","referenced_tweets":[{"type":"retweeted","id":"202762968700698624"}],"text":"RT @WHO: High blood pressure makes the heart work harder than it should, causing it to get weaker over time http://t.co/Y9ftdUM2 #Stat12 ...","id":"202766804693696512","lang":"en","created_at":"2012-05-16T14:25:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":113,"end":121,"tag":"DIA2012"}],"annotations":{},"urls":[{"start":92,"end":112,"url":"http://t.co/hRl8qoiw","expanded_url":"http://bit.ly/K4b8SR","display_url":"bit.ly/K4b8SR"}]},"source":"TweetDeck","conversation_id":"202766773550972930","referenced_tweets":[{"type":"retweeted","id":"202762830812950528"}],"text":"RT @DrugInfoAssn: Pediatric Drug Development Progress: 15 Years Later and Across the Globe  http://t.co/hRl8qoiw #DIA2012","id":"202766773550972930","lang":"en","created_at":"2012-05-16T14:25:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":{},"annotations":[{"start":40,"end":45,"probability":0.5353,"type":"Place","normalized_text":"Region"},{"start":75,"end":102,"probability":0.3952,"type":"Other","normalized_text":"World Health Statistics 2012"}],"urls":{}},"source":"TweetDeck","conversation_id":"202766547230539777","referenced_tweets":[{"type":"retweeted","id":"202747195097743361"}],"text":"RT @WHO_Europe: Nearly 1 in 3 people in Region have raised blood pressure! World Health Statistics 2012, launched today: http://t.co/zbr ...","id":"202766547230539777","lang":"en","created_at":"2012-05-16T14:24:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":40,"end":48,"tag":"WDD2012"},{"start":66,"end":70,"tag":"WDD"}],"annotations":[{"start":74,"end":81,"probability":0.5385,"type":"Organization","normalized_text":"Facebook"},{"start":84,"end":90,"probability":0.6214,"type":"Product","normalized_text":"Twitter"},{"start":113,"end":118,"probability":0.6492,"type":"Product","normalized_text":"Flickr"}],"urls":{}},"source":"Twitter Web Client","conversation_id":"202766267059404801","referenced_tweets":[{"type":"retweeted","id":"202738815050330113"}],"text":"RT @IntDiabetesFed: Start following the #WDD2012 campaign! Follow #WDD on Facebook, Twitter and post pictures on Flickr! http://t.co/BS9 ...","id":"202766267059404801","lang":"en","created_at":"2012-05-16T14:23:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/QwWp4ymN","expanded_url":"http://bit.ly/JFu4ZV","display_url":"bit.ly/JFu4ZV"}]},"source":"Twitter Web Client","conversation_id":"202761920669941761","referenced_tweets":{},"text":"Our offices are closed tomorrow and Friday. We have an emergency out-of-hours phone number for medicine problems: http://t.co/QwWp4ymN","id":"202761920669941761","lang":"en","created_at":"2012-05-16T14:06:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/px6fdNjs","expanded_url":"http://bit.ly/K7HWKa","display_url":"bit.ly/K7HWKa"}]},"source":"bitly bitlink","conversation_id":"202736273360818176","referenced_tweets":{},"text":"We've launched new e-learning course for Article 57 (2) requirements on submission of information on medicines \nhttp://t.co/px6fdNjs","id":"202736273360818176","lang":"en","created_at":"2012-05-16T12:24:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":154,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202714403534155776","referenced_tweets":[{"type":"retweeted","id":"202714271245811713"}],"text":"RT @WHO: 1 in 3 adults worldwide has high blood pressure - cause of about half of all deaths from stroke, heart disease http://t.co/JeGy ...","id":"202714403534155776","lang":"en","created_at":"2012-05-16T10:57:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":[{"start":80,"end":86,"probability":0.81,"type":"Person","normalized_text":"Dr Chan"}],"urls":{}},"source":"TweetDeck","conversation_id":"202710291153293312","referenced_tweets":[{"type":"retweeted","id":"202691300364009472"}],"text":"RT @WHO: World Health Statistics help countries plan, implement health actions. Dr Chan: What gets measured gets done http://t.co/JeGyBv ...","id":"202710291153293312","lang":"en","created_at":"2012-05-16T10:41:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":92,"end":99,"tag":"Stat12"}],"annotations":{},"urls":[{"start":71,"end":91,"url":"http://t.co/CKKkcAZt","expanded_url":"http://goo.gl/1qCgP","display_url":"goo.gl/1qCgP"}]},"source":"TweetDeck","conversation_id":"202710260597800961","referenced_tweets":[{"type":"retweeted","id":"202690118333628417"}],"text":"RT @WHO: Statistiques sanitaires mondiales 2012 disponible en Français http://t.co/CKKkcAZt #Stat12","id":"202710260597800961","lang":"fr","created_at":"2012-05-16T10:41:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":181,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":[{"start":33,"end":55,"probability":0.3198,"type":"Other","normalized_text":"World Health Statistics"}],"urls":[{"start":113,"end":133,"url":"http://t.co/EoEALcBM","expanded_url":"http://goo.gl/oYrT4","display_url":"goo.gl/oYrT4"}]},"source":"TweetDeck","conversation_id":"202684164212932609","referenced_tweets":[{"type":"retweeted","id":"202683769755418624"}],"text":"RT @WHO: For the first time, the World Health Statistics include info on high blood pressure, blood sugar levels http://t.co/EoEALcBM #S ...","id":"202684164212932609","lang":"en","created_at":"2012-05-16T08:57:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":44,"end":64,"url":"http://t.co/QwWp4ymN","expanded_url":"http://bit.ly/JFu4ZV","display_url":"bit.ly/JFu4ZV"}]},"source":"bitly bitlink","conversation_id":"202682017333256192","referenced_tweets":{},"text":"Our offices are closed tomorrow and Friday: http://t.co/QwWp4ymN","id":"202682017333256192","lang":"en","created_at":"2012-05-16T08:48:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":128,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202681986278629377","referenced_tweets":[{"type":"retweeted","id":"202681931668783104"}],"text":"RT @WHO: World Health Statistics 2012, released today, puts the spotlight on growing burden of noncommunicable diseases http://t.co/JeGy ...","id":"202681986278629377","lang":"en","created_at":"2012-05-16T08:48:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":52,"end":67,"username":"scelgolasalute","id":"273457637"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202080555775434753","referenced_tweets":[{"type":"retweeted","id":"202064738283298817"}],"text":"RT @Aifa_ufficiale: La campagna AIFA in evidenza RT @scelgolasalute: Antibiotici: un uso corretto contro lo sviluppo di batteri resisten ...","id":"202080555775434753","lang":"it","created_at":"2012-05-14T16:58:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":{},"urls":[{"start":116,"end":136,"url":"http://t.co/0vCv1o7i","expanded_url":"http://goo.gl/0yLQZ","display_url":"goo.gl/0yLQZ"}]},"source":"TweetDeck","conversation_id":"202080508312698882","referenced_tweets":[{"type":"retweeted","id":"202062454665134081"}],"text":"RT @WHO: Health researchers, statisticians, health providers, help shape WHO’s Intl Classification of Diseases here http://t.co/0vCv1o7i ...","id":"202080508312698882","lang":"en","created_at":"2012-05-14T16:58:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202042549068763137","referenced_tweets":[{"type":"retweeted","id":"202041867595026432"}],"text":"RT @Aifa_ufficiale: In Italia non sono in corso sperimentazioni su nuove molecole di antibiotici, mentre il fenomeno dell'antibiotico... ...","id":"202042549068763137","lang":"it","created_at":"2012-05-14T14:27:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202039567283535872","referenced_tweets":[{"type":"retweeted","id":"202038694750859264"}],"text":"RT @FDA_Drug_Info: Safety Communication: Revised recommendations for cardiovascular monitoring and use of MS drug Gilenya. http://t.co/s ...","id":"202039567283535872","lang":"en","created_at":"2012-05-14T14:16:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":44,"end":52,"username":"YouTube","id":"10228272"}],"hashtags":{},"annotations":{},"urls":[{"start":53,"end":73,"url":"http://t.co/gElbFKA9","expanded_url":"http://youtu.be/PW36ZBu86Lg?a","display_url":"youtu.be/PW36ZBu86Lg?a"}]},"source":"TweetDeck","conversation_id":"202029941527814144","referenced_tweets":[{"type":"retweeted","id":"202022761110048768"}],"text":"RT @Aifa_ufficiale: Ho caricato un video di @YouTube http://t.co/gElbFKA9 \"Antibiotici? Difendi la tua difesa. Usali con cautela\"","id":"202029941527814144","lang":"it","created_at":"2012-05-14T13:37:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":44,"end":52,"username":"YouTube","id":"10228272"}],"hashtags":{},"annotations":{},"urls":[{"start":53,"end":73,"url":"http://t.co/HnvwJibG","expanded_url":"http://youtu.be/hegH85agR24?a","display_url":"youtu.be/hegH85agR24?a"}]},"source":"TweetDeck","conversation_id":"202019243468931073","referenced_tweets":[{"type":"retweeted","id":"202019180491456512"}],"text":"RT @Aifa_ufficiale: Ho caricato un video di @YouTube http://t.co/HnvwJibG Campagna AIFA \"Antibiotici. Difendi la tua difesa. Usal","id":"202019243468931073","lang":"it","created_at":"2012-05-14T12:55:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":116,"end":121,"username":"SfEP","id":"39253242"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"202003783490879488","referenced_tweets":[{"type":"retweeted","id":"202003711550173184"}],"text":"RT @ECDC_EU: Climate change's effects on infectious diseases: ECDC study featured in Science for Environment Policy @SfEP, http://t.co/m ...","id":"202003783490879488","lang":"en","created_at":"2012-05-14T11:53:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200914707786383360","referenced_tweets":[{"type":"retweeted","id":"200914526869262336"}],"text":"RT @Legemiddelinfo: Standardmerking av sikkerhetsinformasjon som sendes til leger: Legemiddelindustrien oppfordres til å bruke stand...  ...","id":"200914707786383360","lang":"no","created_at":"2012-05-11T11:46:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":61,"end":65,"tag":"EMA"},{"start":115,"end":131,"tag":"PilloledalMondo"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200894349930795009","referenced_tweets":[{"type":"retweeted","id":"200893997034647552"}],"text":"RT @Aifa_ufficiale: Parere positivo per Ferumoxytol dal CHMP #EMA per l'anemia nei pazienti con nefropatia cronica #PilloledalMondo... h ...","id":"200894349930795009","lang":"it","created_at":"2012-05-11T10:25:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":38,"end":53,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":114,"end":126,"tag":"antibiotics"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200886087839784960","referenced_tweets":[{"type":"retweeted","id":"200883396895969280"}],"text":"RT @ECDC_EU: Italian Medicines Agency @Aifa_ufficiale launches web &amp; social media campaign for prudent use of #antibiotics. http://t ...","id":"200886087839784960","lang":"en","created_at":"2012-05-11T09:52:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"hashtags":{},"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/RuWqgADG","expanded_url":"http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html","display_url":"ich.org/products/guide…"}]},"source":"TweetDeck","conversation_id":"200886010685566976","referenced_tweets":[{"type":"retweeted","id":"200875051308953601"}],"text":"RT @ICH_news: ICH Q11 Guideline on Development and Manufacture of Drug Substances reaches Step 4 of the ICH Process! http://t.co/RuWqgADG","id":"200886010685566976","lang":"en","created_at":"2012-05-11T09:52:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200885993027547136","referenced_tweets":[{"type":"retweeted","id":"200874579370065920"}],"text":"RT @ICH_news: New E14 Q&amp;As on Sex Differences, Incorporating New Technologies, Late Stage Monitoring and Heart Rate Correction. http ...","id":"200885993027547136","lang":"en","created_at":"2012-05-11T09:52:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200861330872352769","referenced_tweets":[{"type":"retweeted","id":"200860986662600704"}],"text":"RT @Aifa_ufficiale: RICORDATI DI RICORRERE AGLI ANTIBIOTICI SOLO QUANDO NECESSARIO E DIETRO PRESCRIZIONE DEL MEDICO.\n\nIl consumo... http ...","id":"200861330872352769","lang":"it","created_at":"2012-05-11T08:14:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200858388018626562","referenced_tweets":[{"type":"retweeted","id":"200858036129120256"}],"text":"RT @Europarl_EN: Are you a journalist interested in health? Apply until 31 July for 2012 EU Health Prize for Journalists http://t.co/b3F ...","id":"200858388018626562","lang":"en","created_at":"2012-05-11T08:02:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":[{"start":123,"end":138,"tag":"futureconsumer"}],"annotations":{},"urls":[{"start":102,"end":122,"url":"http://t.co/fxpdMMJo","expanded_url":"http://bit.ly/J0nYpO","display_url":"bit.ly/J0nYpO"}]},"source":"TweetDeck","conversation_id":"200606157625229314","referenced_tweets":[{"type":"retweeted","id":"200606117632552960"}],"text":"RT @beuctweet: BEUC notre stratégie pour une politique de consommateurs en 2020 est déjà disponible - http://t.co/fxpdMMJo #futureconsumer","id":"200606157625229314","lang":"fr","created_at":"2012-05-10T15:20:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":20,"end":32,"tag":"Antibiotici"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200594690075148288","referenced_tweets":[{"type":"retweeted","id":"200594639777050624"}],"text":"RT @Aifa_ufficiale: #Antibiotici nel 2011 2.581 segnalazioni di sospette reazioni avverse inviate alla Rete di Farmacovigilanza AIFA. ht ...","id":"200594690075148288","lang":"it","created_at":"2012-05-10T14:34:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":[{"start":92,"end":107,"tag":"futureconsumer"}],"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/Zk3AzFNK","expanded_url":"http://bit.ly/JjR4Nf","display_url":"bit.ly/JjR4Nf"}]},"source":"TweetDeck","conversation_id":"200590960273530880","referenced_tweets":[{"type":"retweeted","id":"200590846654021633"}],"text":"RT @beuctweet: BEUC Verbraucherstrategie 2020 online - deutscher Text http://t.co/Zk3AzFNK  #futureconsumer","id":"200590960273530880","lang":"de","created_at":"2012-05-10T14:19:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":77,"end":97,"url":"http://t.co/HyoJm8Vj","expanded_url":"http://bit.ly/JdxDnf","display_url":"bit.ly/JdxDnf"}]},"source":"Twitter Web Client","conversation_id":"200585597235118080","referenced_tweets":{},"text":"We upgraded our website earlier this week, based on feedback from our users: http://t.co/HyoJm8Vj","id":"200585597235118080","lang":"en","created_at":"2012-05-10T13:58:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":0,"end":12,"username":"AlecGaffney","id":"73774967"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200547882414260224","referenced_tweets":[{"type":"replied_to","id":"200547882414260224"}],"text":"@AlecGaffney Thanks for your feedback. We'll take this into account for our next upgrade.","id":"200585243068088320","lang":"en","created_at":"2012-05-10T13:57:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"73774967"},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":{},"annotations":{},"urls":[{"start":37,"end":57,"url":"http://t.co/ZUkQI7hU","expanded_url":"http://bit.ly/KcdZN6","display_url":"bit.ly/KcdZN6"}]},"source":"TweetDeck","conversation_id":"200560848505282561","referenced_tweets":[{"type":"retweeted","id":"200545364552589312"}],"text":"RT @beuctweet: BEUC fete ses 50 ans  http://t.co/ZUkQI7hU - mais quel est le futur pour la politique des consommateurs? participez sur # ...","id":"200560848505282561","lang":"fr","created_at":"2012-05-10T12:20:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":17,"end":27,"username":"beuctweet","id":"3061421219"}],"hashtags":{},"annotations":{},"urls":[{"start":60,"end":80,"url":"http://t.co/a2rOdNoi","expanded_url":"http://bit.ly/KcdZN6","display_url":"bit.ly/KcdZN6"}]},"source":"TweetDeck","conversation_id":"200542875061207041","referenced_tweets":[{"type":"retweeted","id":"200534973948772353"}],"text":"RT @EU_Consumer: @beuctweet celebrates 50 years of activity http://t.co/a2rOdNoi &amp; initiates discussions on future consumer policy t ...","id":"200542875061207041","lang":"en","created_at":"2012-05-10T11:08:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":51,"end":52,"probability":0.9418,"type":"Place","normalized_text":"UK"}],"urls":[{"start":114,"end":134,"url":"http://t.co/xaex4u8e","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON152637","display_url":"mhra.gov.uk/NewsCentre/CON…"}]},"source":"TweetDeck","conversation_id":"200542784631996417","referenced_tweets":[{"type":"retweeted","id":"200532862137671680"}],"text":"RT @MHRAGovUkPress: Withdrawal of co-proxamol from UK market 'has saved the lives of around 300 people per annum' http://t.co/xaex4u8e","id":"200542784631996417","lang":"en","created_at":"2012-05-10T11:08:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"},{"start":109,"end":117,"username":"EC_live","id":"800896050"}],"hashtags":[{"start":100,"end":108,"tag":"Barroso"},{"start":118,"end":133,"tag":"futureconsumer"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200542696555823105","referenced_tweets":[{"type":"retweeted","id":"200531410598117377"}],"text":"RT @beuctweet: BEUC organises conf on the future of consumer policy,with video address by President #Barroso @EC_live #futureconsumer ht ...","id":"200542696555823105","lang":"en","created_at":"2012-05-10T11:07:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":{},"annotations":[{"start":105,"end":117,"probability":0.9892,"type":"Person","normalized_text":"Paola Testori"},{"start":123,"end":135,"probability":0.9701,"type":"Person","normalized_text":"Malcolm Harbo"}],"urls":{}},"source":"TweetDeck","conversation_id":"200542484240150529","referenced_tweets":[{"type":"retweeted","id":"200523914353451008"}],"text":"RT @beuctweet: BEUC organises conference \"A Vision for 2020 Consumer Policy Strategy\" with keynotes from Paola Testori and Malcolm Harbo ...","id":"200542484240150529","lang":"en","created_at":"2012-05-10T11:07:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"hashtags":{},"annotations":{},"urls":[{"start":50,"end":70,"url":"http://t.co/ZUkQI7hU","expanded_url":"http://bit.ly/KcdZN6","display_url":"bit.ly/KcdZN6"}]},"source":"TweetDeck","conversation_id":"200542459216928768","referenced_tweets":[{"type":"retweeted","id":"200522953102868481"}],"text":"RT @beuctweet: BEUC celebrates 50th anniversary - http://t.co/ZUkQI7hU - but what is the future in consumer policy?join discussions thro ...","id":"200542459216928768","lang":"en","created_at":"2012-05-10T11:07:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/HyoJm8Vj","expanded_url":"http://bit.ly/JdxDnf","display_url":"bit.ly/JdxDnf"}]},"source":"Twitter Web Client","conversation_id":"200541232559161344","referenced_tweets":{},"text":"We've made some improvements to our website: more RSS feeds, a 5-star feedback mechanism, downloadable search results: http://t.co/HyoJm8Vj","id":"200541232559161344","lang":"en","created_at":"2012-05-10T11:02:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200515410561470464","referenced_tweets":[{"type":"retweeted","id":"200504241922654208"}],"text":"RT @Aifa_ufficiale: Farmacista 33 parla della campagna web di sensibilizzazione sull'uso appropriato degli antibiotici lanciata dall'AIF ...","id":"200515410561470464","lang":"it","created_at":"2012-05-10T09:19:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":55,"end":66,"username":"MarMalagut","id":"368821278"},{"start":68,"end":83,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":46,"end":51,"tag":"AIFA"},{"start":122,"end":134,"tag":"antibiotici"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"200515385903169536","referenced_tweets":[{"type":"retweeted","id":"200503461006163968"}],"text":"RT @Aifa_ufficiale: Farmacista 33 su campagna #AIFA RT @MarMalagut: @Aifa_ufficiale Nuova campagna sul corretto uso degli #antibiotici:  ...","id":"200515385903169536","lang":"it","created_at":"2012-05-10T09:19:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":29,"end":34,"username":"rivm","id":"35527415"}],"hashtags":[{"start":13,"end":18,"tag":"ECDC"},{"start":20,"end":24,"tag":"RKI"},{"start":60,"end":74,"tag":"Schmallenberg"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199893160757964802","referenced_tweets":[{"type":"retweeted","id":"199887773380001792"}],"text":"RT @ECDC_EU: #ECDC, #RKI and @rivm joint risk assessment on #Schmallenberg virus: very unlikely that it poses a risk to humans. http://t ...","id":"199893160757964802","lang":"en","created_at":"2012-05-08T16:06:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":80,"end":100,"url":"http://t.co/HyoJm8Vj","expanded_url":"http://bit.ly/JdxDnf","display_url":"bit.ly/JdxDnf"}]},"source":"bitly bitlink","conversation_id":"199881154818609152","referenced_tweets":{},"text":"We've upgraded our website with new features, based on feedback from our users: http://t.co/HyoJm8Vj","id":"199881154818609152","lang":"en","created_at":"2012-05-08T15:19:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":88,"end":93,"tag":"AIFA"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199864397441671168","referenced_tweets":[{"type":"retweeted","id":"199863425759854594"}],"text":"RT @Aifa_ufficiale: \"Antibiotici? Usali solo quando necessario\"  online la campagna web #AIFA per l'uso appropriato degli antibiotici\nht ...","id":"199864397441671168","lang":"it","created_at":"2012-05-08T14:12:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199863992242544640","referenced_tweets":[{"type":"retweeted","id":"199846893994520576"}],"text":"RT @Aifa_ufficiale: “ANTIBIOTICI? USALI SOLO QUANDO NECESSARIO”\nIl consumo inappropriato ed eccessivo di antibiotici e lo sviluppo... ht ...","id":"199863992242544640","lang":"it","created_at":"2012-05-08T14:11:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":118,"end":138,"url":"http://t.co/NXhg8bYQ","expanded_url":"http://bit.ly/KzOK8s","display_url":"bit.ly/KzOK8s"}]},"source":"Twitter Web Client","conversation_id":"199863770485497856","referenced_tweets":{},"text":"We are closed tomorrow, 9 May. We have an out-of-hours phone number for problems with centrally authorised medicines: http://t.co/NXhg8bYQ","id":"199863770485497856","lang":"en","created_at":"2012-05-08T14:10:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/NXhg8bYQ","expanded_url":"http://bit.ly/KzOK8s","display_url":"bit.ly/KzOK8s"}]},"source":"Twitter Web Client","conversation_id":"199826427909120002","referenced_tweets":{},"text":"Our offices are closed tomorrow. We have an emergency phone number for problems with centrally authorised medicines: http://t.co/NXhg8bYQ","id":"199826427909120002","lang":"en","created_at":"2012-05-08T11:41:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":68,"end":77,"username":"PLS_NORD","id":"336147969"},{"start":78,"end":92,"username":"rarediseaseuk","id":"274030199"},{"start":93,"end":107,"username":"GeneticAll_UK","id":"413849446"},{"start":108,"end":121,"username":"barretstown1","id":"2192061559"},{"start":122,"end":131,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":37,"tag":"raredisease"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199773115578986496","referenced_tweets":[{"type":"retweeted","id":"198391010483638272"}],"text":"RT @eurordis: Come to EU #raredisease conference to hear views from @PLS_NORD @rarediseaseuk @GeneticAll_UK @Barretstown1 @EMA_News http ...","id":"199773115578986496","lang":"en","created_at":"2012-05-08T08:09:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"hashtags":[{"start":47,"end":55,"tag":"WDD2012"}],"annotations":{},"urls":[{"start":95,"end":115,"url":"http://t.co/NZZoQlIH","expanded_url":"http://bit.ly/mRYAjo","display_url":"bit.ly/mRYAjo"}]},"source":"TweetDeck","conversation_id":"199772092420456448","referenced_tweets":[{"type":"retweeted","id":"199772017027854336"}],"text":"RT @WDD: On Monday, May 14 we will launch the  #WDD2012 Campaign! Subscribe to our newsletter! http://t.co/NZZoQlIH","id":"199772092420456448","lang":"en","created_at":"2012-05-08T08:05:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":33,"end":53,"url":"http://t.co/NXhg8bYQ","expanded_url":"http://bit.ly/KzOK8s","display_url":"bit.ly/KzOK8s"}]},"source":"bitly bitlink","conversation_id":"199530974814543872","referenced_tweets":{},"text":"We're closed on Wednesday 9 May: http://t.co/NXhg8bYQ","id":"199530974814543872","lang":"en","created_at":"2012-05-07T16:07:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"urls":[{"start":59,"end":79,"url":"http://t.co/oohUAVq2","expanded_url":"http://bit.ly/LvqqDW","display_url":"bit.ly/LvqqDW"}]},"source":"TweetDeck","conversation_id":"199508913014587392","referenced_tweets":[{"type":"retweeted","id":"199508696051617792"}],"text":"RT @LV_MPA: Månadsrapport från CHMP och PhVWP (april 2012) http://t.co/oohUAVq2","id":"199508913014587392","lang":"sv","created_at":"2012-05-07T14:40:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":20,"end":29,"tag":"Diabetes"}],"annotations":{},"urls":[{"start":60,"end":80,"url":"http://t.co/cV6PXnrC","expanded_url":"http://nyti.ms/J89Cjd","display_url":"nyti.ms/J89Cjd"}]},"source":"TweetDeck","conversation_id":"199482369483350017","referenced_tweets":[{"type":"retweeted","id":"199478499566829569"}],"text":"RT @IntDiabetesFed: #Diabetes is no longer an ‘adult-onset’ http://t.co/cV6PXnrC @nytimeshealth","id":"199482369483350017","lang":"en","created_at":"2012-05-07T12:54:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"unicefceecis","id":"864326555526348802"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199481944306757632","referenced_tweets":[{"type":"retweeted","id":"199449065723924481"}],"text":"RT @unicefceecis: Join us! WHO - UNICEF- ECDC invites you to Live QnA on EIW site on Thursday 10 May on building trust in immunization.  ...","id":"199481944306757632","lang":"en","created_at":"2012-05-07T12:52:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":54,"end":62,"username":"ECDC_EU","id":"204752573"},{"start":67,"end":80,"username":"unicefceecis","id":"864326555526348802"}],"hashtags":[{"start":122,"end":131,"tag":"vaccines"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"199481901545824257","referenced_tweets":[{"type":"retweeted","id":"199448556329902080"}],"text":"RT @WHO_Europe_VPI: Join us this Thursday, along with @ECDC_EU and @unicefceecis, for a live Q&amp;A on building trust in #vaccines http ...","id":"199481901545824257","lang":"en","created_at":"2012-05-07T12:52:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"IATDMCT","id":"488649401"}],"hashtags":{},"annotations":{},"urls":[{"start":112,"end":132,"url":"http://t.co/HheQdgxL","expanded_url":"http://bit.ly/Ky7qFR","display_url":"bit.ly/Ky7qFR"}]},"source":"TweetDeck","conversation_id":"199449034325360641","referenced_tweets":[{"type":"retweeted","id":"199410207196053504"}],"text":"RT @IATDMCT: European Medicines Agency guideline on bioanalytical method validation: what more is there to say? http://t.co/HheQdgxL","id":"199449034325360641","lang":"en","created_at":"2012-05-07T10:42:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"EUDevNews","id":"327327578"}],"hashtags":{},"annotations":[{"start":15,"end":32,"probability":0.5601,"type":"Person","normalized_text":"Commissioner Dalli"}],"urls":[{"start":83,"end":103,"url":"http://t.co/i6GeBh52","expanded_url":"http://bit.ly/IwLacI","display_url":"bit.ly/IwLacI"}]},"source":"TweetDeck","conversation_id":"198065919535230976","referenced_tweets":[{"type":"retweeted","id":"198005452246745089"}],"text":"RT @EUDevNews: Commissioner Dalli launches the 4th EU Health Prize for Journalists http://t.co/i6GeBh52","id":"198065919535230976","lang":"en","created_at":"2012-05-03T15:06:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":32,"end":35,"tag":"EU"},{"start":36,"end":43,"tag":"health"}],"annotations":[{"start":17,"end":21,"probability":0.8415,"type":"Person","normalized_text":"HEIDI"},{"start":105,"end":112,"probability":0.9851,"type":"Place","normalized_text":"Brussels"}],"urls":{}},"source":"TweetDeck","conversation_id":"198065636784619520","referenced_tweets":[{"type":"retweeted","id":"198050087610494977"}],"text":"RT @EU_Consumer: HEIDI, the new #EU #health information &amp; data wiki released at high level conference in Brussels today. http://t.co ...","id":"198065636784619520","lang":"en","created_at":"2012-05-03T15:05:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"198064895349100544","referenced_tweets":[{"type":"retweeted","id":"198064397611048960"}],"text":"RT @euparkinsons: MHRA seizes more than £25 million of counterfeit medicine in last 5 years as new anti-counterfeiting strategy launches ...","id":"198064895349100544","lang":"en","created_at":"2012-05-03T15:02:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":19,"username":"Translate_Blogs","id":"343554519"},{"start":121,"end":134,"username":"GxP_Services","id":"258279900"}],"hashtags":{},"annotations":[{"start":21,"end":45,"probability":0.6137,"type":"Organization","normalized_text":"European Medicines Agency"}],"urls":[{"start":97,"end":117,"url":"http://t.co/n6gvSATG","expanded_url":"http://bit.ly/IoSWBI","display_url":"bit.ly/IoSWBI"}]},"source":"TweetDeck","conversation_id":"198061984795738114","referenced_tweets":[{"type":"retweeted","id":"198050980309385216"}],"text":"RT @Translate_Blogs: European Medicines Agency publishes new versions of controlled vocabularies http://t.co/n6gvSATG by @GxP_Services","id":"198061984795738114","lang":"en","created_at":"2012-05-03T14:50:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":34,"end":42,"tag":"doctors"},{"start":56,"end":68,"tag":"vaccination"},{"start":118,"end":135,"tag":"EuropeDoctorMeet"}],"annotations":{},"urls":[{"start":69,"end":89,"url":"http://t.co/QheHT0hg","expanded_url":"http://bit.ly/IkWt69","display_url":"bit.ly/IkWt69"}]},"source":"TweetDeck","conversation_id":"197996883740860417","referenced_tweets":[{"type":"retweeted","id":"197986905562955778"}],"text":"RT @ECDC_EU: Programme on role of #doctors in childhood #vaccination http://t.co/QheHT0hg Join the live tweet, follow #EuropeDoctorMeet  ...","id":"197996883740860417","lang":"en","created_at":"2012-05-03T10:31:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":{},"urls":[{"start":58,"end":78,"url":"http://t.co/nRMTJfN5","expanded_url":"http://bit.ly/Iola0z","display_url":"bit.ly/Iola0z"}]},"source":"TweetDeck","conversation_id":"197962077300727808","referenced_tweets":[{"type":"retweeted","id":"197961834106601473"}],"text":"RT @eurordis: Patients have say in the future of research http://t.co/nRMTJfN5","id":"197962077300727808","lang":"en","created_at":"2012-05-03T08:13:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":13,"end":37,"tag":"AntimicrobialResistance"},{"start":90,"end":103,"tag":"PublicHealth"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"197959354073358336","referenced_tweets":[{"type":"retweeted","id":"197959046190473216"}],"text":"RT @EPHA_EU: #AntimicrobialResistance has been described as one of the biggest threats to #PublicHealth. Know what can be done at: http: ...","id":"197959354073358336","lang":"en","created_at":"2012-05-03T08:02:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":42,"end":51,"tag":"advanced"}],"annotations":{},"urls":[{"start":114,"end":134,"url":"http://t.co/ZfVJOGNZ","expanded_url":"http://bit.ly/IPGe0N","display_url":"bit.ly/IPGe0N"}]},"source":"Twitter Web Client","conversation_id":"197679679942037505","referenced_tweets":{},"text":"Our reflection paper on classification of #advanced-therapy medicines is open for comments until the end of July: http://t.co/ZfVJOGNZ","id":"197679679942037505","lang":"en","created_at":"2012-05-02T13:31:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":97,"end":102,"tag":"AIFA"},{"start":103,"end":113,"tag":"sicurezza"}],"annotations":{},"urls":[{"start":117,"end":137,"url":"http://t.co/75uPI6zS","expanded_url":"http://fb.me/1dKgqM9qI","display_url":"fb.me/1dKgqM9qI"}]},"source":"TweetDeck","conversation_id":"197679323094859777","referenced_tweets":[{"type":"retweeted","id":"197676499590057985"}],"text":"RT @Aifa_ufficiale: Nuove raccomandazioni per i pazienti in trattamento con Gilenya (fingolimod) #AIFA #sicurezza... http://t.co/75uPI6zS","id":"197679323094859777","lang":"it","created_at":"2012-05-02T13:29:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":37,"end":40,"probability":0.5106,"type":"Organization","normalized_text":"MHRA"}],"urls":{}},"source":"TweetDeck","conversation_id":"197679287103520768","referenced_tweets":[{"type":"retweeted","id":"197678276750217217"}],"text":"RT @MHRAGovUkPress: Find out why the MHRA have launched a new strategy on combating counterfeit medical products by watching this video  ...","id":"197679287103520768","lang":"en","created_at":"2012-05-02T13:29:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":24,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":46,"end":61,"tag":"immunizeEurope"},{"start":95,"end":107,"tag":"vaccination"},{"start":108,"end":123,"tag":"ImmunizeEurope"}],"annotations":{},"urls":[{"start":74,"end":94,"url":"http://t.co/aP0sMRJq","expanded_url":"http://bit.ly/KnLwyw","display_url":"bit.ly/KnLwyw"}]},"source":"TweetDeck","conversation_id":"197668631600050178","referenced_tweets":[{"type":"retweeted","id":"197667745570099200"}],"text":"RT @ECDC_EU: @WHO_Europe: Summary of our chat #immunizeEurope now online! http://t.co/aP0sMRJq #vaccination #ImmunizeEurope","id":"197668631600050178","lang":"en","created_at":"2012-05-02T12:47:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":55,"end":64,"tag":"advanced"}],"annotations":{},"urls":[{"start":108,"end":128,"url":"http://t.co/ZfVJOGNZ","expanded_url":"http://bit.ly/IPGe0N","display_url":"bit.ly/IPGe0N"}]},"source":"Twitter Web Client","conversation_id":"197612234782937088","referenced_tweets":{},"text":"We've released a reflection paper on classification of #advanced-therapy medicines for public consultation: http://t.co/ZfVJOGNZ","id":"197612234782937088","lang":"en","created_at":"2012-05-02T09:03:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":[{"start":74,"end":83,"tag":"advanced"}],"annotations":{},"urls":[{"start":103,"end":123,"url":"http://t.co/ZfVJOGNZ","expanded_url":"http://bit.ly/IPGe0N","display_url":"bit.ly/IPGe0N"}]},"source":"bitly bitlink","conversation_id":"197012809572294656","referenced_tweets":{},"text":"Please send us your comments on our reflection paper on classification of #advanced-therapy medicines: http://t.co/ZfVJOGNZ","id":"197012809572294656","lang":"en","created_at":"2012-04-30T17:21:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":11,"end":30,"probability":0.7839,"type":"Other","normalized_text":"World Veterinary Day"}],"urls":[{"start":80,"end":100,"url":"http://t.co/breMiKH6","expanded_url":"http://bit.ly/JrlDl5","display_url":"bit.ly/JrlDl5"}]},"source":"Twitter Web Client","conversation_id":"196964896922009600","referenced_tweets":{},"text":"We support World Veterinary Day. This year's theme is antimicrobial resistance: http://t.co/breMiKH6","id":"196964896922009600","lang":"en","created_at":"2012-04-30T14:11:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":26,"end":35,"probability":0.6167,"type":"Other","normalized_text":"Labour Day"}],"urls":[{"start":118,"end":138,"url":"http://t.co/iVb9iVTa","expanded_url":"http://bit.ly/JrjXba","display_url":"bit.ly/JrjXba"}]},"source":"Twitter Web Client","conversation_id":"196964724674527235","referenced_tweets":{},"text":"We're closed tomorrow for Labour Day. Emergency number for out-of-hours problems with centrally authorised medicines: http://t.co/iVb9iVTa","id":"196964724674527235","lang":"en","created_at":"2012-04-30T14:10:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":111,"end":131,"url":"http://t.co/LI9twTlF","expanded_url":"http://bit.ly/JK8l5s","display_url":"bit.ly/JK8l5s"}]},"source":"Twitter Web Client","conversation_id":"196964572563906560","referenced_tweets":{},"text":"Updated vocabularies for Article 57(2) requirements on submitting information on medicines are on our website: http://t.co/LI9twTlF","id":"196964572563906560","lang":"en","created_at":"2012-04-30T14:09:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":90,"end":110,"url":"http://t.co/66L2xpfz","expanded_url":"http://bit.ly/JK85DJ","display_url":"bit.ly/JK85DJ"}]},"source":"Twitter Web Client","conversation_id":"196964372378169344","referenced_tweets":{},"text":"In March, our committee for herbal medicines issued its 100th herbal Community monograph: http://t.co/66L2xpfz","id":"196964372378169344","lang":"en","created_at":"2012-04-30T14:09:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":42,"end":54,"username":"CPME_EUROPA","id":"440810430"}],"hashtags":[{"start":13,"end":31,"tag":"EuropeDoctorsMeet"}],"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"196904842214637570","referenced_tweets":[{"type":"retweeted","id":"196904484377604096"}],"text":"RT @ECDC_EU: #EuropeDoctorsMeet: ECDC and @CPME_Europa will be tweeting live on 4 May. Our topic: childhood vaccination &amp; role of do ...","id":"196904842214637570","lang":"en","created_at":"2012-04-30T10:12:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":0,"end":12,"username":"AliceBlezat","id":"368277484"}],"hashtags":{},"annotations":{},"urls":{}},"source":"TweetDeck","conversation_id":"196879292360179713","referenced_tweets":[{"type":"replied_to","id":"196879292360179713"}],"text":"@AliceBlezat Thanks for your tweet. Please email your question to info@ema.europa.eu so that we can respond to you directly.","id":"196883977003470849","lang":"en","created_at":"2012-04-30T08:49:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"368277484"},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":[{"start":11,"end":30,"probability":0.7736,"type":"Other","normalized_text":"World Veterinary Day"}],"urls":[{"start":33,"end":53,"url":"http://t.co/breMiKH6","expanded_url":"http://bit.ly/JrlDl5","display_url":"bit.ly/JrlDl5"}]},"source":"Twitter Web Client","conversation_id":"196870721652264960","referenced_tweets":{},"text":"We support World Veterinary Day: http://t.co/breMiKH6","id":"196870721652264960","lang":"en","created_at":"2012-04-30T07:56:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":113,"end":133,"url":"http://t.co/iVb9iVTa","expanded_url":"http://bit.ly/JrjXba","display_url":"bit.ly/JrjXba"}]},"source":"Twitter Web Client","conversation_id":"196870636616941568","referenced_tweets":{},"text":"Our offices are closed tomorrow. Emergency number for out-of-hours problems with centrally authorised medicines: http://t.co/iVb9iVTa","id":"196870636616941568","lang":"en","created_at":"2012-04-30T07:56:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":87,"end":107,"url":"http://t.co/LI9twTlF","expanded_url":"http://bit.ly/JK8l5s","display_url":"bit.ly/JK8l5s"}]},"source":"Twitter Web Client","conversation_id":"196870386498023424","referenced_tweets":{},"text":"Last week, we updated the vocabularies used to comply with Article 57(2) requirements: http://t.co/LI9twTlF","id":"196870386498023424","lang":"en","created_at":"2012-04-30T07:55:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":{},"hashtags":{},"annotations":{},"urls":[{"start":70,"end":90,"url":"http://t.co/66L2xpfz","expanded_url":"http://bit.ly/JK85DJ","display_url":"bit.ly/JK85DJ"}]},"source":"Twitter Web Client","conversation_id":"196870221104029698","referenced_tweets":{},"text":"Our herbal committee has issued its 100th herbal Community monograph: http://t.co/66L2xpfz","id":"196870221104029698","lang":"en","created_at":"2012-04-30T07:54:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":17,"username":"joaocarapinha","id":"39525118"}],"hashtags":{},"annotations":{},"urls":[{"start":119,"end":139,"url":"http://t.co/oyd5chxU","expanded_url":"http://bit.ly/InpQra","display_url":"bit.ly/InpQra"}]},"source":"TweetDeck","conversation_id":"196869950927933441","referenced_tweets":[{"type":"retweeted","id":"195950981903695872"}],"text":"RT @joaocarapinha: European Medicines Agency’s Scientific Coordination Board Starts Reflection On Best Cooperation ... http://t.co/oyd5chxU","id":"196869950927933441","lang":"en","created_at":"2012-04-30T07:53:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"entities":{"mentions":[{"start":3,"end":13,"username":"shakulbio","id":"54853071"}],"hashtags":{},"annotations":[{"start":15,"end":39,"probability":0.4754,"type":"Organization","normalized_text":"European Medicines Agency"}],"urls":{}},"source":"TweetDeck","conversation_id":"196869848201039874","referenced_tweets":[{"type":"retweeted","id":"195923861966045184"}],"text":"RT @shakulbio: European Medicines Agency publishes new versions of controlled vocabularies used to comply with Article 57 (2)...: http:/ ...","id":"196869848201039874","lang":"en","created_at":"2012-04-30T07:53:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}}]
